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1.1 The freshwater polyp Hydra  
In Greek mythology Hydra was described as a nine-headed monster with eight mortal heads 
and one immortal. When Heracles cut away one head, two heads were regenerated.  
The freshwater polyp of the genus Hydra was first described by van Leeuwenhoek in 1702 
(van Leeuwenhoek, 1702), but shares no similarities with this mystical beast except for its 
high regeneration capacity (Bosch, 2007).  
The sessile Hydra polyps vary from 0.5 to 3cm in size and are found ubiquitary in freshwater 
ponds and lakes, where they feed on insect larvae and small crustaceans, such as Daphnia.  
Representatives of the genus Hydra belong to the phylum of Cnidaria which is proposed to be 
a sister group of the bilateria (Collins, 2002; Martindale et al., 2002; Philippe et al., 2005; 
Putnam et al., 2007) (see Figure 1.1).  
 
 
Figure 1.1: A schematic phylogenetic tree of the animal kingdom.  
The Porifera are a sister group to all Eumetazoans. The Cnidaria represent a sister group to all Bilateria. Within 
the Cnidaria, five classes are defined: the basal class of Anthozoa; the class of Staurozoa; the Cubozo; the 
Scyphozoa; and the Hydrozoa. Included are some representatives of the various taxa. (Schematic drawing of 





In contrast to Porifera, Cnidaria, as one of the most basal representatives of eumetazoans, 
possess true tissues connected by tight junctions, sensory, nerve and muscle cells, a gastric 
cavity and a blastoporus (Nielsen et al., 1996). In contrast to the triploblastic bilateria that are 
composed of endodermal, ectodermal and mesodermal germ layers the diploblastic Cnidaria 
lack the mesoderm resulting in one oral-aboral axis and a radial symmetrical body.  
Within the Cnidaria, two alternating forms of differentiation can occur; the polyp being 
attached to the substratum and the free-floating medusa.  
All Cnidaria are characterized by their phylotypic feature; the presence of the cnidocyte 
(nematocyte) for capturing prey (Tardent, 1995).  
The Cnidaria are subdivided into five classes: the most basal class of Anthozoa, including the 
corals and the sea anemones, followed by the classes of Staurozoa, Scyphozoa, Cubozoa and 
Hydrozoa, to which Hydra spec. belongs (Collins et al., 2006). 
Because of the complexity of their cnidocytes, their nervous system, their developmental 
lifecycles, and their ectodermal gonads the Hydrozoans are referred to as the most derived but 
secondary reduced class (Collins et al., 2006; Steele, 2002).  
Using two nuclear and two mitochondrial marker genes as well as morphological criteria, e.g. 
the appearance of different holotrichous isorhizas, a special type of cnidocyte, the phylogeny 
of several Hydra species commonly used as model organisms was determined by Hemmrich 
and colleagues. (Hemmrich et al., 2007a) (see Figure 1.2). 
 
 
Figure 1.2: Phylogenetic relations within the genus Hydra.  
The tree includes molecular and morphological data with a schematic drawing of holotrichous isorhizas of the 




The species Hydra viridissima forms a symbiotic association with unicellular algae of the 
genus Chlorella spec. (Habetha et al., 2003; Oschman, 1967) and is located at the base of this 
phylogenetic tree followed by Hydra circumcincta, the stalk-possessing group of Hydra 
robusta and Hydra oligactis, the group consisting of Hydra carnea and the laboratory strain 
of Hydra vulgaris (AEP) (Martin et al., 1997) and the most derived group of Hydra vulgaris 
and Hydra magnipapillata.  
Because of the already mentioned basal placement in the animal tree of life, its simple body 
structure, its high regeneration capacity, the easy cultivation and the short reproduction times 
leading to clonal cultures, Hydra has been a classical study object for a variety of biological 
questions, like axial patterning (Gierer and Meinhardt, 1972; Meinhardt and Gierer, 1974; 
Meinhardt and Gierer, 2000), stem cell behaviour (Bosch et al., 2010; Bosch and David, 
1987) and regeneration (Bosch, 2007).  
The stable transfection of the strain Hydra vulgaris (AEP) that frequently undergoes sexual 
reproduction is now possible via microinjection into the developing embryo (Wittlieb et al., 
2006). This provides new possibilities for the functional characterization of ancient 
defensome genes. 
In 2010 the genome of Hydra magnipapillata was published (Chapman et al., 2010) and as 
well as an EST-library of Hydra magnipapillata is available, 454 second generation 
technology was used to generate transcriptome datasets of Hydra oligactis, Hydra viridis and 
Hydra vulgaris (AEP) (AG Bosch, unpublished data). These datasets provide new important 
tools for comparative research on Hydra. Not only Hydra was a subject for extensive genome 
and transcriptome sequencing, EST databases that are available for many additional cnidarian 
species and the sequencing of the genome of the anthozoan Nematostella vectensis provide 
new possibilities for comparative research on these ancestral animals (Putnam et al., 2007). 
 
1.1.1 Hydra’s morphology  
Hydra’s body plan is simple and can be subdivided into three parts along the oral-aboral axis: 
(i) the head region made up of four to twelve tentacles used to capture prey surrounding the 
hypostome with the mouth; (ii) the tube-like body column on which gonads and buds are 
formed; and (iii) the foot region that constitutes a basal disc for the attachment to the 
substrate, depending on the species that may or may not possess a stalk (see Figure 1.3).  
Hydra’s actinomorphic body is made up of two monolayered epithelia; the ectoderm at the 
outside that secretes a glycocalyx as an outer surface and the endoderm that surrounds the 
gastric cavity. The glycocalyx is supposed to contribute to the protection of the animal against 





Figure 1.3: Morphology and life cycle of Hydra.  
(A) Schematic drawing of Hydra including a detailed view on a histological longitudinal section. Abbreviations: 
end epi (endodermal epithelial cell); gland (gland cell); i cell (interstitial cell); ect epi (ectodermal epithelial 
cell); m (mesogloea); ect (ectoderm); end (endoderm). (Taken from Bosch, 2007). (B) Life cycle of Hydra. The 
freshwater polyp can either reproduce asexually by budding or sexually by forming gametes. Budding is the 
prevalent form. (Modified from Bosch, 2009b).  
 
Within the gastric cavity the extracellular digestion of food is performed via peristalsis. In 
addition to prey, potential pathogenic microorganisms can be ingested as well. Both epithelial 
layers secrete the mesogloea, a thin extracellular matrix separating the two tissue layers and 
providing stability and elasticity to the polyp. Hydra possesses three independent stem cell 
lines that contribute to these tissues: the ectodermal epithelial cells, the endodermal epithelial 
cells and the interstitial cells (Bosch, 2009b; Bosch et al., 2010).  
The body shape is predetermined by the epithelio-muscle cells of both tissue layers. The 
ectodermal epithelial cells of the basal disc can secrete mucus for the attachment to the 
substrate. The endodermal epithelial cells are ciliated and phagocytise the pre-digested food 
particles and distribute the nutrients to the entire animal. The interstitial stem cell lineage 
gives rise to several derivatives: (i) the nerve cells forming a diffuse net within the entire body 
(Bode et al., 1973); (ii) the endodermally located gland cells secreting mucus and digestive 
enzymes to the gastric cavity; (iii) the different types of nematocytes that are formed by 
proliferating and differentiating nests of nematoblasts and are taken up in the tentacles by a 
specially differentiated type of ectodermal epithelial cell, the battery cell, harbouring 8 to 24 
cnidocytes (Campbell, 1987; Slautterback, 1967; Wood and Novak, 1982); and (iv) the 
ectodermally located germ cells.  
Asexual budding is the primary mode of reproduction in Hydra. The Hydra tissue is subjected 




(Campbell, 1967). The amount of new cells is tightly linked to the feeding conditions (Bosch 
and David, 1984). The polyp’s cells are permanently in a steady state equilibrium and the 
excess of tissue is displaced into the bud that is formed in the lower part of the body column. 
Under optimal feeding conditions the polyps can form one bud per three days.  
As well as by budding Hydra can also reproduce sexually through the formation of 
ectodermally-located testis and oocytes (Bosch and David, 1987; Littlefield, 1985; Littlefield, 
1991). Different species can be hermaphroditic or dioecious (Hemmrich et al., 2007a). The 
formation of gametes can be induced by environmental changes, e.g. the reduction of the 
temperature in Hydra oligactis (Littlefield, 1991) or withholding of food in Hydra vulgaris 
(AEP) (Bosch and David, 1987; Sugiyama and Fujisawa, 1977).  
In Hydra there is experimental evidence that no separated germ line is present (Bosch and 
David, 1987). The multipotent interstitial stem cells that give rise to the somatic derivatives 
also give rise to a germline restricted population of stem cells (Bosch and David, 1987; 
Littlefield, 1985; Littlefield, 1991). This population is also maintained in sexually 
undifferentiated polyps (Holstein and David, 1990) (see Figure 1.4).  
Spermatogenesis starts with a local proliferation of the interstitial cells at the area of the 
future testis leading to a swelling of the ectodermal tissue and a subsequent lifting of the 
covering epithelial cells that will form the outer wall of the testis (Tardent, 1974). The 
clusters of accumulated interstitial cells synchronously undergo meiotic divisions. The 
subsequent differentiation processes result in cell layers of differentiation stages within the 
intercellular space between the mesogloea and the epithelial cells (Munck and David, 1985).  
Different Hydra species can form one or several oocytes simultaneously. During oogenesis, 
the egg-restricted interstitial cells aggregate and proliferate beneath the ectodermal epithelial 
cells giving rise to a cluster of several thousand cells (Honegger et al., 1989). Transplantation 
experiments have shown that many of these cells have the potency to differentiate into the 
oocyte (Miller et al., 2000), but only one centrally located cell is selected by an unknown 
mechanism to become the oocyte. After the determination of the oocyte the surrounding 
interstitial cells differentiate into nurse cells. These nurse cells accumulate nutrients, like 
lipids and glycogen, and undergo an apoptotic program that is arrested during embryogenesis, 
characterized by condensed chromatin and DNA fragmentation into large pieces of 8-15 kb in 
length, completed after hatching of the offspring (Honegger et al., 1989; Technau et al., 
2003). This apoptotic program starts during phagocytosis of the nurse cells by the developing 
oocyte that dramatically increases in size resulting in a large amoeboid symplastic egg. The 
nurse cells are incorporated into the cytoplasm and persist in the developing embryo up to 
several months until the new polyp hatches (Technau et al., 2003). Although the nurse cells 




mature egg breaks through the covering ectodermal epithelial cells and forms a sphere at the 
outer surface of the mother polyp where it is fertilized and embryogenesis is committed. The 
embryo develops within the egg without any larval state. 
 
 
Figure 1.4: The interstitial cell lineage of Hydra.  
(A) Model of the multipotent interstitial stem cell line; the stem cells give rise to nematocytes, gland cells, nerve 
cells and germline restricted unipotent stem cells. Environmental stimuli can induce gamete formation. Male 
differentiation can suppress female differentiation. (Modified after Fraune, 2008; Littlefield, 1991) (B) 
Oogenesis in Hydra starting with the accumulation of germline restricted female interstitial cells and the 
determination of the future oocyte. The oocyte (grey) grows and phagocytoses the surrounding cells that 
differentiate into nurse cells. (Modified from Holstein and Emschermann, 1995). 
 
As a limnic organism Hydra is in permanent contact with its surrounding potential pathogenic 
microorganisms like protists, fungi, oomycetes, bacteria and viruses. To inhibit an overgrowth 





1.2 An introduction into immunity  
For each living organism it is of tremendous importance to distinguish self from nonself and 
to recognize pathogens or degenerated cells to initiate various defence strategies for the 
protection of its survival and reproduction (Khalturin and Bosch, 2007; Rosenstiel et al., 
2009).  
In Homo sapiens and other jawed vertebrates the adaptive and the innate arm of the immune 
system can be distinguished (Khalturin and Bosch, 2007; Rosenstiel et al., 2007). The defence 
mechanisms of the adaptive immune response are relatively slow, but highly specific and 
mediate an immune memory that protects the organism against attacks of the same pathogen 
in the future (Cooper and Alder, 2006). In contrast to that, the innate immune response is 
activated fast and therefore the first line of defence confronting the pathogen. The repertoire 
of proteins contributing to innate immunity is relatively limited but directed against a broad 
spectre of pathogens (Beutler, 2004). The innate immune response does not lead to an 
immune memory and relies on germline-encoded receptors (Takeuchi and Akira, 2010). 
Many components of the innate immune defence are conserved among all eukaryotes 
(Hemmrich et al., 2007b; Hibino et al., 2006; Rosenstiel et al., 2009).  
The first line of defence is represented by the epithelia that separate an organism from its 
environment (Schreiber et al., 2005). The epithelial cells are tightly interconnected by cellular 
junctions and act as a physical barrier. In addition, migrating phagocytes take up invading 
pathogens and infected cells. Both cells use receptors that can recognize components that are 
conserved in many potentially pathogenic but also commensal microbes and are therefore 
called “microbe associated molecular patterns” or MAMPs (Takeuchi and Akira, 2010). 
These include for example lipopolysaccharide (LPS), flagellin, CpG-DNA or bacterial cell 
wall components like muramyl dipeptide (MDP). Furthermore, these “pattern recognition 
receptors” (PRRs) are also capable of recognizing endogenous molecules released from 
damaged cells termed damage associated molecular patterns (DAMPs) (Takeuchi and Akira, 
2010). The PRRs mediate immune responses through signal transduction cascades leading to 
the induction of defence mechanisms such as the onset of inflammation to recruit further 
immune cells through the production and release of proinflammatory cytokines, type I 
interferons (IFNs) and chemokines or the production and secretion of effector proteins with 
an inhibitory or killing activity against microbes, the antimicrobial peptides (AMPs) 
(Takeuchi and Akira, 2010).  
A persistent inflammatory response may also be the cause for tumour formation and the 
development of cancer as a last consequence via an accumulation of gain-of-function and 




homolog (KRAS) or myelocytomatosis viral oncogene homolog (MYC) or in tumour 
suppressor genes like adenomatous polyposis coli (APC) or tumor protein p53 (TP53) through 
the production of radical oxygen species (ROS) as a result of inflammation (Grivennikov et 
al., 2010).  
In addition to the cellular mediated innate immune reactions a humoral innate immunity is 
represented by the plasma proteins of the complement system (Beutler, 2004). 
 
1.2.1 The innate pattern recognition receptors 
In mammals four families of PRRs have been identified that can be divided into two groups: 
the (i) transmembrane proteins of the C-type lectin receptors (CLRs) and the Toll-like 
receptors (TLRs); the (ii) intracellular located RIG-I-like receptors (RLRs) and the NOD-like 
receptors (NLRs) (Takeuchi and Akira, 2010).  
The C-type lectin receptors are characterized by the presence of a carbohydrate-binding 
domain. With the help of that domain they recognize carbohydrates on microorganisms, such 
as viruses, bacteria and fungi, and stimulate the production of proinflammatory cytokines or 
inhibit TLR-mediated immune complexes (Geijtenbeek and Gringhuis, 2009). 
The Retinoic acid-inducible gene (RIG)-I-like receptors are composed of two N-terminal 
caspase recruitment domains (CARDs), a central DEAD box helicase/ATPase domain and a 
C-terminal regulatory domain. Activation by e.g. RNA viruses leads to onset of the 
expression of type I IFN genes and to activation of nuclear factor of kappa light polypeptide 
gene enhancer in B-cells (NF-κB) via TRADD (Tumor necrosis factor receptor type 1-
associated via DEATH domain), FADD (Fas-associated via DEATH domain) and caspase 8 
or 10 (Kawai and Akira, 2006; Takeuchi and Akira, 2009). 
The well-characterized Toll-like receptors sense invading pathogens outside of the cell or in 
intracellular endosomes and lysosomes (Akira et al., 2006). They are characterized by  
N-terminal leucine-rich repeats (LRRs) and a transmembrane domain followed by a 
cytoplasmic Toll/ interleukin 1 receptor (IL1R) homology (TIR) domain. Ten TLRs have 
been identified in humans; each TLR can recognize particular MAMPs or DAMPs leading to 
transcriptional upregulation of distinct genes depending on the TLRs and cell types involved. 
Depending on the usage of distinct adaptor molecules TLR signalling can be divided into two 
pathways; the MyD88-dependent and the TRIF-dependent signalling pathway (Takeuchi and 
Akira, 2010). 
MyD88 (myeloid differentiation primary response gene 88) is composed of a DEATH domain 
(DD) and a TIR domain and interacts with the DD of the serine/treonine kinase interleukin-1 




activated protein (MAP) kinase signalling or the activation of NF-κB via TAK1, the IKK 
complex and IκB inducing the expression of cytokine genes and AMPs (Froy, 2005).  
TLR3 and TLR4 can use the adaptor protein TRIF (TIR domain-containing adaptor inducing 
IFN-β) to activate NF-κB and interferon regulatory factor (IRF) controlling the expression of 
proinflammatory cytokines and type-I IFN genes (Takeuchi and Akira, 2010). Via the 
cooperative binding of RIPK (receptor interacting serine-threonine protein kinase) 1 (Hsu et 
al., 1996; Stanger et al., 1995) and FADD (Chinnaiyan et al., 1995) and the activation of 
caspase 8, TRIF can induce apoptosis as well. In addition to the initiation of apoptosis 
caspase 8 can also contribute to the TLR-induced NF-κB activation (Maelfait and Beyaert, 
2008). 
 
1.2.2 The NOD-like receptors and their signal transduction cascades 
The family of NLRs comprises cytoplasmic PRRs (Rosenstiel et al., 2008). NLRs belong to 
the family of signal transduction ATPases with numerous domains (STAND) within the group 
of P-loop NTPases (Leipe et al., 2004). Two subgroups of NBD domain containing proteins 
are recognized; (i) the AP (apoptotic)-ATPases with e.g. APAF1 (apoptotic protease 
activating factor-1) (Zou et al., 1997), which harbour the NB-ARC domain (van der Biezen 
and Jones, 1998) and (ii) the NACHT-NTPases that are mostly represented by the bona fide 
NLRs, which contain a NACHT (domain present in neuronal apoptosis inhibitor protein 
(NAIP), the major histocompatibility complex (MHC) class II transactivator (CIITA), HET-E 
and telomerase associated protein 1 (TEP1)) domain (see Figure 1.5). 
 
 
Figure 1.5: The structure of a variety of NBD domain containing proteins.  
All NLRs have a tripartite domain architecture comprised of an N-terminal effector domain, a central NACHT 
domain and a C-terminal series of LRRs. They share structural similarities with the APAF1 homologues and 




NLRs are a complex family of tripartite receptors that have in common the eponymous central 
nucleotide-binding domain and oligomerization domain (NOD), synonymously called 
NACHT or NBD, and C-terminal LRRs (Schreiber et al., 2005). The mammalian NLRs are 
subdivided into five subfamilies based on the type of their N-terminal effector domain (Chen 
et al., 2009): NLRA and NLRB each with one human member, the first has a CARD domain 
with an acidic domain and the latter has three BIR (baculovirus inhibitor of apoptosis protein 
repeat) domains. The third group of NLRC contains five human members, each of them 
contains N-terminal CARD domains. To this group belong also the best characterized family 
members NOD1 (Bertin et al., 1999; Inohara et al., 1999) and NOD2 (Ogura et al., 2001b). 
The 14 members of the fourth and largest group are called NLRPs. All have in common an  
N-terminal Pyrin domain. The well characterized NLRP1 and NLRP3 belong to this family as 
well. The fifth group called NLRX contains one member with a not yet characterized  
N-terminal part.  
For some NLRs the minimal elicitors are known. NOD1 and NOD2 recognize peptidoglycan 
moieties secreted by bacteria (Chamaillard et al., 2003; Inohara et al., 2003). NLRP3 can 
recognize a broad spectrum of ligands including MAMPs, like LPS or MDP, but also 
chemicals, like silica or asbestos, and endogenous DAMPs, like uric acid crystals, suggesting 
that the agonists might not bind directly to the receptor, but need a co-receptor for recognition 
(Chen et al., 2009).  
Upon recognition of the elicitor by the LRRs, these proteins form large complexes by a 
conformational change of the LRRs that usually block the oligomerization of the receptors by 
masking the NACHT domain (Schreiber et al., 2005). The proteins self-oligomerize by the 
interactions of their NACHT domains (Inohara et al., 2000; Schroder and Tschopp, 2010). 
This brings the effector domains of these proteins in close proximity to each other, activating 
the protein complex to recruit downstream proteins via homophilic interactions of the effector 
domains, a mechanism that is termed “induced proximity” (Inohara et al., 2000). According 
to the identity of the activated NLR different complexes are formed leading to the activation 
of different signalling cascades. NOD1 and NOD2 form the NODosome with the CARD-
containing receptor-interacting serine-threonine kinase 2 (RIPK2) (Inohara et al., 2000; 
McCarthy et al., 1998; Ogura et al., 2001b). Similar to TLR signalling NF-κB is activated 
leading to the transcription of inflammatory cytokines and chemokines such as tumor necrosis 
factor (TNF)-α, IL6 and IL8 and antimicrobial peptides (Chen et al., 2009; Voss et al., 2006). 
Furthermore, the NODosome can also activate MAP kinase signalling including the p38, 
extracellular signal-regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK) 






Figure 1.6: The signal transduction cascades performed by human NLRs.  
NOD1 or NOD2 sense peptidoglycan (PNG) subunits. Upon activation the proteins form a complex via 
homotypic binding of CARD domains with RIPK2 leading to the activation of NF-κB or MAP kinase signalling. 
NLRP1, NLRP3 and NLRC4 can sense a variety of agonists (DAMPs, MAMPs and chemicals) leading to the 
formation of the inflammasome with ASC and caspase 1. The activation of caspase 1 can lead to pyroptosis and 
the cleavage of proinflammatory cytokines. Colour code of protein domains: yellow (LRR), dark blue (NACHT), 
violet (CARD), orange (Pyrin), green (caspase), turquoise (serine/threonine kinase). 
 
Upon activation NLRP1, NLRP3 and NLRC4 form an oligomeric complex termed the 
inflammasome (Chen et al., 2009) (Figure 1.6, right panel). The Pyrin domains interact with 
the Pyrin domain of the adaptor protein ASC (adaptor protein apoptosis speck protein with 
caspase recruitment) (Srinivasula et al., 2002) enabling the recruitment of procaspase 1, 
synonymously called ICE (IL1 converting enzyme). The homotypic interaction between the 
CARD domains of ASC and procaspase 1 leads to the autoactivation of caspase 1 that 
subsequently cleaves pro-IL1β and pro-IL18 resulting in their release (Martinon et al., 2002; 
Schroder and Tschopp, 2010).  
The structure of the inflammasome shares similarity with the apoptosome formed by APAF1 
upon cytochrome c release by damaged mitochondria leading to the recruitment of 
procaspase 9 via a CARD-CARD interaction resulting in induction of apoptosis (Zou et al., 
1997; Zou et al., 1999). Indeed, activation of the inflammasome can also lead to a newly 




formation of plasma membrane pores, cellular lysis and the release of IL1β and IL18 
(Bortoluci and Medzhitov, 2010).  
Not only in NLR signalling pathways, but also in the other PRR signalling pathways 
described above, the homotypic interactions of effector domains made up of the DEATH fold 
family, like the CARD, DEATH, DED (DEATH effector domain) and Pyrin domains, play 
key roles in the transduction of the signal. Although they share few sequence similarities, they 
all have in common the six antiparallel α-helical bundle structure (Liang and Fesik, 1997; Liu 
et al., 2003). These domains have been identified in a variety of proteins involved in 
apoptosis and immunity (Aravind et al., 1999; Chinnaiyan et al., 1995; Medema et al., 1997; 
Schreiber et al., 2005; Zou et al., 1997).  
Dysregulated PRR pathways have been implicated in a variety of severe autoinflammatory 
diseases (Chen et al., 2009; Rosenstiel et al., 2007; Schreiber et al., 2005). For example, 
NOD2 was the first susceptibility gene described for Crohn’s disease, a chronic inflammatory 
bowel disease (Hampe et al., 2001; Ogura et al., 2001a). Different single nucleotide 
polymorphisms (SNPs) in the part of the NOD2 gene coding for the LRRs, like the 
L1007finsC variant leading to a truncated LRR, significantly increase the risk for disease 
development (Annese et al., 2005). 
 
1.2.3 Evolution of NLRs 
It is known that the TLRs are a group of phylogenetically very ancient receptors (Hibino et 
al., 2006; Miller et al., 2007; Wiens et al., 2007). They were originally discovered in 
Drosophila melanogaster (Anderson et al., 1985a; Anderson et al., 1985b). The Toll protein 
is involved in dorso-ventral patterning and immunity (Lemaitre and Hoffmann, 2007; 
Lemaitre et al., 1995). The TLRs and conserved signal transduction components can also be 
found in the sponge and in cnidarians at the base of metazoan evolution (Bosch et al., 2009; 
Hemmrich et al., 2007b; Miller et al., 2007; Wiens et al., 2007). In contrast, little is known 
about the evolution of the NLRs. 
Although the described mammalian NLRs share high structural similarities with the resistance 
(R) genes of plants it was the general opinion for a long time that these molecules were 
acquired independently (Ting and Davis, 2005) (see Figure 1.5). The R proteins are 
comprised of a central NB-ARC domain linked to C-terminal LRRs and an N-terminal TIR or 
coiled coil domain (Meyers et al., 2003; van der Biezen and Jones, 1998). Unlike vertebrate 
NLRs, these proteins do not detect MAMPs, but specifically recognize pathogen-encoded 
virulence factors by the avirulence (avr) genes (Meyers et al., 2003). This gene-for-gene 




and explains the large variety of R proteins. The activation of R proteins leads to the death of 
the infected tissue via hypersensitive response (HR) (Ma and Berkowitz, 2007).  
A large expansion of NLR orthologues has also been discovered in teleost fishes. 201 NLRs 
were detected in the zebrafish and 70 were found in the pufferfish (Stein et al., 2007).  
Since except of the structurally related APAF1 orthologues CED4 and DARK of 
Caenorhabditis elegans (Yuan and Horvitz, 1990) and Drosophila melanogaster (Rodriguez 
et al., 1999) no proteins belonging to the NLR family sensu stricto were present in these 
ecdysozoan model organisms, it was assumed that NLRs were vertebrate-specific (Ting and 
Davis, 2005).  
The first hint for invertebrate NLRs was given by the workgroup of Jonathan Rast in 2006 
showing that the sea urchin Strongylocentrotus purpuratus posseses more than 200 NLR 
orthologues (Hibino et al., 2006; Rast et al., 2006). Remarkably, the vast majority of these 
NLRs have DEATH domains instead of CARD or Pyrin domains. The Pyrin domain still 
seems to be vertebrate specific.  
In 2008, a large amount of NLR orthologues was also detected in the chordate Branchiostoma 
floridae (Huang et al., 2008). The amphioxus genome encodes for more than 100 NLRs.  
Although these recent studies have begun to elucidate the origins of NLR signalling, it is still 
unclear how early in evolution these receptors have evolved.  
 
1.3 Hydra and other cnidarians provide insight into evolution of innate 
immunity 
As mentioned above, human chronic inflammatory diseases of epithelial barrier organs are 
frequently associated with loss-of-function variations in PRRs (Rosenstiel et al., 2007). But 
not only genetic variations, also a change of living conditions within the past century 
accompanied by a modified microbial community with new metabolic patterns have been 
implicated to contribute to the development of chronic inflammatory diseases (Rosenstiel et 
al., 2009; Wen et al., 2008). Basal eumetazoan organisms such as cnidarians can help to 
understand the processes leading to the development of these diseases. It was shown that 
many genes that have been lost in ecdysozoan model organisms can be found in cnidarians 
suggesting the last common ancestor of cnidarians and bilaterians already possessed these 
genes (Miller et al., 2005; Technau et al., 2005). Therefore, cnidarians represent a good 
model system to understand, how selective pressures contribute to diversity in conserved 




Eugene Rosenberg proposed in his “coral probiotic hypothesis” that corals can adapt to their 
changing environment quickly by changing their bacterial symbionts and therefore gaining 
resistance to diseases (Reshef et al., 2006). This “holobiont”-hypothesis gives cues for 
understanding the role of a symbiotic microflora of humans in the development of barrier 
disorders. 
Many facets of immunity are a subject of recent studies in cnidarians. Work on intraspecies 
competitions in Anthozoans and the discovery of the allorecognition locus in the colonial 
Hydrozoan Hydractinia echinata show that these animals are capable of distinguishing self 
from nonself (Cadavid, 2004; Nicotra et al., 2009). Another major field of interest is the 
symbiotic association of Cnidarians with photosynthetically active unicellular algae, as in the 
extensively studied field of the Anthozoa-Zooxanthellae mutualism and the effect of coral 
bleaching due to environmental stressors (Mydlarz et al., 2010; Rosenberg et al., 2009; Weis, 
2008). The presence of mannose-binding lectins potentially involved in the recognition of 
pathogens and symbionts was reported for the coral Acropora millepora (Kvennefors et al., 
2008). In sea fan corals, it was shown that the attack of a pathogenic fungus leads to tissue 
melanisation by the usage of the prophenoloxidase known to be involved in the immune 
response of Arthopods (Mydlarz et al., 2008). Furthermore, orthologues of proteins of the 
complement system appear to be present in anthozoans and hydrozoans, but so far without 
any proven function in immunity (Kimura et al., 2009; Miller et al., 2007). 
As mentioned above, Hydra has a very simple body plan. Except for the thin glycocalyx it 
does not have any protective layers to separate it from its environment (Bosch et al., 2009). 
The freshwater polyp does not possess any migratory immune cells, so it has to rely 
exclusively on an epithelial defence making it a useful model system to study epithelial 
defence mechanisms (Augustin et al., 2010). 
It was demonstrated more than 25 years ago by Rahat and Dimentman that sterile cultivated 
polyps have a reduced budding rate indicating a beneficial effect of the microbial community 
on their host (Rahat and Dimentman, 1982). In 2003, Kasahara and Bosch showed that 
extracts from polyps depleted in interstitial cells have an increased growth inhibition effect 
against the Gram-positive bacterium Bacillus subtilis and Gram-negative bacterium E. coli 
(Kasahara and Bosch, 2003). Fraune and colleagues could show that these interstitial cell 
depleted animals have a different microbial community indicating an effect of the interstitial 
cells in shaping the composition of the microbial symbionts (Fraune et al., 2009).  
Via 16S rDNA analysis it was detected that different Hydra species support particular 
bacterial guilds and that this association of the host with its symbionts is stable over years 




Effector molecules that might take part in this shaping of Hydra’s microbial community have 
also been discovered: Hydra expresses a variety of antimicrobial peptides in its endodermal 
layer. Hydramacin-1 and the arminin protein family are expressed by the endodermal 
epithelial cells and the expression of the hydramacin-1 protein is inducible via treatment with 
LPS (Augustin et al., 2009a; Bosch et al., 2009; Jung et al., 2009). Another peptide, which 
shows antimicrobial activity, is kazal2 being strongly expressed by the endodermal gland 
cells (Augustin et al., 2009b). Other good candidates for being antimicrobial peptides are the 
members of the periculin gene family that are predominantly expressed within the developing 
egg and the embryo (Fraune, 2008). One reason for the mainly endodermal expression of 
these peptides might be the uptake of food and accompanying putative pathogenic bacteria by 
the endodermal epithelial cells (Bosch et al., 2009). Interestingly, many of these peptides do 
not show any homology with other peptides and are therefore taxonomically restricted, which 
as been observed for many immune effector molecules (Khalturin et al., 2009). 
The expression of these taxonomically restricted AMPs may be controlled by conserved 
signal transduction pathways (Bosch et al., 2009). The presence of a TLR and the conserved 
components of its signalling pathway as well as components of MAP kinase signalling in 
Nematostella shows their phylogenetically old roots (Hemmrich et al., 2007b; Miller et al., 
2007). A truncated orthologue for NF-κB was detected in Nematostella as well (Sullivan et 
al., 2007; Sullivan et al., 2009).  
Hydra does not possess a sensu stricto TLR, but it was shown using a HEK293 cell based in 
vitro assay that a TIR-transmembrane domain protein, HyTRR1, can form a functional 
subunit with its co-receptor HyLRR2 upon stimulation with flagellin (Bosch et al., 2009) (see 
Figure 1.7). 
In addition to this unusual TLR, Hydra possesses conserved components of the TLR 
signalling cascade, like MyD88, TRAF6, TAK1 and IKK and components of MAP kinase 
signalling, like JNK and AP1 (Hemmrich et al., 2007b; Miller et al., 2007; Philipp et al., 
2005). In contrast to previous findings the new transcriptome datasets gave first evidence for 
a putative NF-κB orthologue (G. Hemmrich, pers. communication).  
Some orthologues of proteins involved in apoptosis were detected in Hydra, like HyBcl-2, 
HyBak, HyBax and ten caspases, most of them resembling the human caspase 3 (Böttger and 
Alexandrova, 2007; Cikala et al., 1999). 
To conclude, Hydra is an important tool for studying a variety of immunological questions 







Figure 1.7: The epithelial defence in Hydra. (A) Model of the TLR signalling cascade in Hydra. Upon 
activation with flagellin HyTRR-1 and HyLRR-2 interact. Conserved TLR signalling cascade members are 
present in Hydra. The activation of TLR signalling may lead to the secretion of effector proteins. (Modified from 
Bosch et al., 2009). (B) A cross-section of the gastric region of Hydra; (C) A cross-section of the human small 
intestine. (Taken from Bosch, 2009a). 
 
 
1.4 Aims of the study 
NLRs are a family of intracellular innate immune receptors sensing MAMPs and endogenous 
danger signals (Rosenstiel et al., 2008). Upon activation these receptors form multimeric 
complexes with downstream signalling components resulting in an immune response 
including the release of AMPs and pro-inflammatory cytokines (Chen et al., 2009; Voss et al., 
2006). Genetic variants of NLRs have been associated with the manifestation of chronic 
inflammatory diseases of epithelial barrier organs in Homo sapiens (Rosenstiel et al., 2007).  
Although these receptors are key players in epithelial defence, the information about their 
evolution within the animal kingdom is very limited (Hibino et al., 2006; Huang et al., 2008; 
Ting and Davis, 2005). In order to broaden the understanding of NLR evolution, one goal of 
the study was to screen the genomes of several animal species with a focus on basal 




The freshwater polyp Hydra is continuously surrounded by potential pathogenic microbes and 
must have acquired effective epithelial defence mechanisms accompanying its adaption to its 
ecological niche (Augustin et al., 2010; Rosenstiel et al., 2009). Using Hydra as model 
organism for epithelial defence, the expression of Hydra NLRs should be analysed in more 
detail.  
Furthermore, putative interaction partners for these receptors should have been identified and 
characterized. In order to elucidate the interaction of Hydra NLRs with these proteins and the 
result of these interactions, first functional analyses should be performed.  
A disturbed function of immunity may lead to a disturbed microflora (Fraune et al., 2009; 
Salzman et al., 2010; Zaki et al., 2010). This disturbance has been discovered in a strain of 
Hydra oligactis, which accidentally formed tumour-like structures upon isolation from nature 
and cultivation under laboratory conditions. The second goal of the study was to characterize 
this tumour bearing strain using histological and molecular biological methods in order to get 







2.1 The family of NBD domain containing proteins is highly complex in 
basal metazoans 
Proteins containing NBD domains like NACHT and NB-ARC domains fulfil various 
functions in immunity or apoptosis (Rosenstiel et al., 2008; Zou et al., 1997). While a host of 
data has been presented on the biological roles of selected members of the family (e.g. NOD2 
and NALP3) in Homo sapiens and other vertebrates (Chen et al., 2009; Schroder et al., 2010), 
hardly anything is known about the evolution of these gene families. To broaden this 
knowledge and ask the question whether NLRs were already present at the base of animal 
evolution, a screening for orthologues of NBD domain containing proteins was performed in 
the genomes and transcriptomes of various animal species via BLAST (basic local alignment 
search tool) (Altschul et al., 1990) searches with the domains of vertebrate NLRs or sequence 
analysis using hidden Markov model algorithms (HMMER) (Eddy, 1996). All hits were 
subsequently verified by protein domain predictions. As well as basal species such as the 
sponge Amphimedon queenslandica, the cnidarian anthozoan species Acropora millepora, 
Nematostella vectensis and the hydrozoan species Hydra magnipapillata were investigated, 
but also the genomes of one arthropod species, Daphnia pulex, the agnathostome Petromyzon 
marinus and three gnathostome species: Oryzias latipes; Xenopus tropicalis; and Gallus 
gallus. These organisms were included to elucidate the appearance of NBD-domain 
containing proteins at different diverging nodule points of animal evolution.  
In Figure 2.1 the absolute numbers of NBD-containing proteins of various multicellular 
organisms with a sequenced genome are compared. Figure 2.2 shows a detailed view of the 
domain compositions as well as the numbers of these proteins of selected screened animal 
species in comparison to published NBD domain containing proteins of other species (Bai et 
al., 2002; Cecconi et al., 1998; Hibino et al., 2006; Huang et al., 2008; Kanneganti et al., 
2007; Meyers et al., 2003; Rast et al., 2006; Rodriguez et al., 1999; Schreiber et al., 2005; 
Sodergren et al., 2006; Stein et al., 2007; Yuan and Horvitz, 1990; Zmasek et al., 2007; Zou 
et al., 1997). A detailed list of all hits obtained in this screening with the predicted domain 
compositions is present in the appendix.  
It is known that Homo sapiens and Mus musculus have with 23 and 35 genes a relatively low 
number of NBD-coding genes (Bergelson et al., 2001; Kanneganti et al., 2007; Schreiber et 
al., 2005; Zou et al., 1997), compared to 70 and 201 genes of two teleost fish species, 




these genes in vertebrates, the genomes of a bird (Gallus gallus), an amphibian (Xenopus 
tropicalis), and another teleost fish (Oryzias latipes) were screened.  
 
 
Figure 2.1: Number of NBDs in selected multicellular organisms. 
The NACHT and NB-ARC domains were counted in Gallus gallus, Xenopus tropicalis, Oryzias latipes, 
Petromyzon marinus, Daphnia pulex, Hydra magnipapillata, Nematostella vectensis and Amphimedon 
queenslandica at the basis of homology searches via BLAST, HMMER or gene models. The total numbers of 
NBDs in Amphimedon queenslandica cannot be clearly estimated due to the fact that single genome reads were 
screened. For Homo sapiens (Schreiber et al., 2005; Zou et al., 1997), Mus musculus (Cecconi et al., 1998; 
Kanneganti et al., 2007), Takifugu rubripes (Stein et al., 2007), Danio rerio (Stein et al., 2007), Branchiostoma 
floridae (Huang et al., 2008; Zmasek et al., 2007), Ciona intestinalis (Sodergren et al., 2006), 
Strongylocentrotus purpuratus (Hibino et al., 2006; Rast et al., 2006; Zmasek et al., 2007), Drosophila 
melanogaster (Rodriguez et al., 1999), Caenorhabditis elegans (Yuan and Horvitz, 1990), Arabidopsis thaliana 
(Meyers et al., 2003) and Oryza sativa (Bai et al., 2002) previous publications were taken into consideration.  
 
In the chicken genome, six orthologous gene models for NOD-like receptors and one for 
APAF1, including the models published by Hughes et al. (Hughes, 2006), were detected (see 
Figures 2.1 and 2.2).  
A total of 17 NBD containing gene models were discovered in the genome of Xenopus 
tropicalis (see Figure 2.1). Within these gene models a NAIP and an APAF1 orthologue are 


















Figure 2.2 (continued): Overview of structures of NBD containing proteins in selected animals.  
For H. sapiens (Schreiber et al., 2005; Zou et al., 1997), B. floridae (Huang et al., 2008; Zmasek et al., 2007), 
C. intestinalis (Sodergren et al., 2006), S. purpuratus (Hibino et al., 2006; Rast et al., 2006; Zmasek et al., 
2007), D. melanogaster (Rodriguez et al., 1999), C. elegans (Yuan and Horvitz, 1990), N. vectensis (2 NB-ARC 
domain containing models) (Zmasek et al., 2007) previous publications were taken into consideration. Below the 
predicted protein structure the numbers of proteins are mentioned. Red box indicates the bona fide NLR 
orthologues in Nematostella and Acropora; Abbreviations: AD (acidic domain), DFD (DEATH-fold domain), 
TIR (toll-interleukin-1 receptor), TPR (tetratricopeptide repeat), NB-ARC (nucleotide binding adaptor shared by 
APAF1, R gene products and CED-4), DD (DEATH domain), NACHT (domain present in neuronal apoptosis 
inhibitor protein (NAIP), the major histocompatibility complex (MHC) transactivator (CIITA), HET-E and 
TP1), LRR (Leucine rich repeat), DED (DEATH effector domain), CARD (Caspase recruitment domain), PYD 
(Pyrin domain), BIR (baculovirus inhibitor of apoptosis repeat), CC (coiled coil), ank (ankyrin repeat), RVT 
(reverse transcriptase), FIIND (domain with function to find), ucd (uncharacterized domain) The lengths of 
proteins and domains are not to scale. The number of repetitions of a repetitive domain (WD40, LRR, TPR, ank) 
does not reflect the exact number of repeats. 
 
In the genome of the teleost fish Oryzias latipes 78 loci for NBDs were detected (see Figure 
2.1). About one half of the hits are represented by a gene model, some are supported by ESTs. 
Some of these NBDs appear to be clustered on different chromosomes, e.g. chromosome 2 
(21 NBDs), chromosome 18 (9 NBDs) and ultracontig 205 (6 NBDs) (see Table 9.1 in the 
appendix). 
It is known that the number of NBD-coding genes in two basal chordate species varies a lot 
(Huang et al., 2008; Sodergren et al., 2006). Whereas Branchiostoma floridae NBD-coding 
genes underwent a broad expansion, leading to 106 representatives (Huang et al., 2008), the 
urochordate Ciona intestinalis does not seem to contain any genes coding for NBDs 
connected with other domains (Sodergren et al., 2006). To elucidate the situation in a basal 
vertebrate species, the genome of the agnathostome Petromyzon marinus was investigated. 
Interestingly, no orthologue for NOD-like receptors was detected here, except of an APAF1 
orthologue (see Figure 2.1), represented by four short genome contigs with a size range from 
4.6 to 17.9 kb. Due to the short contig length and to the fact that the contigs cover different 
parts of the APAF1 gene, these hits are assumed to belong to one locus in the genome.  
Because D. melanogaster and C. elegans do not have any NLR orthologues except APAF1 
(Rodriguez et al., 1999; Yuan and Horvitz, 1990), it was assumed that this gene family is 
absent in all ecdysozoan species (Ting and Davis, 2005). In order to question this assumption, 
the genome of the arthropod species Daphnia pulex was investigated. In the genome of the 
freshwater crustacean two gene models coding for proteins with a NACHT domain followed 
by LRRs were discovered in addition to an APAF1 homologue (see Figure 2.1 and Table 9.1 
in the appendix). One of these NLRs gives best BLAST hits to two predicted proteins of the 
same domain composition of two mosquito species, Aedes aegypti and Culex 
quinquefasciatus (XP_001658101, XP_00184881). Furthermore, a gene model coding for a 




Since nothing was known about the presence of NBD coding genes in basal metazoan species, 
it was previously thought that NLRs evolved at the state of the deuterostomes (Ting and 
Davis, 2005). The genomes of a demosponge, Amphimedon queenslandica, of two cnidarian 
species, the anthozoan Nematostella vectensis, and the hydrozoan Hydra magnipapillata, and 
the EST databases of the anthozoan Acropora millepora were investigated to determine 
whether these basal animals could use NLRs for their defence against pathogens as well.  
It is not yet possible to survey the complete NBD gene repertoire of the sponge Amphimedon 
queenslandica because no genome assembly is available. A total of 349 NACHT domains 
were identified in the trace archive genomic sequence data, which were assembled to 61 
genome contigs (see Figures 2.1 and 2.2). This implied presence of a large number of 
NACHT proteins suggests a relatively complex NBD repertoire in early diverging Metazoa.  
In collaboration with Yvonne Weiss from the workgroup of David J. Miller the EST 
databases of the anthozoan cnidarian species Acropora millepora were screened. One bona 
fide NOD-like receptor orthologue consisting of a DED, a NACHT domain and LRRs was 
detected and verified by cloning of the entire open reading frame (red box in Figure 2.2). In 
addition, another NACHT and LRR containing EST, two NACHT and one NB-ARC 
containing ESTs were detected. An orthologue for APAF1 coding for two CARD domains 
instead of one was cloned (see Figure 2.2).  
In addition to two published NB-ARC domain containing proteins (Zmasek et al., 2007), 70 
loci coding for NBD domains were detected in a second anthozoan species, Nematostella 
vectensis. These include an orthologue of the Acropora millepora NLR (red box in Figure 
2.2), more than 30 NACHT domains linked to LRRs and many other proteins showing a large 
variety of domain compositions, e.g. NACHT domains that are connected to WD40 repeats or 
ankyrin repeats and eleven NACHT domains connected to coiled coils. Another group of six 
proteins link an NB-ARC domain with TPRs. A single bona fide APAF1 homologue is 
present as well (see Figure 2.2).  
In the genome of Hydra magnipapillata two large groups of in total 290 NBD domain 
containing proteins were detected (see Figures 2.1, 2.3).  
The first group includes 130 NACHT domain coding loci. Using HMMER analysis in 16 of 
them a DEATH domain was found upstream of the NACHT domain on the genomic contig, 
in one of them a DED domain (see Figure 2.2). No LRRs appear to be present in Hydra 
orthologues for NOD-like receptors, but ESTs coding for LRR containing proteins were 
identified (data not shown). Neither by computational analysis methods, nor by attempts to 
physically link NACHT-coding with LRR-coding contigs via PCR, could an NLR with a 




amino acid as well as on the nucleotide level. With a set of primers 170 transcript fragments 
were amplified and cloned from cDNA that could be assembled to 19 contigs and 30 
singletons, indicating that at least 49 genes are definitely transcribed (see also appendix 
9.4.1). The database screening for NACHT containing genes is supported by a Southern blot 
hybridisation resulting in a complex band pattern (see Figure 2.3B).  
 
 
Figure 2.3: Analysis of NBDs in Hydra magnipapillata.  
(A) The schematic tree was built on the basis of an amino acid alignment of non-fragmented NBDs according to 
HMMER prediction. The drawing of the protein structure shows a representative protein of this group. 
Abbreviations: TPR (tetratricopeptide repeat), NB-ARC (nucleotide binding adaptor shared by APAF1, R gene 
products and CED-4), DD (DEATH domain), NACHT (domain present in neuronal apoptosis inhibitor protein 
(NAIP), the major histocompatibility complex (MHC) transactivator (CIITA), HET-E and TP1), CARD 
(Caspase recruitment domain). (B) Southern blot hybridisation with a probe coding for a NACHT domain from 
Hydra magnipapillata. The genomic DNA from Hydra magnipapillata was digested with HindIII, XbaI and 
EcoRV. The probe used for the hybridisation reflects the NACHT domain, the most conserved part of the 
HyNLR gene sequences. 
 
The second group of NBD proteins in Hydra is represented by the 160 NB-ARC domain 
containing proteins (see Figures 2.2, 2.3). In the genome one APAF1 homologue coding for a 
CARD domain, a NB-ARC domain and WD40 repeats was identified (see Figures 2.2, 2.3). 
Furthermore, a large group of NB-ARC domains connected with TPRs was found. In 159  
NB-ARC domain coding genome contigs 116 were linked to a TPR repeat (see Figure 2.2). 
Additional five contained not only TPRs but also an N-terminal DEATH domain. This 
unusual architecture was experimentally verified for several of the Hydra gene predictions. 
Twelve transcript variants were cloned and sequenced from cDNA with primers for conserved 




Except from Hydra and Nematostella this new uncharacterized protein family has so far only 
been detected in Branchiostoma floridae (Zmasek et al., 2007). Remarkably, these proteins 
give best BLAST hits to bacterial proteins also containing NB-ARC domains connected to 
TPRs. RT-PCR performed on mRNA isolated from separated ectodermal and endodermal 
tissue layers showed that this gene family is exclusively expressed in the ectodermal 
epithelium of Hydra (data not shown).  
A phylogenetic analysis using Bayesian interference with selected NACHT-domain 
representatives (Figure 2.4) resulted in a polytomy and revealed that throughout animal 
evolution vast species-specific NLR gene expansions frequently occurred.  
These expansions can be observed for A. queenslandica, H. magnipapillata, S. purpuratus 
and partially for N. vectensis, B. floridae, X. tropicalis and for the human NLRP genes. 
Whereas almost all human NLR genes and their vertebrate orthologues appear to be 
vertebrate-specific, NOD1 and NOD2 form a cluster not only with vertebrates, but also with 
two cnidarian representatives indicating a putative phylogenetically old origin for NOD1 and 
NOD2, at least for their NACHT domains. Remarkably, all Hydra NACHT domains are 
located within one group of exclusive vertebrate sequences, indicating a relatively high 
sequence similarity between these groups.  
An alignment with some representative NACHT domains that were used to build the 
phylogenetic tree (see appendix 9.2) shows that the various NACHT-domain motifs, like the 
P-loop and the Mg2+-binding site (Koonin and Aravind, 2000), are conserved throughout 






Figure 2.4: Phylogenetic analysis of representative NACHT-domains across the animal kingdom.  
The tree was built by Bayesian interference of phylogeny. Percentages indicate posterior probabilities. Posterior 
probabilities below 50 % are not shown; bright yellow box: Hydra NACHT domains are located within one 
group with vertebrate sequences; grey box: indicates a cluster of vertebrate NOD1 and NOD2 orthologues with 
similar cnidarian NACHT domains; as outgroup the NB-ARC domain of RPS4 (A. thaliana) was used. 
Abbreviations: Amil (A. millepora), Atha (A. thaliana), Nvec (N. vectensis), Spur (S. purpuratus), Bflo (B. 
floridae), Aque (A. queenslandica), Xtro (X. tropicalis), Olat (O. latipes), Hmag (H. magnipapillata), Hsap (H. 




2.2 The expression profile of HyNLR type 1, a Hydra-NLR representative 
gene 
In contrast to anthozoans, Hydra lacks a classical NLR with a NACHT-LRR structure, but 
contains several proteins with an N-terminal DEATH domain followed by a NACHT domain. 
To provide insight into the function of the Hydra NLR-like proteins, the transcript 
architecture and expression pattern of one of Hydra NLR-type genes, HyNLR type 1, was 
analyzed in detail (Figure 2.5).  
 
 
Figure 2.5: Expression profiling of HyNLR type 1.  
(A) The gene structure of HyNLR type 1. The gene consists of five exons of various sizes and encodes a 
transcript of about 2,417 bases. At the 5’ end the trans-spliced leader B is added. The 688 aa long protein 
product contains a predicted DEATH and a NACHT domain but lacks LRRs. (B) Semiquantitative reverse 
transcriptase PCR performed on RNA extracted from the ectodermal and the endodermal cell layers of Hydra 
after procaine treatment showing a predominant expression of HyNLR type 1 in the endodermal layer. As control 
genes the housekeeping gene actin, the ectodermally expressed nematoblast gene nb042 (Milde et al., 2009) and 
the endodermally expressed gland cell gene HyDkk1/2/4 C (Augustin et al., 2006) were used. (C) Splice 
isoforms of HyNLR type 1. In addition to the most abundant HyNLR type 1 transcript (light blue) three other 
transcript variants (dark blue, orange and green) that show an alternative splice pattern were cloned and 
sequenced. HyNLR type 1 var 3 and 4 were cloned partially. (D) Quantitative real time PCR showing a light up-
regulation of HyNLR  type 1 after stimulation with LPS and flagellin. The fold-change of the expression of 






The complete transcript of HyNLR type 1 was amplified using 3’RACE (rapid amplification 
of cDNA ends)-PCR technique and sequenced subsequently from cDNA. The gene is 
represented on the Hydra magnipapillata genome scaffold contig35932 
(http://hydrazome.metazome.net) and is transcribed from five exons of various sizes to an 
mRNA with a length of about 2,417 bases with a coding sequence of 2,067 bases (Figure 
2.5A). The 5’ untranslated region (5’ UTR) contains the Hydra-specific trans-spliced leader B 
sequence (Stover and Steele, 2001). Thus, a clear transcription start cannot be estimated 
easily. Sequencing of different PCR products revealed that the trans-spliced leader can be 
added on two different splice acceptor sites resulting in two different 5’ UTRs varying in their 
length (see also appendix 9.4.1.1). The transcript codes for a protein of 688 amino acid (aa) 
residues with a predicted DEATH domain and a subsequent NACHT domain. BLAST 
searches with the complete protein against the mammalian protein databases result in NLRPs 
as best hits, resulting from a similarity in DEATH and NACHT domains. The C-terminal part 
that follows the NACHT domain does not contain LRRs and gave no significant matches with 
the NCBI non redundant (NR) database, implying that this part of the protein is unique for 
Hydra.  
Since in situ hybridisation did not lead to interpretable results, the gene’s expression profile 
was assessed using semiquantitative reverse transcription (RT)-PCR following a procaine 
treatment to separate the two tissue layers of Hydra (Figure 2.5B). The HyNLR type 1 gene is 
predominantly expressed in the endodermal tissue layer and to a decreased amount in the 
ectodermal layer.  
In addition to the most abundant HyNLR type 1 transcript three additional transcript variants 
that are transcribed from both alleles were amplified from cDNA as a result of alternative 
splicing events (Figure 2.5C, see also appendix 9.4.1.1). The complete transcript of 
HyNLR type 1 var 2 was cloned and subsequent sequencing showed that the transcript lacks 
80 nucleotides in the third exon. The variants 3 and 4 were partially amplified from cDNA. In 
the HyNLR type 1 var 3 the second exon contains twelve additional nucleotides at the 5’ end 
and another deletion of 253 bases in the third exon. HyNLR type 1 var 4 contains the same 
deletion and in addition the exons I, II and III are not spliced at all. In all cases the canonical 
splice sites GU-AG were used.  
In order to analyse whether the expression of the HyNLR type 1 transcript is inducible upon 
stimulation with bacteria or MAMPs, incubation experiments were performed. In the first 
experiment polyps were incubated either with a suspension of the freshwater bacterium 
Pseudomonas fluorescens or Escherichia coli, or with a supernatant of the human pathogenic 




incubation, RT-PCRs were performed. The transcription of the HyNLR type 1 gene was not 
induced upon treatment with these stimuli (data not shown).  
A possible explanation for no observed induction of the HyNLR type 1 transcript might be the 
poor accessibility of the endodermal cell layer for the bacterial stimuli. Under normal 
conditions, the mouth of Hydra is tightly closed and separates the gastric cavity from the 
environment. In order to overcome this problem a second incubation experiment was 
performed. Now the MAMPs, LPS and flagellin, were directly injected into the gastric cavity 
of Hydra in addition to the incubation of the polyps within these MAMPs. To exclude an 
effect due to tissue injury, Hydra medium alone was injected into control animals. A 
quantitative real-time (qRT)-PCR was conducted using the extracted mRNA as template. The 
fold-changes of the HyNLR type 1 expression were calculated in comparison to the expression 
levels of the non treated animals. Upon stimulation with LPS, an upregulation of 1.55-fold 
was detected, after challenging the polyps with flagellin a 1.5-fold induction was observed.  
 
2.3 The putative interactome of HyNLR type 1 and other HyNLRs 
Upon activation NLRs recruit several supporting proteins that are necessary to form large 
molecular complexes, e.g. the inflammasome comprised of NLRP1 or NLRP3 monomers 
(Schroder and Tschopp 2010), ASC (apoptosis-associated speck-like protein containing a 
CARD) (Masumoto et al., 1999) and caspase 1 (Cerretti et al., 1992; Thornberry et al., 1992) 
or the NODosome, formed by NOD1 or NOD2 in association with the serine-threonine kinase 
RIPK2 (Inohara et al., 2000; Ogura et al., 2001b). Additionally, chaperones and co-
chaperones are required to foster and modulate the functional state of the complexes (Hahn, 
2005; Mayor et al., 2007). To elucidate the conservation of the NLR-associated molecular 
pathways, the Hydra magnipapillata genome was screened for genes whose protein products 
may interact with the HyNLR type 1 protein in an ancient NLR signalling cascade (Figure 
2.5). To further investigate their roles in a HyNLR signalling cascade, selected candidate 
genes were subsequently cloned from cDNA using RACE PCR techniques in order to obtain 
their entire coding sequence. 
Three orthologues of the NLR-chaparone HSP90 (Mayor et al., 2007), and orthologues of the 
NLR co-chaperones Chp-1 (Hahn, 2005) and SGT1 (Mayor et al., 2007) were identified 
(Figure 2.5B) and the full open reading frame (ORF) of one of the co-chaperones, HySGT1, 
consisting of 1,979 bases, was cloned and sequenced.  
To identify the initiators of downstream signals elicited by NLR activitation, the EST and 
genome databases were screened for genes whose predicted protein products contain an 




A gene encoding a protein consisting of two DEATH domains was identified and the entire 
ORF of 915 bases was cloned (Figure 2.6B). This Double-DEATH protein HyDODE could 
function as an adaptor protein like ASC in the human NLRP1 and NLRP3 inflammasomes 
and could serve as a bridge for the interaction of Hydra NLRs with further effector proteins 
like caspases or kinases.  
 
 
Figure 2.6: Screening for the putative interactome of HyNLRs.  
(A) A putative model how the signal transduction of an NLR in H. magnipapillata could be performed. The 
NLR needs a chaperone and a co-chaperone to foster and modulate its functional state. Upon activation it could 
either activate a caspase or a kinase directly or indirectly via an adaptor protein. The caspase could induce 
apoptosis or cleave substrate proteins and the kinase could activate transcription factors that may regulate the 
expression of e.g. antimicrobial peptides. (B) Table of the putative interactome of HyNLRs. The complete ORFs 
for HySGT1, HyDODE, HyCARD-Caspase, HyDD-Caspase, HyDED-Caspase and HyJUN were cloned. 
Abbreviations: DD (DEATH domain), DED (DEATH effector domain), CARD (Caspase recruitment domain), 
CH (CHORD), S-L (SGT1-like domain), S_TKc (serine/threonine protein kinase), RHD (Rel homology 
domain), IPT (Ig like, plexins, transcription factors), B (basic region leucine zipper); The HyDD-Caspase, the 
HyDED-Caspase and HyDODE transcripts contain the trans-spliced leader B, the protein structure of HyNF-κB 
and HyDED-DD-Kinase are derived from transcripts from H. vulgaris (AEP).  
 
Furthermore, the complete transcript sequence consisting of 1,431 bases coding for a caspase 
containing a CARD domain at the N-terminus was identified and cloned (Figure 2.6B). 
The Hydra magnipapillata orthologues of two suggested transcripts encoding Hydra caspases 
that contain an N-terminal DED (HyDED-Caspase, 1,215 bp) or a DEATH domain  
(HyDD-Caspase) (Böttger and Alexandrova, 2007) were cloned and the ORF of the  
HyDD-Caspase gene was completed from 1,182 to 1,224 bases using trans-spliced leader 
PCR. The HyDD-Caspase is unique for Hydra. Thus, HyNLRs could form an ancient 
inflammasome with one of these caspases directly or indirectly via homotypic interaction of 




Another possibility could be a signal transduction through a kinase that activates subsequent 
NF-κB or MAP kinase signalling pathways. A group of kinase coding genes was identified in 
the transcriptome database of H. vulgaris (AEP) (3) and in the genome of Hydra 
magnipapillata (3) that have a unique protein domain composition consisting of an  
N-terminal DED and a DEATH domain followed by a kinase domain not orthologous to 
RIPK1 or RIPK2. The DEATH-kinase structure resembles the domain composition of the 
interleukin-1 receptor-associated kinase 1 (IRAK1), but these proteins give best BLAST hits 
to MAP kinases. A BLAST search without the kinase domain resulted in the apoptosis 
signalling adaptor protein FADD (Fas-associated via death domain) as best hit. The unusual 
domain composition of these genes was verified by partially amplifying one H. vulgaris 
(AEP) orthologue in H. magnipapillata cDNA (Figure 2.6B).  
This protein kinase could activate the H. magnipapillata orthologues for NF-κB or JUN. The 
Hydra NF-κB orthologue, partially cloned from cDNA, contains a Rel homology domain 
necessary for DNA binding and an Ig-like domain, but seems to lack the C-terminal part of 
other NF-κB orthologues containing ankyrin repeats and a DEATH domain used for 
transactivation (see Figure 2.6B). An orthologue for JUN, HyJUN is present in Hydra as well. 
Remarkably, the transcripts for HyDODE, the HyCARD-Caspase, the HyDD-Caspase and the 
HyDED-Caspase contain the same trans-spliced leader as HyNLR type 1. 
A Southern blot hybridisation performed for HySGT1, HyDODE, the HyDD-Caspase, the 
HyDED-Caspase and the HyCARD-Caspase showed that, in contrast to the HyNLRs, these 
genes are single or low copy genes (data not shown). 
A prerequisite for an interaction of protein products is the co-expression of the coding genes. 
Since the expression for HySGT1, HyDODE, the HyCARD-Caspase and the HyDED-Caspase 
could not be determined via in situ hybridisation, the same RT-PCR on procaine treated tissue 
samples, mentioned in section 2.2, was performed for all candidate genes and in addition, a 
primer combination was used to amplify a couple of HyNLRs (pan HyNLR) (Figure 2.7A).  
The HyNLR group, HyDODE, the HyCARD-Caspase and the HyDD-Caspase showed a 
predominant expression in the endodermal layer and a weaker expression in the ectodermal 
tissue, whereas HySGT1, HyDED-Caspase and the HyDED-DD-Kinase are equally expressed 
in both layers. HyNF-κB and HyJUN showed an endodermal expression as well, but a 
stronger expression level in the ectodermal tissue. The RT-PCR result for the HyDD-Caspase 
is supported by the in situ hybridisation, which shows the predominant endodermal 
expression (Figure 2.7B). Thus, all genes are co-expressed in the endodermal tissue of Hydra 






Figure 2.7: Analysis of the gene expression patterns of the putative HyNLR interactome. 
(A) Semiquantitative RT-PCR performed on RNA extracted from the ectodermal and the endodermal cell layers 
of Hydra after procaine treatment. As control genes the housekeeping gene actin, the ectodermally expressed 
nematoblast gene nb042 and the endodermally expressed gland cell gene HyDkk1/2/4 C are used. The  
HyDD-Caspase, HyDODE and the HyCARD-Caspase are predominantly expressed in the endodermal layer, 
HySGT1, the HyDED-Caspase and the HyDED-DD-Kinase are equally expressed, HyNF-κB and HyJUN are 
predominantly expressed in the ectodermal layer. (B) In situ hybridisation performed for the HyDD-Caspase 
showing an endodermal expression in the whole body column. Abbreviations: ec/ecto (ectoderm), en/endo 
(endoderm). 
 
The HyNLR group, HyDODE, the HyCARD-Caspase and the HyDD-Caspase showed a 
predominant expression in the endodermal layer and a weaker expression in the ectodermal 
tissue, whereas HySGT1, HyDED-Caspase and the HyDED-DD-Kinase are equally expressed 
in both layers. HyNF-κB and HyJUN showed an endodermal expression as well, but a 
stronger expression level in the ectodermal tissue. The RT-PCR result for the HyDD-Caspase 
is supported by the in situ hybridisation, which shows the predominant endodermal 
expression (Figure 2.7B). Thus, all genes are co-expressed in the endodermal tissue of Hydra 
and most of them are expressed in the ectoderm as well.  
To investigate the inducibility of the expression of HySGT1, HyDODE, the  
HyCARD-Caspase, the HyDD-Caspase, the HyDED-Caspase and HyCARD upon bacteria or 
MAMP stimulation the mRNA obtained from the incubation experiment mentioned in section 
2.2 served as RT-PCR template for these candidate genes as well. For none of the candidate 




2.4 The exons of HyNLRs and their putative interaction partners are in 
phase 
The broad variety of NLR orthologues in Hydra gave rise to speculations about their origins. 
They may have arisen from few precursors by gene duplication and exon shuffling events. 
Another striking observation was that many putative interacting proteins have a protein 
domain composition which is so far unique for Hydra, e.g. HyDODE, the HyDD-Caspase or 
the HyDED-DD-Kinase. A prerequisite for successful exon shuffling is that all exons start 
and end in the same phase of a base triplet and that an entire domain is encoded by one exon 
(Liu and Grigoriev, 2004; Liu et al., 2005). By this it can be assured that the exons do not 
destroy the open reading frame upon rearrangement and that the whole domain can be 
transferred into other proteins. In most cases across the animal kingdom these exons start and 
end in phase 1 of the base triplet (Liu and Grigoriev, 2004). To investigate whether the 
HyNLRs and their interaction partners may also have been a target for exon shuffling, the 
exon-intron structures of two HyNLR representatives (HyNLR type 1 and the HyNLR coding 
for an N-terminal DED-domain), HyDODE as well as the HyDD-Caspase were analysed. 
Remarkably, all exons of all investigated genes were in the same phase, i.e. phase 1, of the 
coding base triplet indicating that these genes may indeed have arisen by exon shuffling 
events (see appendix 9.4.1.1, 9.4.1.2, 9.5.4, 9.5.6).  
 
2.5 Functional characterisation of HyNLR type 1 and its putative 
interaction partners 
Numerous putative interaction partners were detected in the H. magnipapillata genome. They 
seemed to be co-expressed in both epithelial layers of Hydra and therefore could interact in an 
ancient NLR signalling cascade. To demonstrate their interactions two different approaches 
were performed. In an in vitro assay the direct interaction of HyNLR type 1 and two caspases 
was investigated. An unbiased in vivo assay was performed to analyse the effect of the 
activation of HyNLR type 1. For both assays the principle described in Figure 2.7 was used.  
Since the endogenous ligands for HyNLRs are not known, the C-terminal part of 
HyNLR type 1 was replaced with two FKBP subunits that can be artificially linked by the 
addition of a small lipophilic ligand (AP20187). This oligomerisation should mimic the 
endogenous activation of the HyNLR (Figure 2.8) as it was shown for NOD2 by Ogura et al. 




Upon oligomerisation the DEATH domains of the HyNLR type 1::FKBP2 chimera should 
recruit the downstream signalling protein through homophilic interaction with its DEATH 
fold domain.  
 
 
Figure 2.8: Principle of activation of the HyNLR chimeric protein. 
The C-terminal part of the HyNLR type 1 protein was replaced with two FKBP subunits. Upon induced 
oligomerisation using the small lipophilic ligand AP20187 the DEATH domains of the HyNLR should recruit 
the downstream proteins via homophilic interactions with the DEATH fold domain. Abbreviations: DD 
(DEATH domain), DFD (DEATH fold domain), NACHT (domain present in neuronal apoptosis inhibitor 
protein (NAIP), the major histocompatibility complex (MHC) transactivator (CIITA), HET-E and TP1), FKBP 
(FK506 binding protein), X (unknown domain). 
 
2.5.1 HyNLR type 1 and two Hydra caspases interact in vitro 
The interaction of the HyNLR type 1::FKBP2 protein with the HyDD-Caspase and the 
HyDED-Caspase was investigated in vitro using HEK293 cells as heterologous expression 
system. The cells were co-transfected with expression-constructs for the Flag-tagged chimeric 
HyNLR type 1::FKBP2 and the Myc-tagged HyDD-Caspase or HyDED-Caspase (Figure 
2.9A, see also appendix 9.7.1).  
The immunoblotting analysis showed that all transfected constructs were similarly expressed 
(Figure 2.9B). 
Remarkably, the HyNLR type 1::FKBP2 protein co-precipitated with the HyDD-Caspase 
upon forced oligomerisation in a ligand concentration-dependent manner. Addition of 100 nM 
AP20187 led to a robust co-precipitation of both overexpressed proteins, whereas in the 
absence of the ligand a weak interaction was detectable. 
Also with the HyDED-Caspase the HyNLR type 1::FKBP2 was co-precipitated. In this case 




These results give first hints that the HyDD-Caspase, as well as the HyDED-Caspase, may be 
direct endogenous interaction partners for the HyNLR type 1 protein and may be involved in 
HyNLR-mediated cytoplasmic defence responses. 
 
 
Figure 2.9: Co-immunoprecipitation experiments of the HyNLR type 1::FKBP2 chimera and two Hydra 
caspases expressed in HEK293 cells. 
(A) HEK293 cells were co-transfected with an expression construct coding for the Flag-tagged 
HyNLR type 1::FKBP2 protein under the control of an CMV promoter, and either an expression construct coding 
for the Myc-tagged HyDD-Caspase or the Myc-tagged HyDED-Caspase in order to check their interactions and 
to measure apoptosis. (B) The co-immunoprecipitation experiment performed on the co-expressed 
HyNLR type 1::FKBP2 protein and the HyDD-Caspase or the HyDED-Caspase with increasing amounts of 
AP20187. Line 1: Immunoprecipitation was performed using an α-Myc antibody to catch the HyDD-Caspase or 
the HyDED-Caspase. Western blot was performed using an α-Flag antibody to detect the co-precipitated 
HyNLR type 1::FKBP2 fusion protein. The amount of the precipitated HyNLR type 1::FKBP2 chimera increases 
with the ligand concentration in the case of the HyDD-Caspase, whereas the amount of the chimeric protein does 
not increase in the case of the expression of the HyDED-Caspase. Line 2: Expression control for the Flag-tagged 
HyNLR type 1::FKBP2 chimeric protein in HEK293 cells. Line 3: Expression control for the Myc-tagged 
HyDD-Caspase. Line 4: Expression control for the Myc-tagged HyDED-Caspase. (C) Percentage of FITC 
Annexin V positive HEK293 cells expressing HyNLR type 1::FKBP2 protein and the HyDED-Caspase measured 
by flow cytometry, (mean ± standard deviation; n = 4; t test was performed for the HyNLR type 1::FKBP2/ 
HyDED-Caspase expressing cells, P = 0,06). Abbreviations: WB (Western blot), IP (immunoprecipitation), 
DED (DEATH effector domain), DD (DEATH domain), NACHT (domain present in neuronal apoptosis 
inhibitor protein (NAIP), the major histocompatibility complex (MHC) transactivator (CIITA), HET-E and 
TP1), FKBP (FK506 binding protein), Casp (Caspase domain). 
 
In order to analyse whether the interaction of the HyNLR type 1 chimera and one of the 




a FITC-Annexin V staining and subsequent counting by flow cytometry after incubation with 
and without the ligand (Figure 2.9C). The cells co-expressing HyNLR type 1::FKBP2 and the 
HyDD-Caspase did not undergo apoptosis upon ligand addition (data not shown). In contrast 
to that, the HyDED-Caspase showed the ability to induce apoptosis upon forced 
oligomerization of the HyNLR type 1 resulting in a similar amount of apoptotic cells like in 
the staurosporin-treated positive control. This was not the case in the absence of the ligand.  
These results indicate that the HyNLR type 1 and the HyDED-Caspase can indeed interact in 
vitro and that the activated HyNLR on his part can activate the HyDED-Caspase to induce 
apoptosis. This can be seen as a first hint that apoptosis may be used as an innate immune 
defence mechanism in Hydra. To prove these results the function of the HyNLR type 1 
protein needs to be characterized in vivo. 
 
2.5.2 Characterization of HyNLR type 1 in vivo  
To confirm the in vitro findings three different constructs were generated for overexpression 
experiments in transfected Hydra (Figure 2.10).  
 
 
Figure 2.10: Generation of overexpression constructs to elucidate the function of HyNLRs in vivo.  
Schematic drawing of the three constructs that have been generated. All constructs were double expression 
constructs using GFP under the expression control of the actin promoter and terminator in an opposite reading 
frame orientation. HyNLR type 1 long::FKBP2-HA contains the DEATH and NACHT domain of HyNLR type 1 
fused to the two FKBP subunits with a C-terminal HA tag under the control of an actin promoter and terminator. 
The HyNLR type 1 short::FKBP2-HA construct contains the DEATH domain of HyNLR type 1 fused to the 
FKBP domains. A construct containing only the FKBP subunits (FKBP2-HA) was generated to serve as a 
negative control.  
 
All expression constructs contained a GFP coding sequence fused to the first nucleotides of 
actin to trace the transgenic cells (see also appendix 9.7.2). In the opposite reading frame 
direction three different ORFs containing a codon optimized FKBP2 fused to a C-terminal 
HA-tag were inserted, that were fused to some actin coding bases as well. The 
HyNLR type 1 long::FKBP2-HA construct contained both the DEATH and the NACHT 




the DEATH domain in case that the long version is constitutively active due to the 
oligomerisation of the NACHT domains. The third construct contained no sequence parts of 
HyNLR type 1 and was designed as a negative control to exclude unspecific cell signalling 
effects due to the oligomerisation of the FKBP domains alone.  
In total, six transgenic Hydra lines expressing GFP were obtained by microinjection of the 
expression constructs into developing embryos. For none of the three lines transfected with 
the long HyNLR construct could an expression of the HA-fused chimera be detected, neither 
by western blotting, nor by immunohistochemical approaches (data not shown).  
The two lines A6 and B2 showed an expression of the short fusion protein of the expected 
size of about 48 kDa in the immunoblot (Figure 2.11A). 
The line C10, being transfected with the negative control, also expressed the protein of the 
estimated size (26 kDa) (Figure 2.11B). The immunoblot results are supported by the 
immunofluorescence staining performed on all three lines (Figure 2.11C-K). Unfortunately, 
only a small amount of GFP positive cells additionally expressed the HA-tagged protein 
(arrows) in all tested lines. Some HA-positive cells did not express the GFP (arrowheads). 
The expression of GFP and the fusion proteins seems to be uncoupled in all tested lines and 
GFP cannot be used as a tracer to select for HA-positive cells. Although the expression of 
these fusion proteins was successful, living polyps cannot be used for apoptosis assays or 
other experiments because a too small amount of GFP-positive cells expresses the chimeric 
protein. A possible solution for further experiments might be the enrichment of the GFP and 
HyNLR type 1::FKBP2 expressing cells via cell sorting for in vitro assays, e.g. Annexin V 
staining, to detect apoptosis. The animals might also be used for co-precipitation experiments 
to find the endogenous downstream interacting protein. For future studies new constructs 
should be generated, in which the expression of the chimeric HyNLR protein is directly 





Figure 2.11: Detection of the fusion proteins in Hydra.  
(A) Western blot performed to confirm the expression of HyNLR type 1 short::FKBP2-HA using an α-HA 
antibody; the detected proteins in the tested lines B2 and A6 had the expected size of 48 kDa; (B) Western blot 
performed to confirm the expression of FKBP2-HA using an α-HA antibody; the detected protein in the tested 
line C10 had the expected size of 26 kDa; in (A) and (B) the coomassie-stained gels are shown as loading 
control; as a negative control, GFP expressing (GFP) and wildtype animals (WT) were used. (D), (E), (F) 
immunofluorescence staining performed on the line B2 using an α-HA antibody; (G), (H), (I) 
immunofluorescence staining performed on the line A6 using an α-HA antibody; (J), (K), (L) 
immunofluorescence staining performed on the line C10 using an α-HA antibody; (C), (F), (I) overlay of all 
three detected wavelengths, indicating that only a small amount of cells expresses the HA-tagged protein; (D), 
(G), (J) detection of the HA-tagged protein; (E), (H), (K) detection of the DAPI-stained nuclei and the GFP-
positive cells; red (α-HA); blue (DAPI); green (GFP); arrows (cells coexpressing GFP and the HA-tagged 





2.6 Tumour bearing polyps provide an example for a disturbed microbial 
community 
It is known from experiments conducted in mammals that pattern recognition receptors and 
their signalling pathways are crucially involved not only in host-commensal mutualism, but 
also in intestinal tissue homeostasis and tumourigenesis (Rakoff-Nahoum and Medzhitov, 
2007; Rakoff-Nahoum et al., 2004). In Hydra, a tumour bearing strain of Hydra oligactis 
showed an imbalanced homeostasis of the associated microbiota (Figure 2.12). This wildlife 
strain was isolated from the environment of St. Petersburg by Dr. Boris Anokhin.  
In H. oligactis, endosymbiotic bacteria belonging to the group of α-Proteobacteria have been 
detected in the endodermal as well as in the ectodermal epithelial cells in an equal distribution 
(Figure 2.12A, B) (Fraune and Bosch, 2007). In contrast to that, the fluorescence in situ 
hybridisation (FISH) assay performed on the tumour bearing polyps led to a dramatically 
different result (Figure 2.12C, D).  
Remarkably, as shown in Figure 2.11C, the ectodermal tissue was free of endosymbiotic 
bacteria, whereas the endodermal layer contained large clumps of bacteria not belonging to 
the same species as the normal endosymbiont of H. oligactis (Figure 2.12C, D). The 
transmission electron microscopy picture shows that these bacteria reside within cells. They 
have a rod-like shape and a size of about 1 µm in length. Their cytoplasm looks very 
heterogeneous with one to two electron-dense areas per cell of different sizes (Figure 2.12E). 
A 16S rDNA analysis demonstrated that these bacteria belong to the class of β-Proteobacteria 
and with a probability of 56 % to the order of Neisseriales (Figure 2.12F). This group was 
never detected in any other H. oligactis microbial community (S. Fraune, personal 
communication) indicating that the tumour bearing polyps have a drastic change in their 
microbiota.  
After isolation of this strain from the environment, it spontaneously developed tumour-like 
























Figure 2.12 (continued): Analyis of microbiota of the tumour bearing Hydra.  
 (A, B) FISH performed on control H. oligactis ectodermal (A) and endodermal (B) tissue, showing an equal 
distribution of bacterial endosymbionts. (C, D) FISH performed on tumour bearing H. oligactis ectodermal (C) 
and endodermal (D) tissue showing that the endogenous endosymbiotic strain is not present and that clumps of 
bacteria are located within the endoderm. Green (eubacterial probe), blue (DAPI), red (phalloidin), yellow 
(probe specific for the endosymbiont of H. oligactis, results in an overlay of the red specific probe and the green 
eubacterial probe). (E) TEM image showing a clump of bacteria with a heterogenous cytoplasm surrounded by a 
membrane. (F) Phylogenetic positions (16S rDNA sequences, neighbor-joining tree) of identified bacterial 
phylotypes in the tumour bearing polyps and in control H. oligactis polyps. Bootstrap values are shown at the 
corresponding nodes (n = 1000). The branch length indicator displays 0.05 substitutions per site, the gray 
shadowed phylotype represents the dominant clone isolated from the tumour bearing samples. Light red 
(phylotypes isolated from the H. oligactis laboratory culture), dark red (phylotypes isolated from H. oligactis 
samples from the lake Ploen or lake Pohlsee). 
 
Figure 2.13 shows a morphological comparison of a tumour bearing polyp with a normal 










Figure 2.13: Different phenotypes of Hydra oligactis. 
(A) A sexually undifferentiated budding polyp with a small insertion of a schematic drawing of a H. oligactis 
specific holotrichous isorhiza (taken from Holstein and Emschermann, 1995). (B) A male differentiated polyp 
with shortened tentacles and numerous testes. (C) A female differentiated polyp producing several eggs and 
abortive eggs simultaneously. (D) A polyp from the tumour bearing H. oligactis strain releasing cells through its 
mouth (arrow). Insertion (holotrichous isorhiza from the tumour bearing strain indicating that this strain belongs 
to the species of H. oligactis). 
 
Below the budding zone H. oligactis possesses a stalk region (Hemmrich et al., 2007a). The 
colour of H. oligactis is brown to orange due to the inclusion of carotenoids. Its 
synapomorphic feature is a special type of holotrichous isorhiza with an unordered 
arrangement of the external tubes (Figure 2.13A, see also Figure 1.2) (Hemmrich et al., 
2007a). H. oligactis is strictly dioecious and this species hardly ever switches between the two 




induced by cultivating the animals at 10 °C for approximately two weeks (Littlefield, 1991). 
Gametogenesis is accompanied by shortening of the tentacles (Brien, 1965) due to the 
consumption of interstitial cells. This leads to the death of the animal if gametogenesis is 
proceeded for a long time, a phenomenon called “crise gamétogénique” (Brien and Reniers-
Decoen, 1949). The male polyp contains numerous spirally arranged testes throughout the 
entire body column (Figure 2.13B). The female differentiated polyp contains synchronously a 
couple of eggs in the distal gastric region and in addition numerous “abortive eggs” (Figure 
2.13C) (Brien and Reniers-Decoen, 1949). The tumour bearing polyps have an abnormal body 
shape with bulges of tissue in the distal gastric region (Figure 2.13D). By their unordered 
arrangement of the external tube within the holotrichous isorhiza they could be identified as 
H. oligactis species. The yellowish polyps hardly ever bud and for reproduction of the culture 
the polyps had to be cut longitudinally. Remarkably, the animals frequently release cells 
through their mouth (arrow).  
In the following chapters these tumour bearing polyps are characterised under histological and 
biomolecular aspects.  
 
2.6.1 Histological characterisation of the tumour bearing polyps 
In order to gain a deeper understanding of the cellular composition of the tumour-like 
structures, the animals were cross-sectioned and subjected to light microscopy (Figure 2.14A-
L). The tissue sections show that the tissue layers of the tumour bearing Hydra are thickened 
in comparison to the control tissue (Figure 2.14A-H).  
The tumour-like structure consists of numerous interstitial cells (Figure 2.14C, D). Interstitial 
cells with two nucleoli were detected as well (Figure 2.14G, arrow), indicating a high 
synthesis activity of these cells. In addition, numerous rounded cells with a morphology 
resembling apoptotic cells were present in the ectodermal tissue layer (arrowheads). 
Remarkably, these cells resemble nurse cells in shape and staining characteristics (Figure 
2.14F) (see also Fröbius et al., 2003). 
Nurse cells are differentiated interstitial cells arrested in apoptosis, which are taken up by the 
developing egg during oogenesis (Honegger et al., 1989). The cells lose their nucleolus and 











Figure 2.14 (continued): Histological characterisation of the tumour bearing polyps.  
 (A-L) Cross-sections of a control polyp (A, E, I), a female polyp (B, C, D) and a tumour bearing polyp (C, D, G, 
H, K, L) stained with Richardson (A-H) or Sudan Black (I-L). (A) Overview of a cross-section in a control 
polyp. (B) Cross-section overview in a female differentiated polyp with a developing oocyte (arrowhead). (C) 
Cross-section overview of a tumour bearing polyp. (D) Enlargement of the cross-section showing that the 
tumour cells are interstitial cells. (E) Enlargement of the ectodermal and endodermal tissue of the control polyp. 
(F) Enlargement of the developing oocyte with ingested nurse cells in a female polyp. (G) Enlargement of the 
ectodermal layer of the tumour bearing polyp showing a cell with two nucleoli (arrow) and rounded cells 
(arrowheads). (H) Enlargement of the endodermal layer of the tumour bearing polyp. (I) Cross-section of a 
control polyp showing the endodermally located lipid droplets. (J) Cross-section of a developing oocyte with 
ingested nurse cells. (K) Cross-section of the ectodermal tissue of a tumour bearing polyp showing small lipid 
droplets located in the interstitial cells. (L) Cross-section of the endodermal tissue of the tumour bearing polyp 
showing large lipid droplets. (M) Phalloidin staining of actin filaments in a control polyp and (N) in a tumour 
bearing polyp indicating that the arrangement of the actin filaments is looser than in the control tissue. Scalebars: 
A-D (100 µm), E-L (20 µm). 
 
In the case of the tumour bearing polyps, rounded cells containing condensed chromatin can 






Figure 2.15: The rounded cells of the tumour bearing polyps resemble nurse cells.  
TEM pictures of (A) a nurse cell in a female differentiated H. oligactis polyp. The cell is located within the 
developing oocyte. (B) A rounded cell of the tumour bearing polyp, that is not phagocytosed by a developing 
oocyte. Both cells contain nuclei with condensed chromatin. Scalebars (5 µm); abbreviation: Nu (nucleus). 
 
A terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay to detect 
apoptotic cells within the tumour bearing polyps resulted in no dramatically induced apoptosis 
throughout the whole body column in comparison to the control animal, although apoptotic 
cells could be detected within the tumour (Figure 2.16B).  
The Sudan Black staining performed on the tumour bearing polyps shows a different size and 
distribution of lipid droplets in comparison to the sexually undifferentiated control tissue, e.g. 
the unusual presence of numerous small lipid droplets in the ectodermal interstitial cells 
(Figure 2.14K) and the dramatically enlarged lipid droplets on the endodermal tissue layer 




2.14J). The nurse cells contain small lipid droplets and large lipid droplets can also be found 
in the endoderm. 
A B
 
Figure 2.16: Detection of apoptosis in a tumour bearing polyp in comparison to a control animal.  
TUNEL staining was performed in a control polyp (A) and in a tumour bearing polyp (B). There is no enlarged 
apoptosis detectable in the body column of the tumour bearing polyp although there are TUNEL positive cells 
within the tumour (box). 
 
A phalloidin staining of the actin filaments shows that in comparison to the control animals 
the actin filaments of the tumour bearing polyps have a much looser arrangement than the 
filaments of the control polyps (Figure 2.14M, N). This may be a result of the large number of 
the interstitial cells that intercalate between the epithelial cells. 
 
2.6.2 Gene expression analysis in the tumour bearing polyps 
For many examples of cancerogenesis in vertebrates it is known that the oncogene KRAS, 
that is involved in the regulation of the cell cycle, can be dysregulated.  
Two orthologues genes of the small GTPases KRAS (Der et al., 1982) and RRAS (Lowe et 
al., 1987), ras1 and ras2, have been identified in a previous study in H. magnipapillata 
(Bosch et al., 1995). In order to analyse a putative involvement of the RAS signalling 
pathway in the tumour bearing Hydra, the orthologues were partially amplified from  




The expression of the RRAS orthologue ras2 was not altered in the tumour bearing polyps, 
whereas the expression level of the KRAS orthologue ras1 was induced in comparison to the 
control H. oligactis.  
 
Figure 2.17: Ras1 and Cniwi transcripts are upregulated within the tumour bearing polyps.  
The RT-PCR was performed on mRNA isolated from tumour bearing polyps and two isolates from control 
polyps for the transcripts of ras1, ras2 and Cniwi; the housekeeping genes actin and gapdh served as 
equilibration controls. 
 
Since the tumour-like structures contain large amounts of undifferentiated interstitial cells and 
some cells that resemble the morphology of nurse cells, one could hypothesise that the 
interstitial cells in the tumours predominantly differentiate into gamete cells. Therefore, the 
expression level of Cniwi, a gene being primarily expressed within the interstitial cells 
determined to become germline cells (Puchert, 2008; Seipel et al., 2004), was analysed as 
well. Indeed, the transcription of this gene was induced in the tumour bearing polyps.  
In order to confirm these results, one of the two NANOS1 (Jaruzelska et al., 2003) 
orthologues, Cnnos1, that have been identified in H. magnipapillata (Mochizuki et al., 2000), 
served as marker for interstitial cells restricted to gametogenesis in an in situ hybridisation 
(Figure 2.18).  
In sexually undifferentiated polyps of the species H. magnipapillata, this gene is expressed in 
few groups of interstitial cells along the body column (Mochizuki et al., 2000). This was also 
the case for sexually undifferentiated H. oligactis polyps (data not shown). In male as well as 
in female differentiated animals, this gene is expressed on the bases of the testis (Figure 
2.18A) and within the developing eggs (Figure 2.18B). In the tumour bearing polyps, the 
Cnnos1 gene is expressed in large patches within the tumours, in cells that are located 
between the ectodermal epithelial cells and the mesogloea (Figure 2.18C, D).  
The induced expression of Cniwi and the large tissue patches of the tumour bearing polyps 
expressing Cnnos1, indicate that the dramatically increased interstitial cells forming the 








Figure 2.18: Cnnos1 is expressed within the interstitial cells that are located in the tumour.  
In situ hybridisation with Hydra oligactis was performed on a male differentiated polyp (A), the small insertion 
showing the sense control, a female differentiated polyp (B) and two tumour bearing polyps (C,D).  
 
 
2.6.3 The female germline marker periculin 1a is expressed within the tumours 
Since the interstitial cells within the tumour-like structure appeared to be cells restricted to the 
female germline, an immunofluorescence staining using an antiserum against the cationic part 
of the periculin 1a protein (Bosch et al., 2009; Fraune, 2008), which is exclusively expressed 







Figure 2.19: Immunofluorescence staining of periculin 1a.  
Immunofluorescence staining using an antiserum generated against the cationic part of the periculin 1a protein 
with female control H. oligactis (A) and tumour bearing H. oligactis (B). Red (phalloidin), blue (DAPI), green 
(α-periculin 1a antiserum). (C) Induction of gametogenesis in a tumour bearing Hydra. Arrow (egg). 
 
In control tissue the antibody stains small nests of interstitial cells (Figure 2.19A). The 
periculin 1a protein is located within vesicles. In the tissue of the tumour bearing polyp, large 
amounts of periculin 1a-expressing cells were detected (Figure 2.19B), indicating that the 
interstitial cells that build up the tumour are female restricted interstitial cells. Like in the 
control population of H. oligactis, oogenesis is never performed by the tumour bearing Hydra 
under normal culturing conditions. Oogenesis can be induced in these polyps by cultivating 
them at 10 °C for about 14 days (Figure 2.19C). Remarkably, the differentiated polyps looked 
different than the female control polyps (as shown in Figure 2.19C). They do not contain 
abortive eggs and they produce only one egg. This may indicate a disturbance of the 
differentiation pathway of the interstitial stem cells or an onset of a loss of interstitial cells. 
 
2.6.4 Dying tumour bearing polyps have lost a large amount of interstitial cells 
Regularly tumour bearing polyps died. That led to a limited number of animals and therefore 
to a limited number of experiments that could be performed. Two of these dying animals have 
been macerated and the amount of interstitial cells and their derivatives has been counted in 
relation to the number of epithelial cells in comparison to two macerated control polyps 
















































Figure 2.20: Analysis of the interstitial cell lines in dying tumour bearing polyps.  
(A) Counting of interstitial cells and their derivatives in relation to 100 epithelial cells. Two female control 
polyps and two dying tumour bearing polyps were macerated and cells of two slides per animal were counted. 
The mean value of the two animals was built. (B) A dying tumour bearing polyp showing a decreased length of 
tentacles and a smooth surface of the tentacles.  
 
The numbers of interstitial stem cells and all their derivatives, including nematoblasts, 
nematocytes, nerve cells and gland cells, were dramatically decreased in the dying tumour 
bearing polyps in comparison to the control animals. This finding is additionally supported by 
the observation that the dying animals had shortened tentacles with a smooth appearance 
indicating that hardly any nematocytes were present in the tentacles of these animals (Figure 
2.20B). This indicates a misbalance in the tissue homeostasis in dying tumour bearing polyps. 
This misbalance may be due to the enhanced differentiation of interstitial cells into germline-
restricted stem cells. This may lead to a subsequent lack of multipotent stem cells giving rise 
to other differentiation products of the interstitial stem cell lineage with the death of the polyp 







3.1 Screening for NBD-containing proteins at the base of the animal 
kingdom 
In the screening for NBD-containing proteins performed as part of this thesis an extraordinary 
large number of NACHT and NB-ARC domain containing proteins was identified at the base 
of animal evolution (see section 2.1).  
The presence of 349 NACHT domains in the raw genome data of Amphimedon queenslandica 
that led to 61 assembled contigs was the first hint that this sponge may use a large repertoire 
of NLRs for immune defence (see section 2.1). A subsequent screening of the assembled 
genome will help to confirm these preliminary results. Little is known about the immune 
system of the sponge (Böhm et al., 2001; Wiens et al., 2005). At the molecular level, 
components of the TLR signalling pathway, orthologues for one TLR, MyD88, NF-κB and 
IRAK-4 have been discovered in the demosponge Suberites domuncula (Wiens et al., 2005; 
Wiens et al., 2007). Although these filter-feeders do not possess true tissue, the TLR 
orthologue is expressed at the epithelial surfaces that separate it from its external environment 
indicating an ancient form of epithelial defence. However, an effective defence cannot be 
achieved using only one TLR. It is likely that the sponge uses NLR orthologues for pattern 
recognition as well.  
Two anthozoan cnidarian species, A. millepora and N. vectensis have one bona fide NLR with 
a DED at its N-terminus, a NACHT domain and LRRs (see section 2.1). The expression of 
this receptor was confirmed by PCR in Acropora. Unfortunately, the total number of 
Acropora NLRs cannot truly be determined due to the lack of a sequenced genome.  
In the genome of Nematostella a total of 72 NBD-containing proteins were identified (see 
section 2.1). Interestingly, many genome scaffolds in Nematostella contain several NLR 
genes indicating a putative transcriptional co-regulation of these genes. Moreover, several of 
them contain various C-terminal repetitive domains, including ankyrin repeats, WD40 
domains, LRRs and TPRs. Remarkably, 11 gene models were detected displaying structural 
similarities to plant R proteins by the presence of an N-terminal coiled coil domain. The 
appearance of this domain must be proven by analysing the coding sequence, but it could be 
seen as another hint for a last common ancestor of plants and animals that might have used 
NBD containing proteins for defence. However, these coiled coil domains could also have 
been acquired in an analogous manner to the plant R genes.  
It seems that in H. magnipapillata as a representative of the Hydrozoa that branched from the 




containing proteins occurred. 130 NACHT and 160 NB-ARC containing genes were found in 
the genome of H. magnipapillata.  
Being cnidarians, the body plans of Nematostella and Hydra are relatively simple. Both are 
built up of two monolayered epithelia; the ectoderm and the endoderm that are separated by 
the mesogloea. Although migratory cells with a putative immune function have been reported 
for anthozoans (Ellner et al., 2007; Mydlarz et al., 2008), both animals have to rely on an 
effective epithelial defence mechanism (Bosch, 2008; Bosch et al., 2009). Together with 
ingested prey, numerous putatively pathogenic microorganisms can be taken up and pass into 
the gastric cavities of the animals (Bosch et al., 2009). The phagocytic endodermal epithelial 
cells cannot distinguish between food particles and pathogens and as a result, Hydra 
individuals could be easily infected. However, in Hydra it was shown that they also live in 
close contact to symbiotic bacteria hat may also benefit to their fitness (Fraune and Bosch, 
2007). In the case of H. oligactis these symbiotic bacteria are located inside the epithelial 
cells surrounded by a membrane (Fraune and Bosch, 2007). Therefore it is important to 
differentiate between pathogenic and non-pathogenic organisms. An immune defence reaction 
against extracellularly-located pathogens would be detrimental to Hydra, because 
antimicrobial peptides that are secreted into the gastric cavity will be released from the cavity 
through the mouth. A more effective scenario would be the direct defence against 
phagocytosed cytoinvasive bacteria by the release of antimicrobial peptides into the 
phagosome or an intracellular defence mechanism performed by the NLRs. This could be a 
possible explanation for the high number of intracellular NLRs in Nematostella and in Hydra 
compared to a low number of membrane-spanning TLRs (one in Nematostella and two 
truncated versions in Hydra) (Bosch et al., 2009; Hemmrich et al., 2007b; Miller et al., 2007). 
It is highly likely that the TLRs and the NLRs in these organism function together in a 
complex network leading to apoptosis or the production of AMPs to control the microbial 
community that surrounds Hydra and Nematostella.  
Finding classical NLRs in anthozoan cnidarians directly contradicts the assumption that NLRs 
evolved at the level of the teleost fishes (Ting and Davis, 2005). This led to a reinvestigation 
of their apparent absence from ecdysozoans. 
It was reported that the ecdysozoans D. melanogaster and C. elegans do not contain any 
NLRs, only the APAF1 orthologues DARK and CED-4 are present (Rodriguez et al., 1999; 
Yuan and Horvitz, 1990). It was shown by Miller, Tenchau and colleagues that these species 
are rapidly evolving and divergent from other animal species (Miller et al., 2005; Miller et al., 
2007; Technau et al., 2005). Several gene losses were reported for this group. Nevertheless in 
the genome of the arthropod D. pulex four NBD containing genes were identified, with two of 




LRRs. In contrast to previous statements (Ting and Davis, 2005), NLR-resembling proteins 
are present in arthropods, but they are very limited in number.  
Therefore it is likely that arthropods rely on other proteins for the recognition of pathogens. In 
addition to a relatively small number of peptidoglycan recognition proteins (PGRPs) and 
Gram-negative binding proteins (GNBPs) that can activate the Toll or the immune deficiency 
(IMD) pathway in Drosophila (Lemaitre and Hoffmann, 2007; Pal and Wu, 2009), arthropods 
use another highly variable system for pattern recognition. They can express thousands of 
isoforms of the immunoglobulin (Ig)-superfamily receptor Down syndrome cell adhesion 
molecule (Dscam) that are generated through a mechanism of alternative splicing (Watson et 
al., 2005).  
In the sea urchin S. purpuratus as well as in the chordate B. floridae, a vast expansion of 
NLRs and TLRs has occurred (Hibino et al., 2006; Huang et al., 2008; Rast et al., 2006). In 
contrast, the urochordate C. intestinalis does not seem to have any NLRs as only single 
NACHT domains were detectable (Sodergren et al., 2006). In the jawless vertebrate  
P. marinus no NLRs were detected by the performed screening (see section 2.1). 
Interestingly, this species has in addition only two TLR orthologs (Ishii et al., 2007). 
However, the lamprey uses a highly variable receptor system; the variable lymphocyte 
receptors (VLRs) composed of highly diverse leucine-rich repeats (LRR) that are somatically 
rearranged for the specific recognition of pathogens expressed by migratory immune cells 
(Pancer et al., 2004).  
In order to validate the relatively small amount of NBD containing proteins in jawed 
vertebrates the analysis was extended with a screening of a teleost fish species, O. latipes, an 
amphibian, X. tropicalis, and G. gallus as a representative of birds. Although all jawed 
vertebrates use the somatic recombination of Ig-domain coding gene families within 
migratory immune cells to generate highly specific antibodies directed against thousands of 
epitopes (Cooper and Alder, 2006), the total numbers of NBD containing genes vary greatly 
within this group. In general, the gene family seems to be expanded within the teleost fish, 
with more than 200 representatives in the zebrafish D. rerio (Stein et al., 2007), but the 
number of NBD coding genes of land living vertebrates is relatively low with 17 orthologs in 
the frog, 7 genes in the chicken, 35 representatives in the mouse (Cecconi et al., 1998; 
Kanneganti et al., 2007) and 23 in man (Schreiber et al., 2005; Zou et al., 1997).  
The phylogenetic analysis shows that in Hydra as well as in many other species throughout 
the entire animal kingdom like in A. queenslandica and S. purpuratus, and partially in N. 
vectensis, B. floridae, O. latipes, X. tropicalis and also H. sapiens species-specific NLR gene 




and T. rubripes (Stein et al., 2007). With regard to a possible function in immunity, this may 
indicate species-specific adaptations in a variety of ecological niches.  
Each organism must defend itself effectively against putative pathogens that persist in its 
external environment. A prerequisite for an effective defence is a highly specific recognition 
of pathogens by the use of a highly variable repertoire of receptor proteins. It is very likely 
that different defence strategies have evolved dependent on an organism’s adaptation to its 
habitat and corresponding to its phenotype. In addition to species-specific recognition 
strategies, conserved pathways such as the TLR signalling pathway including MAP kinase 
and NF-κB signalling are highly conserved throughout animal evolution (Hemmrich et al., 
2007b; Hibino et al., 2006; Miller et al., 2007; Wiens et al., 2007).  
A good example for a well-adapted immune answer can be found in plants. They are sessile 
but have a very high self-regeneration capacity. They use a large repertoire of intracellular 
R proteins for the specific recognition of pathogens by their avirulence (avr) factors 
(Chisholm et al., 2006; Lukasik and Takken, 2009; Mansfield, 2009). These R proteins share 
structural similarities with the NLRs of the animal kingdom (Głowacki et al., 2010; van der 
Biezen and Jones, 1998). They contain an N-terminal coiled coil or a TIR domain, a central 
NB-ARC domain and C-terminal LRRs. An even higher specificity is achieved through 
alternative splicing and a very fast evolution of these R genes (Bergelson et al., 2001; Dinesh-
Kumar and Baker, 2000). The tissue that is affected by pathogen attack dies by a mechanism 
called hypersensitive response (HR) to prevent a spreading of the pathogen (Ma and 
Berkowitz, 2007). Before this study it was assumed that plants and vertebrates have invented 
the tripartite NBD-containing receptors independently because no NLRs have been 
discovered in D. melanogaster and C. elegans (Ting and Davis, 2005), but the current thesis 
gives the first evidence that a scenario is very likely where the last common ancestor of plants 
and animals already had at least the domains that are necessary to built up this kind of 
receptors. Indeed, NACHT and NB-ARC domains are already present in some eubacterial 
species, where they perform other functions (Koonin and Aravind, 2000; Leipe et al., 2004). 
However, these domains might have been acquired through horizontal gene transfer. In 
addition, the NBD domains can be connected to repetitive domains like TPRs or WD40 
repeats or to TIR domains. In contrast, it seems that the 6-helical DEATH fold which the 
DEATH, the DED, the CARD and the Pyrin domain have in common is unique to the animal 
kingdom (see also Aravind et al., 1999). It is already present in the sponge (Müller et al., 
2001) and it was proposed that it evolved from ankyrin repeats (Boldin et al., 1995).  
One can conclude that the numbers of NBD-coding genes of various species does not follow 
any rule, but that each organism needs an effective and highly specific immune response 




and each organism has developed its own pathogen recognition strategy to be best adapted to 
its ecological niche and its physiological predispositions. 
3.1.1 Hydra uses a complex repertoire of NBD-coding genes 
In the genome of H. magnipapillata 130 NACHT and 160 NB-ARC-containing genes have 
been identified (see section 2.1). Even on the nucleotide level the NBD coding genes of 
Hydra are very similar to each other making it difficult to work specifically on one particular 
representative gene. As supported by phylogenetic analysis, it is very likely that this variety 
was achieved by gene duplication events and exon shuffling. The Hydra genome contains a 
high number of transposable elements (Chapman et al., 2010). In this screening many NLR 
like genes were found in close proximity to transposases (data not shown). A prerequisite for 
a successful exon shuffling is the location of domains on single exons and that all exons are in 
the same phase of the coding base triplets so that the open reading frame is not destroyed as a 
result of shuffling (Liu and Grigoriev, 2004; Liu et al., 2005). In the gene HyNLR type 1 and 
another screened representative of HyNLRs this is indeed the case (see section 2.4 and 
appendix 9.4.1.1, 9.4.1.2, 9.5.4, 9.5.6). All exons are phase 1 exons, so the domain 
compositions can be changed easily. Transcripts of other HyNLRs were amplified containing 
the second exon two times or containing NACHT domain coding exons sharing a 100 % 
identity at the nucleotide level, but having completely different effector domain coding exons 
(data not shown). In addition, the gene HyNLR type 1 having one distinct representative in the 
genome of H. magnipapillata appears to be a small gene family of 4 slightly differently 
expressed genes in the transcriptome of H. vulgaris (AEP), a closely related Hydra species 
(data not shown). This can be seen as another hint for the rapid evolution of the HyNLR 
genes. These observations lead to the conclusion that in the case of HyNLRs gene duplications 
and exon shuffling events seem to be used as a relatively fast and effective mechanism for 
genes that need to evolve fast due to their putative role in immune defence. Although many of 
these genes were partially amplified from cDNA proofing that they are indeed transcribed, 
some of them may also represent pseudogenes. Interestingly, the phylogenetic analysis 
showed that Hydra NACHT domains are located within a cluster of exclusively vertebrate 
NACHT domains (see Figure 2.4). This may indicate a similar role in immunity and makes 
Hydra a good model organism to study NLR function, e.g. the function of human NLRPs. 
In contrast to the NLR orthologues detected in Acropora and Nematostella, the surprisingly 
large portion of NACHT domain coding genes in Hydra lack C-terminal LRRs (see Figure 
2.2). Three different scenarios could be possible: (i) there are NLRs present in the Hydra 
genome that contain LRRs, but due to the relatively short average genome scaffold lengths of 
63.4 kb in the CA assembly and 92.5 kb in the RP assembly (Chapman et al., 2010), it was 




excluded, but if there were NACHT domains connected to LRRs it would be very unlikely 
that never a NACHT domain and an LRR are located at the same scaffold accidentally; (ii) 
there may be a Hydra-specific domain for the detection of a ligand present at the C-terminal 
part of the HyNLRs, this is supported by the finding that the C-terminal part of the 
HyNLR type 1 did not have any homologous sequences in other organisms, this 
uncharacterized part may represent a taxonomically restricted ligand detection motif. It would 
be useful to clarify the tertiary structure of this part of HyNLR type 1; potentially one could 
find a repetitive folding element similar to e.g. the LRRs of Toll-like receptors (Bell et al., 
2003). In addition, one could test the ligand recognition ability of the C-terminal part by 
generating fusion proteins with the N-terminal part of e.g. the human NOD2 protein in a 
HEK293 cell-based assay. An activation of the chimera would lead to an activation of NF-κB 
that could be detected using e.g. luciferase assays; (iii) the HyNLRs might need a second 
protein encoding LRRs as a co-receptor. In a recent publication it was shown that the Hydra 
Toll like receptor resembling protein (HyTRR)-1 lacking the external LRRs of bona fide 
TLRs interacts with HyLRR-2 in HEK293 cells upon stimulation with flagellin (Bosch et al., 
2009). This could also be the case for HyNLRs and might be supported by the finding of 26 
ESTs encoding LRRs that are not connected to other domains.  
Besides an orthologue for APAF1, a large family of proteins with a tripartite domain 
composition composed of an N-terminal DEATH domain, a NB-ARC domain and C-terminal 
TPRs has been discovered in Hydra (see section 2.1, Figure 2.2). Predicted proteins of similar 
domain compositions have so far only been reported for B. floridae and N. vectensis without 
any proposed function (Zmasek et al., 2007). As mentioned before, in bacteria and fungi 
proteins with a NB-ARC domain connected to TPRs are present as well (Leipe et al., 2004). 
And the amplified transcripts from H. magnipapillata give best BLAST hits to bacterial 
proteins. But these transcripts could be amplified from H. magnipapillata cDNA, they show 
an exon-intron structure on the genome and contain the trans-spliced leader B sequence (data 
not shown). Therefore, a contamination from bacteria or fungi is excluded. RT-PCR 
performed on mRNA isolated from ectodermal and endodermal tissue samples showed that at 
least a group of these genes is exclusively expressed within the ectodermal layer of Hydra. 
The presence of an NB-ARC domain is a first hint for a possible function of these proteins in 
immunity or cell death in Hydra. To support this idea, e.g. knockout or overexpression 
constructs similar to the HyNLR type 1::FKBP2 fusion protein that can be artificially 





3.2 HyNLR type 1, an ancient NOD-like receptor that could build up an 
ancient inflammasome 
One representative of the discovered Hydra NOD-like receptor gene family, termed 
HyNLR type 1, was analysed in detail (see section 2.2). The gene coding for a C-terminal 
DEATH domain followed by a NACHT domain and a long part without any domain 
predictions is predominantly expressed in the endodermal epithelium and shows a weak 
expression in the ectoderm as well (see Figure 2.5). The endoderm is surrounding the gastric 
cavity of Hydra, the place where the digestion of food is performed. The endodermal 
epithelial cells that phagocyte pre-digested food particles come into close contact to co-
ingested pathogens. This makes the effective protection of the endoderm of great importance 
as mentioned before.  
Not only one HyNLR type 1 transcript is generated, but 3 additional variants result from 
alternative splicing (see Figure 2.5). With a specific antibody targeted against the DEATH 
domain of HyNLR type 1 one could detect the resulting shorter proteins via immunoblotting 
to check if the alternatively spliced transcripts are indeed translated to regulate NLR 
signalling in Hydra. Remarkably, this putative immune-modulatory function of splicing might 
be conserved throughout evolution, as a short splice isoform of the NOD2 transcript is found 
in H. sapiens that negatively regulates NOD2 signalling (Rosenstiel et al., 2006). Also in 
plants, alternative splicing plays an important role in R protein signalling (Dinesh-Kumar and 
Baker, 2000; Ferrier-Cana et al., 2005; Gassmann, 2008). 
The transcription of HyNLR type 1 can be weakly induced by the injection of flagellin and 
LPS into the gastric cavity of Hydra (see Figure 2.5). This induction of gene expression 
dependent on MAMP treatment can be seen as a hint for the involvement of this gene in 
immunity. A reason for this relatively weak induction could be the fact that this receptor must 
be constitutively expressed. A strong expression regulation is not very likely in contrast to the 
expression of putative effector genes that might be up-regulated upon pathogen recognition. 
On the other hand, Hydra is continuously surrounded by bacteria and their cell components. 
This could lead to a constitutive induction of the gene involved in immunity. The 
development of a stable gnotobiotic culture could lead to more drastic changes of gene 
expression levels upon stimulation with MAMPs.  
 
3.2.1 Characterisation of the HyNLR interactome 
An in silico screen for potential interaction partners of Hydra NLRs resulted in several 






Figure 3.1: A model for the HyNLR signalling cascade.  
Upon activation the HyNLR might recruit the HyDD-Caspase or the HyDED-Caspase resulting in apoptosis or 
the HyDED-DD-Kinase resulting in the activation of transcription factors like HyNF-κB or HyJUN. This 
interaction might be performed directly or via the adaptor protein HyDODE. Arrows: supported by experimental 
evidence; dashed arrows: possible interaction. 
 
Three orthologs for HSP90 and one for SGT1 were identified in the Hydra genome. The 
HSP90-SGT1 complex is conserved in plants, fungi and vertebrates and one task is keeping 
the NBD containing receptors in a functional state (da Silva Correia et al., 2007; Mayor et al., 
2007). It is known that the SGT1 protein binds the NLRs in their LRR region (da Silva 
Correia et al., 2007). Since Hydra NLRs do not contain LRRs, co-immunoprecipitation 
experiments could lead to the discovery of an alternative binding site. An orthologue for the 
co-chaperone Chp-1 is also present in the Hydra genome. Chp-1 is orthologous to the plant 
co-chaperone RAR1 that is implicated in R protein-mediated disease resistance (Hahn, 2005). 
In humans the Chp-1 protein is known to form a complex with HSP90 and NOD1 (Hahn, 
2005; Wu et al., 2005). The function of this co-chaperone in innate immune signalling seems 
to be highly conserved. The detection of these proteins also in Hydra strongly supports the 
idea of an ancient phylogenetic origin of the NLR signalling. 
Interestingly, the HyNLR type 1 protein shows the highest similarity with proteins of the 
NLRP family that form the inflammasome in H. sapiens. Several components of an ancient 
inflammasome are present in the Hydra genome. An adaptor protein with two DEATH 
domains was identified that could function in analogy to the ASC protein that mediates the 
binding of caspase 1 to the human inflammasome complex (Chen et al., 2009; Srinivasula et 
al., 2002). Activation of this caspase leads to the cleavage of the cytokine precursor proIL1β 
with the subsequent release of IL1β (Cerretti et al., 1992). Three caspases coding for an  




there is a caspase with an N-terminal CARD domain present in Hydra. This caspase may 
interact with the Hydra orthologue for APAF1 and form the apoptosome. Two additional 
caspases, one coding for an N-terminal DEATH domain, the other coding for a DED domain, 
that were originally identified by Böttger and Alexandrova in Hydra vulgaris (Böttger and 
Alexandrova, 2007) are present in the Hydra magnipapillata genome as well. Interestingly, 
the HyDD-Caspase appears to be specific for the genus Hydra. One or both of these caspases 
could form an ancient inflammasome with HyNLRs that may activate cleavage of a substrate 
protein or induce apoptosis.  
Moreover, all exons of HyDODE and the HyDD-Caspase genes code for entire domains and 
are in phase 1 which is a hint for exon shuffling events to obtain these Hydra specific genes as 
discussed before (see appendix 9.5.4, 9.5.6). 
Upon activation the human NOD1 or NOD2 proteins form the NODosome complex with the 
RIPK2 to induce NF-κB, JUN or p38 signalling (Chen et al., 2009; Inohara et al., 1999; 
Ogura et al., 2001b). No direct orthologue for RIPK2 was detected in the Hydra genome, but 
a new Hydra-specific kinase containing all domains necessary for this signal transduction, the 
HyDED-DD-Kinase. This might function in analogy to RIPK2 and activate NF-κB or JUN 
signalling in Hydra.  
NF-κB proteins are a family of Rel-homology domain containing proteins that serve as 
transcription factors in a variety of signal transduction cascades (Vallabhapurapu and Karin, 
2009). In humans it consists of 5 family members: RelA; c-Rel; RelB; NF-κB1 (p50 and its 
precursor p105); and NF-κB2 (p52 and its precursor p100). The Rel proteins code for the Rel 
homology domain, an Ig-like domain and a transcription activation domain (TAD), whereas 
p100 and p105 do not code for a transcription activation domain, but instead for ankyrin 
repeats followed by a DEATH domain. These proteins need the dimerisation with Rel 
proteins to activate transcription. Upon activation of these proteins, the ankyrin repeats are 
cleaved from the protein resulting in the active protein that can translocate to the nucleus 
(Vallabhapurapu and Karin, 2009).  
Like the NF-κB orthologue from Nematostella (Sullivan et al., 2007; Sullivan et al., 2009), 
the HyNF-κB that is comprised of the Rel homology domain and an Ig-like domain seems to 
lack the C-terminal ankyrin repeats as well as the DEATH domain and homology searches 
result in the p100/p105 group as best hit as well.  
In contrast to this, a NF-κB orthologue was detected in the phylogenetically older 
demosponge A. queenslandica coding for all domains found in p100 and p105 (Gauthier and 
Degnan, 2008), suggesting that this form is more ancient and that the cnidarian NF-κB 




alone, they need a Rel protein containing a transcription activation domain to form a 
heterodimer. If it does not form a heterodimer, it might serve as a repressor of transcription. 
On the other hand, the protein may also contain a not yet identified TAD domain like as in the 
case for the Rel proteins and activate transcription without any co-activator. Future sequence 
analysis will help to elucidate the protein domain structure. 
Furthermore, it may need a protein like IκB containing ankyrin repeats to repress its 
autoactive state. An IκB-like protein is present in Nematostella (Sullivan et al., 2007), but was 
so far not identified in Hydra. An important task for future work will be to screen for 
additional Rel-homology domain containing proteins coding for a transcription activation 
domain and for IκB orthologues to elucidate the function of this transcription factor in Hydra. 
In addition, it will be of great interest to find target genes of HyNF-κB and to perform  
HyNF-κB activation assays using reporter gene constructs. 
All investigated putative interaction partners of HyNLRs are co-expressed within both 
epithelia of Hydra, most of them predominantly in the endodermal layer, so a pre-requisite for 
an interaction is fulfilled (see Figure 2.7). As mentioned above, the endoderm surrounds the 
gastric cavity and is exposed to ingested material putatively containing pathogenic 
microorganisms. The ectodermal layer must also be protected as it is permanently exposed to 
the surrounding environment. The ectodermal epithelial cells secrete the glycocalyx 
surrounding the entire animal whose function might be to build up a physical barrier against 
pathogens. This glycocalyx may also contain antimicrobial active components and serve as a 
chemical barrier as well (R. Augustin, pers. communication). In contrast, the endodermal 
epithelium is not protected by an extracellular layer and may therefore require an increased 
level of protection leading to an increased expression level of the investigated transcripts.  
It seems that the DEATH and DED domains are the folds of the NLR orthologues at the base 
of animal evolution. This must also be carried on by their interaction partners: HyDODE is 
comprised of two DEATH domains instead of ASC with its Pyrin and CARD domain. The 
HyDD-Caspase and the HyDED-Caspase contain DEATH and DED domains instead of the 
CARD-domain of the human caspase 1 and the HyDED-DD-Kinase contains a DED and a 
DEATH domain instead of the CARD domain in the human RIPK2. It seems that in higher 
vertebrates the DEATH domains were replaced by CARD domains (Hibino et al., 2006). The 
first CARD domain in a NLR is present in one NLR orthologue in S. purpuratus, but also 
here the majority of the NLR gene models contain DEATH domains (Hibino et al., 2006). As 
no Pyrin domains were detected neither in Hydra nor in any other invertebrate species by the 
performed screenings, these results support the view that the Pyrin domain is vertebrate-




One can conclude that the general mechanisms, such as the activation of a caspase or a kinase 
by an NLR and the usage of adaptor proteins as well as alternative splicing in NLRs are 
conserved throughout evolution, whereas the domain compositions and sequences of the 
proteins that are involved in the signalling cascade are not conserved and are at least in the 
case of the HyDD-Caspase and the HyDED-DD-Kinase unique to Hydra and therefore 
taxonomically restricted.  
 
3.2.2 Trans-spliced leader additions indicate a putative translational co-regulation 
of the HyNLR interactome 
Remarkably, the transcripts for HyDODE, the HyCARD-Caspase, the HyDD-Caspase and the 
HyDED-Caspase contain the same trans-spliced leader as the HyNLRs. The Hydra-specific 
trans-spliced leader B is added to all these transcripts (Stover and Steele, 2001). It is 
supposed that spliced leaders (SL) are added to at least one third of all Hydra genes 
(Chapman et al., 2010). During spliced leader addition the original 5’UTR is replaced by a 
short RNA leader sequence commonly transcribed from the spaces in between the 5S rRNA 
gene clusters (Drouin and de Sá, 1995) using splice donor and acceptor sites of the leader 
sequence and the transcribed gene (Hastings, 2005; Van der Ploeg, 1986). SL trans-splicing 
was observed in various animal groups including trypanosomes, dinoflagellates, cnidarians, 
rotifers, nematodes, flatworms and urochordates, but not in fungi, plants and vertebrates 
(Derelle et al., 2010; Lall et al., 2004; Matsumoto et al., 2010; Van der Ploeg, 1986; Wallace 
et al., 2010). In Hydra 10 SL sequences were identified (Chapman et al. 2010). A common 
ancient origin of SL addition with independent losses in many lineages and a repeated 
evolution of the mechanism are a current subject of discussion (Douris et al., 2010; Hastings, 
2005).  
The function of SL trans-splicing is not fully understood. It was shown to be involved in 
translational regulation in trypanosomes by providing the 5’ cap structure (Lee and Van der 
Ploeg, 1997). In flatworms it provides the start codon for the initiation of translation (Cheng 
et al., 2006), it can improve translational efficiency (Lall et al., 2004; Maroney et al., 1995; 
Zeiner et al., 2003) or it can help to resolve multicistronic transcripts into capped 
monocistronic mRNAs (Blumenthal, 2005; Marlétaz et al., 2008; Satou et al., 2006). In H. 
magnipapillata 32 putative operons were detected by genome screenings indicating that these 
SL additions might play a role in resolving polycistronic mRNAs to functional mRNA 
subunits (Chapman et al., 2010). It is tempting to speculate that putative immune relevant 
genes might be transcribed simultaneously within one operon and that the SL-B is added to all 
these transcripts for a translational coregulation to ensure that all pathway members are 




cannot be supported, because no genome scaffold with clustered NLR signalling genes could 
be identified in the Hydra genome. In contrast to that, in N. vectensis some NBD-coding 
genes were indeed located on the same scaffolds which could be a hint at transcriptional co-
regulation. However, in contrast to Hydra, no trans-spliced leader sequences are present in 
Nematostella (Chapman et al., 2010).  
 
3.3 Programmed cell death as an ancient immune answer? 
Hydra does not possess migratory immune cells and has an enormous self-renewing capacity 
(Bosch, 2008; Bosch, 2007). A mechanism could be conceived in which pathogen-infected 
cells could undergo apoptosis and not be ingested by neighbouring cells, because this might 
lead to the spreading of the pathogen, and simply be released into the gastric cavity and to the 
environment. The damaged tissue could easily regenerate.  
To prove this hypothesis it is important to find a Hydra pathogen that can be used in 
incubation experiments. It was observed that Hydra can release rounded cells through the 
mouth aperture and first incubation experiments with the spores of the oomycete Saprolegnia 
sp. have shown that Hydra can lose large amounts of ectodermal and endodermal cells upon 
spore attack (R. Augustin, pers. communication).  
The experiments conducted in this thesis in a HEK293 cell-based assay have shown that 
HyNLR type 1 is able to recruit two Hydra caspases; the Hydra specific HyDD-Caspase and 
the HyDED-Caspase as an ortholog of caspase 8 in vitro. This recruitment leads to elevated 
apoptosis of HEK293 cells with the HyDED-Caspase. The interaction of these proteins is 
most probably performed via the homo- or heterotypic interactions of the DEATH fold 
domains of the caspases and the NLR. An interaction of a DEATH domain with a DED 
domain is unusual, but cannot be excluded, because both domains belong to the same fold 
family. In addition, these domains are only the result of a prediction and future work must be 
conducted to elucidate the true domain foldings and their binding capacities, using e.g. 
nuclear magnetic resonance (NMR) spectroscopy or surface plasmon resonance (SPR) 
technology. 
These results can be seen as first hints that apoptosis could be indeed an ancient form of 
immune defence in Hydra. Further experiments need to be performed to prove this 
hypothesis. The interaction of the proteins must be supported independently by assays such as 
yeast two hybrid screens or co-localization experiments. The induction of apoptosis could be 
studied in addition by PARP-cleavage detection assays or DNA laddering experiments. Of 
course, in vivo studies need to be performed. Transgenic Hydra expressing 




addition of the ligand AP20187 the green glowing GFP-expressing cells should undergo 
apoptosis and disappear. With the transgenic Hydra lines that were created in this thesis it was 
not possible to perform reliable apoptosis assays, because the amount of GFP and 
HyNLR type 1::FKBP2 co-expressing cells was too low. New constructs must be generated 
where the successful expression of the HyNLR can be directly tagged visually in living 
animals. For the construction of the present expression vectors the NLR was voluntary not 
linked to a fluorescent protein to inhibit its self-assembly. However, with these constructs co-
immunoprecipitation experiments can be conducted via the HA-tag of the HyNLR fusion 
protein to identify the endogenous interaction partner. Subsequent assays to detect caspase 
activity could be performed in future work.  
Nevertheless, it is important to strictly regulate the putative apoptotic immune reaction in 
Hydra because it is not feasible to induce apoptosis only upon stimulation with a MAMP. 
Hydra is permanently surrounded by bacteria that are not harmful to it and apoptosis can only 
be permitted if a real danger threatens the animal. NLRs are good candidates for this 
activation of apoptosis because they are located intracellularly and might induce the host 
reaction to pathogens only if the pathogen is cytoinvasive similar to the function of the 
R genes in plants. A requirement for simultaneous activation of several HyNLRs to induce 
downstream signalling can not be excluded as well.  
The programmed death of an infected cell is known to play a role in an effective pathogen 
defence in many examples. Plants, sessile organisms without migrating immune cells, use a 
mechanism of programmed cell death, the HR, leading to apoptosis at the site of infection to 
limit the spread of pathogens within the whole plant (Ma and Berkowitz, 2007). HR is 
accompanied by the generation of ROS and NO. It is induced by gene-for gene interactions of 
the plant R gene with its pathogen encoded avirulence (avr) gene and provides host resistance 
to the pathogen (Rafiqi et al., 2009). But not only in plants generation of ROS is an important 
protective mechanism. Recent studies using human cell lines showed an increased ROS 
generation upon NOD2 stimulation (Lipinski et al., 2009). Furthermore, ROS appear to be 
involved in the activation of the NALP3 inflammasome via the thioredoxin-interacting 
protein (TXNIP) (Zhou et al., 2010). 
In mammals, cytotoxic T-cells recognize virus-infected cells by the presentation of a foreign 
antigen and induce their apoptotic program by the release of the pro-apoptotic cytotoxic 
proteins granzyme and granulysin that activate apoptosis by the cleavage of the procaspase 3 
and BH3 interacting domain death agonist (BID) (Lieberman, 2003).  
In invertebrates, caspases are involved in host immune defence as well. In D. melanogaster it 
was shown that loss-of-function mutants of dredd, the ortholog of caspase 8, are highly 




peptide drosomycin (Kuranaga and Miura, 2007). Furthermore the caspase inhibitor protein 
DIAP2 (Drosophila inhibitor of apoptosis 2) has been reported to be required for the IMD 
pathway regulating host defence against Gram-negative bacteria (Leulier et al., 2006).  
In C. elegans, an infection of the intestine with Salmonella typhimurium causes an increase in 
the gonadal cell death. A loss-of-function mutant of the caspase ced-3 with suppressed cell 
death activation is highly susceptible of being killed by Salmonella infections (Aballay and 
Ausubel, 2001).  
In the demosponge Suberites domuncula the expression of a caspase is highly inducible by the 
addition of the synthetic triacyl lipopeptide Pam(3)Cys-Ser-(Lys)(4), a ligand for the 
mammalian TLR1 and TLR2 (Wiens et al., 2007).  
In mammals, the inflammasome-dependent activation of caspase 1, primarily leading to the 
modification of endogenous signalling molecules, may also result in the induction of 
pyroptosis, a kind of programmed cell death that is accompanied by the release of the pro-
inflammatory cytokines IL1β, IL18 and IL33 to recruit immune cells (Bortoluci and 
Medzhitov, 2010).  
Autophagy can also be involved in the control of infections by directing intracellular or 
ingested pathogens to lysosomes leading to their destruction and can also lead to apoptotic 
death of the cell as a consequence (Bortoluci and Medzhitov, 2010).  
Therefore programmed cell death seems to be a conserved mechanism of innate immune 
defence. 
 
3.3.1 A putative immune modulatory function of HyNLRs 
The HyDD-Caspase that can also interact with the HyNLR type 1 did not show the ability to 
induce apoptosis in vitro (see Figure 2.9). This could have many reasons. Firstly, this caspase 
is Hydra specific and therefore its substrate proteins might not be present in human cell lines. 
The replacement of the caspase domain of the HyDD-Caspase and the HyDED-Caspase with 
a human caspase domain could help to compare their activation. Secondly, if the activation of 
the caspase may not lead to apoptosis in Hydra the caspase might have another immune 
modulatory role. The human caspase 1 e.g. that is activated by the inflammasome converts 
pro-inflammatory cytokines into their active released forms (Schroder and Tschopp, 2010). It 
is known that caspases in vertebrates and invertebrates have many roles in developmental 
processes, such as cell proliferation, cell migration, cell differentiation and cell shaping 
depending on the cleavage of different substrate proteins (Kuranaga and Miura, 2007). 
Caspases are also reported to modulate immune responses, like caspase 12 that has an 




Furthermore, caspase 1 is able to cleave the TLR adaptor Mal and can interfere with TLR 
signalling (Ulrichts et al., 2010). In a recent study it was shown that mice deficient for 
NLRP3 or ASC and caspase 1 were highly susceptible to dextran sodium sulphate (DSS) 
induced colitis. This was accompanied by a loss of epithelial integrity and a commensal 
overgrowth and bacteremia (Zaki et al., 2010). Thus, the activation of caspase 1 is involved in 
the maintenance of intestinal homeostasis and protection against ulcerative colitis. As 
discussed above invertebrate caspases also have immune regulatory roles.  
The HyDD-Caspase might also be involved in the cleavage of substrate proteins that can 
directly mediate defence against pathogens, such as proteins that interfere with immune 
signalling or even effector molecules. A genetic knockout of the two caspases in Hydra can 
help to elucidate their roles in immunity.  
If modulations of an immune answer rather than apoptosis are the result of the activation of 
HyNLR type 1, the transgenic polyps expressing the HyNLR type 1::FKBP2 fusion protein 
could also have been used for minimum inhibitory concentration (MIC) assays in order to 
analyse the activation of antimicrobial peptides as putative effector genes of HyNLR 
signalling. This could have been supported by comparative gene expression analyses such as 
qRT-PCR or transcriptome comparisons in order to discover putative target genes of HyNLR 
signalling that could either be conducted using the caspases or the HyDED-DD-Kinase. 
Furthermore, a comparative 16S rRNA gene analysis of the bacterial community might help 
to elucidate the role of NLR signalling in Hydra. As the amount of cells expressing the fusion 
protein is too low for a reliable conduction of these experiments, new transgenic lines must be 
established in the future. 
 
3.4 The tumour bearing polyps have an altered microbial community 
Pathogens cannot only cause apoptosis, but they can also induce tumour formation and cancer 
(Grivennikov et al., 2010; Hussain and Harris, 2007; Rakoff-Nahoum, 2006). In the tissue of 
the tumour bearing Hydra large clumps of intracellularly-located bacteria belonging to the 
order of Neisseriales have been detected within the endodermal layer (see section 2.6). This 
group cannot be detected in undifferentiated control polyps of the same species. 
Representatives of this group, such as Neisseria gonorrhoeae and Neisseria meningitidis, 
cause the human diseases gonorrhoea and meningitis (Virji, 2009). This may be a hint that the 
bacteria of the tumour bearing Hydra may also have the potential to infect an animal species.  
Remarkably, a changed microbial community with a shift to Vibrio spp. has also been 





It is unclear whether the bacteria of the tumour bearing polyps are the cause for or a 
secondary effect of the tumour. Due to the low number of animals curing experiments with 
antibiotics could not be performed. If this bacterial strain is cultivatable, inoculation 
experiments with healthy polyps could be performed to check whether they can induce 
tumour growth in Hydra.  
An example of a bacterial pathogen that can cause cancer in the human stomach is 
Helicobacter pylori. It causes long-term infections of the gastric mucosa accompanied with 
chronic inflammation that can lead to the ulceration of the stomach wall and to gastric cancer 
and mucosa-associated lymphoid tissue (MALT) lymphoma (Grivennikov et al., 2010; 
Hussain and Harris, 2007). It may be possible that the bacteria of the investigated Hydra 
strain also cause the tumour formation. 
In general, chronic inflammation as a result of infection with viruses or bacteria, because of 
inherited diseases such as Crohn’s disease or ulcerative colitis, or as a result of exposure to 
chemicals such as asbestos can be linked to tumorigenesis by providing a pro-tumorigenic 
microenvironment delivering reactive oxygen species (ROS) or reactive nitrogen 
intermediates (RNI) being capable of inducing DNA damage and genomic instability and 
delivering cytokines that may promote tumour growth (Hussain and Harris, 2007). 
Furthermore, epigenetic changes as a result of inflammation can favour tumour initiation 
(Grivennikov et al., 2010; Hussain and Harris, 2007).  
The production of ROS to inhibit pathogen growth is an ancient mechanism in immune 
defence. In addition to vertebrate immunity it was described in plant defence against insects 
(Liu et al., 2010; Moloi and van der Westhuizen, 2006) in C. elegans (Chávez et al. 2009) and 
insect immunity (Molina-Cruz et al., 2008). Until now it is not known, whether Hydra 
produces ROS upon immune stimulation. Answering this question could form an interesting 
part of future work in Hydra immunity.  
It was shown by Fraune et al. that the amount of interstitial cells in the tissue of Hydra has a 
direct effect on the composition of its microbial community (Fraune et al., 2009). A loss of 
the interstitial cell lineage and all its derivatives in the H. magnipapillata strain sf1 resulted in 
a shift from the dominating β-Proteobacteria phylotype to a new dominating phylotype of the 
Bacteroidetes group. If a loss of a cell lineage can change the microbial community than an 
excess of this cell lineage may change the microbial composition as well. The tissue 
homeostasis in the tumour bearing polyps is altered as well and because the tumour is made 
up of many interstitial cells these may cause the change in the microflora by their expressed 
gene products, e.g. antimicrobial peptides. A good candidate gene for shaping the microbial 
community expressed by the interstitial cells is periculin 1a. The expression of periculin 1 is 




et al., 2009) and the protein is located within vesicles. It is built up of an anionic and a 
cationic part and it shows antimicrobial activity. The expression of periculin 1a is restricted to 
the female germ cells. The tumour consists of female germ cells that express the periculin 1a 
protein (see Figure 2.19). Since there is enlarged periculin 1a expression this may cause the 
change of the microbial composition.  
 
3.5 The tissue homeostasis is disturbed in the tumour bearing polyps 
Tumour formation and cancer, the formation of malign tumours or neoplasia, are a 
tremendous problem in the health care system. Statistically, one third of european population 
develops cancer (ECCO, 2009). And it is a cause of death for many people. Therefore cancer 
research is a main focus in the medical research worldwide (Christofori, 2006; Grivennikov et 
al., 2010; Stratton et al., 2009). Mouse models are used to study tumourigenesis but only few 
cases of tumours in various invertebrate phyla including annelids, arthropods, molluscs and 
ascidians resulting from hereditary or environmental factors including pathogen attack have 
been described (Scharrer and Lochhead, 1950).  
Uncontrolled growth of hemocytes as a classical neplasia, also called “clam leukemia”, has 
been discovered in a variety of bivalve molluscs (Barber, 2004; Delaporte et al., 2008; Farley, 
1969a; Farley, 1969b). Few cases of tumour growth have been reported for decapod 
crustaceans (Vogt, 2008). Planarians and Drosophila have been used as invertebrate model 
organisms to study tumour formation (Jang et al., 2007; Oviedo and Beane, 2009; Rodahl et 
al., 2009). Examples for tumour formation have been detected in many coral species from 
more than ten families (Breitbart et al., 2005; Peters et al., 1986; Squires, 1965; Yamashiro et 
al., 2000). In the case of corals abnormal growth that lead to enlarged skeletal elements are 
referred to as tumours (Breitbart et al., 2005).  
In this study the first case of a tumour within a hydrozoan species is described. The tumour is 
made up of numerous interstitial cells including cells that resemble nurse cells. The cells 
express Cnnos1, a marker for germline cells in Hydra (Mochizuki et al., 2000), and 
periculin 1a (Fraune, 2008), which validates the assumption that these cells are restricted to 
the female germ line. Figure 3.2 shows a model that can be used to understand the abnormal 
proliferation of the interstitial stem cells giving rise to the tumour tissue.  
It was shown by Littlefield, Bosch and David that Hydra possesses three interstitial stem cell 
lines that have the capacity to self-renew (Bosch and David, 1987; Littlefield, 1991); the 
multipotent stem cells that give rise to all derivatives of the interstitial cell lineage, 
nematocytes, gland cells, nerve cells and gametes. The male- and female-restricted stem cell 




During oogenesis the interstitial cells start to proliferate and give rise to a large group of cells 
(Honegger et al., 1989). One cell that is located in the middle of this group differentiates into 
the oocyte and starts to phagocytose the surrounding interstitial cells that differentiate into 
nurse cells. Nurse cell differentiation is indicated by the appearance of lipid vesicles in 
interstitial cells. H. oligactis is strictly dioecious and gametogenesis can be induced by 
environmental stimuli, such as temperature decrease (Littlefield, 1991).  
 
 
Figure 3.2: Model of the interstitial cell lineage in the tumour bearing Hydra.  
The multipotent stem cell lineage in Hydra has a self-renewing capacity and gives rise to its derivatives 
nematocytes, gland cells, nerve cells and germline cells. H. oligactis is strictly dioecious and either male or 
female gametes are produced upon induction via environmental stimuli. There are sub-populations of 
gametogenesis restricted stem cell lines that also have the possibility to self-renew. In the case of the tumour 
bearing polyps, there is an over-proliferation of the female restricted stem cell lines with a blocking of the 
terminal differentiation of the oocyte, but sometimes nurse cells appear that are not phagocytosed by the oocyte. 





The tumour bearing polyps show an over-proliferation of the female restricted germline cells 
without the terminal differentiation into the oocyte. Nurse cell resembling cells occur, which 
are not phagocytosed by a developing oocyte. In histological sections one can clearly see the 
lipid droplets that are stored by the interstitial cells indicating the onset of the differentiation 
into nurse cells as shown in Figure 2.13J. Many rounded cells can be seen within the tumour, 
but only few apoptotic cells can be found, which fits to the observation that TUNEL positive 
nurse cells are only found when the new polyp hatches (Technau et al., 2003). The general 
opinion in the literature is that nurse cells start to differentiate after the oocyte is selected 
(Honegger et al., 1989; Miller et al., 2000; Technau et al., 2003). In the tumour bearing 
polyps there is no sign of oocyte differentiation. Either there is no oocyte selected, or if there 
is one, this may have lost the ability to phagocytose. An in situ hybridisation with a marker 
gene that is exclusively expressed within the developing oocyte could help to clarify the 
situation.  
The tumour bearing polyps still have the ability to produce eggs, as it could be shown by 
incubating a tumour bearing polyp under decreased temperature conditions. However, only 
one egg is produced in contrast to the normal oogenesis in H. oligactis, that is defined by the 
production of many eggs simultaneously and the appearance of small abortive eggs (Brien 
and Reniers-Decoen, 1949). This supports the findings of the disturbed oogenesis and could 
be seen as a hint for a lack of interstitial cells that could differentiate into oocytes.  
The lack of interstitial cells fits to the observation that numerous tumour bearing polyps died 
due to a decreased amount of interstitial cells that therefore could not give rise to 
nematocytes, gland cells and nerve cells as shown in Figure 2.19. This might be due to the 
fact that all multipotent stem cells undergo augmented differentiation into the female 
restricted stem cells and as a consequence, a too small amount of multipotent stem cells 
remains. The frequent longitudinal cutting of the animals for culturing purposes may have 
further promoted this situation.  
Drosophila and Hydra oogenesis share striking similarities (Alexandrova et al., 2005; Miller 
et al., 2000; Technau et al., 2003). In both species, the oocyte and nurse cells arise from 
germ-line cells. And in both species apoptosis of germline-derived nurse cells is involved in 
oocyte differentiation. Nurse cells enter the apoptotic program, but are prevented from 
complete degradation for a defined time frame (Miller et al., 2000). The species orthologues 
for caspase 3 are thought to be involved in this different apoptotic processes in Hydra and 
Drosophila (Technau et al., 2003). Although the Hydra nurse cells reside in apoptosis, they 
are still transcriptionally active and express a large number of genes involved in development 




Ovarian tumours have also been described for D. melanogaster (Bai et al., 2002; King, 1969; 
Smith and King, 1966). Here, mutations in the genes ovarian tumor (otu), Sex-lethal (Sxl) and 
sans fille (snf) result in the formation of grossly abnormal egg cysts consisting of hundreds to 
thousands of germ line cells surrounded by an unaffected somatic follicle cell layer (King, 
1969; King and Riley, 1982). The tumorous germ cells are small and fail to differentiate into 
nurse cells and oocytes.  
Also, in hard- and soft-shell clams ovarian tumours have been reported (Barry and Yevich, 
1972; Darriba et al., 2006; Hesselman et al., 1988; Van Beneden et al., 1993; Yevich and 
Berry, 1969). Three types of gonadal neoplasm histotypes have been defined in bivalves: (i) 
germinoma (follicular proliferation of immature germ cells that can expand into and beyond 
interstitial tissues); (ii) gonadal stromal neoplasms (composed of spindle cells); and (iii) 
gonadoblastoma (an intermixture of primitive follicular and stromal elements) (Darriba et al., 
2006). However, these tumours have not been characterized at the molecular level.  
 
3.5.1 Does an increased expression of oncogenes lead to tumour formation in 
Hydra? 
The tumour bearing polyps show an enlarged expression of the KRAS orthologue ras1 (see 
section 2.6.3). The oncogene KRAS encodes for a small GTPase involved in many signal 
transduction pathways as well as in the control of the cell cycle and is known to play a role in 
various cases of cancerogenesis in humans (Friday and Adjei, 2005). In most cases, point 
mutations lead to an expression of a constitutively active form of KRAS, but also gene 
amplifications or overexpression of KRAS have been reported to be implicated in 
tumourigenicity and cancer (Coleman et al., 1994; Galiana et al., 1995). Sequencing of the 
ras1 coding sequence of the tumour bearing polyps with a subsequent single nucleotide 
polymorphism (SNP) analysis in comparison to the ras1 gene of the control population would 
be useful to rule out whether this gene might be a cause for the tumour formation in these 
polyps. A generation of overexpression constructs coding for a constitutively active form of 
ras1 in Hydra could help to understand tumourigenesis in these animals.  
An enlarged expression of ras1 might be a cause for the tumour, but can also be seen as a 
result of the increased proliferation of the interstitial cells. One cannot exclude that the 
detected increase of the ras1 expression is due to a greater number of ras1 expressing 
interstitial cells in the cDNA sample as it is likely the case for the increased expression of 
cniwi. To rule out this possibility it will be necessary to use a non-inducible gene exclusively 
expressed in interstitial cells as equilibration control.  
An orthologue of the human c-myc protooncogene coding for the transcription factor Myc 




identified and characterized in Hydra (Hartl et al., 2010). Both are bHLH-Zip DNA binding 
proteins controlling the expression of up to 15 % of all human genes and regulate cell growth, 
proliferation differentiation metabolism and apoptosis (Eilers and Eisenman, 2008; Eisenman, 
2001). A deregulation of c-myc leading to elevated Myc levels leads to tumourigenesis and 
characterizes about 30 % of all human cancers (Dang et al., 2008; Nesbit et al., 1999). The 
Myc and Max orthologues myc1 and max from Hydra are expressed in fast proliferating stem 
cell populations of the interstitial cell lineage in Hydra, such as the multipotent stem cells, 
nematoblasts and gland cells, and Myc is able to induce cell transformation in avian fibroblast 
assays (Hartl et al., 2010). It would be interesting to analyse the expression levels of myc and 
max in the tumour bearing polyps. If these were elevated this could be another reason for the 
induction of the tumour. 
Another reason for tumour formation in these polyps could be environmental changes. These 
Hydra polyps have been collected from the environment and were subsequently cultivated 
under laboratory conditions. This represents an extreme change of the environment. Maybe 
this was sufficient to incompletely induce oogenesis. Nevertheless, this culture was stable for 
years, so it seems unlikely that just one change in the culturing conditions may have caused 
this extreme change in tissue homeostasis.  
 
3.6 Tumourigenesis in an immortal animal? 
As mentioned above, neoplasia is a burden on healthcare systems worldwide, but relatively 
few cases have been described in invertebrate species. A putative reason for this might be the 
relatively short lifespan of many invertebrates. Hydra is often considered to be immortal 
(Brien, 1951; Tardent, 1978) and can proliferate by budding. All three cell lines of Hydra, the 
ectodermal and the endodermal epithelial cells as well as the interstitial cells, are multipotent 
stem cells and have the ability to self-renew for a very long period of time or even 
perpetually. Therefore they show characteristics which cells of vertebrate species only have in 
embryogenesis (Bosch et al., 2010). Aspects of ageing have not been clearly shown for Hydra 
and it is proposed that it is immortal (Martínez, 1998), except for the “crise gamétogénique” 
that leads to the death of the female H. oligactis polyp after sexual reproduction because of 
the consumption of the interstitial cells (Brien and Reniers-Decoen, 1949; Yoshida et al., 
2006). Because Hydra is immortal, it is hard to define tumourigenesis or cancer as most cells 
have the ability to self-renew and it was shown that Hydra cells also have the ability to 
transdifferentiate (Siebert et al., 2008). In the case of the tumour bearing polyps, the 





A classification of these tumours from a “classic” medical point-of-view is hard because of 
Hydra’s simple body plan. One can clearly say that these tumours are not malignant or 
cancerous, because they do not seem to be tissue-invasive, as no clumps of interstitial cells 
were detected in the endodermal layer. Furthermore, the histological sections show that the 
borders of the neoplasia appear to be well defined. First transplantation experiments show, 
that the tumour cannot grow on the tissue recipients (data not shown) but this may also be due 
to the fact that the acceptor animal was male. It is known that the male germ line has a 
suppressive effect on the female germ line in Hydra (Littlefield, 1991). Therefore it may be 
correct to refer to these tumours, in a neutral way speaking, as a result of uncontrolled cell 
proliferation without implications of true cancer. 
Interestingly, the polyps that carry a tumour cannot produce buds and so the tumour is not 
transferred to the next generation under natural conditions. To obtain a clonal culture the 
polyps were cut longitudinally which would never occur in nature. Although the tumours 
were stable for years, it was not possible to enlarge the culture over a critical number of 
animals. Frequently, animals died due to a lack of interstitial cells, so these tumours cannot 
affect future generations of H. oligactis. 
An immortal animal must have evolved effective mechanisms to protect itself from a variety 
of diseases, either caused by pathogens or somatic mutations. These animals need an effective 
innate immune defence machinery that is so far characterized by the usage of Toll-like 
receptors, a large complexity of NOD-like receptors, conserved and taxonomically restricted 
putative signalling pathway components, a variety of antimicrobial peptides, and a conserved 
apoptosis machinery. In addition they need an efficient DNA repair mechanisms to protect 
themselves from the acquisition of dangerous mutations. The identification of new 
components of innate immune defence and the protection of self and the characterization of 
their networks in Hydra will be a task of future work.  
 
3.7 Hydra, a valuable model organism to analyse innate immunity and 
tissue homeostasis 
Taken together, the results of this thesis show that NLRs are conserved throughout animal 
evolution and therefore phylogenetically older than previously thought.  
The repertoire of Hydra NLRs appears to be very complex. Some mechanisms of NLR 
signalling seem to be conserved throughout animal evolution, such as the signal transduction 
through DEATH-fold effector domains between the NLR and downstream signalling 
components, e.g. adaptor proteins (HyDODE) or caspases (HyDD-Caspase, HyDED-




latter are the species-specific expansions of NLR genes, the unique domain compositions of 
NLR signalling components (HyDODE, HyDD-Caspase, HyDED-DD-Kinase), but also 
effector proteins, such as AMPs (Augustin et al., 2009a; Jung et al., 2009; Khalturin et al., 
2009).  
Furthermore, the analysis of the tumour bearing Hydra strain shows a disturbance in tissue 
homeostasis. Through an unknown trigger female germline-restricted interstitial stem cells 
over-proliferate and form tumour-like structures. These polyps cannot proliferate by budding 
indicating severe defects. These polyps are a valuable tool for further studies of the control of 
cell proliferation and apoptosis. 
Although Hydra, as a representative of early branching metazoan animals, has a very simple 
body plan, it already possesses many mechanisms of innate immunity and maintenance of 
tissue homeostasis. All these mechanisms need to be tightly controlled and are interwoven in 
a complex regulatory network. Because of its simplicity, Hydra is a useful model organism to 
gain insights into these complex networks. 
 
3.8 Future prospects 
NLRs are sensors of MAMPs and endogenous “danger” signals (Chen et al., 2009). They are 
key regulators of the maintenance of epithelial barrier integrity in mammals (Rosenstiel et al., 
2007). However, these receptors are not only present in vertebrates (Hibino et al., 2006; 
Huang et al., 2008). The repertoire of NLR proteins throughout the animal kingdom is very 
diverse and especially in early branching metazoans very complex. This rich repertoire was 
most likely acquired through species-specific gene amplifications in adaptation to their habitat 
and its concomitant pathogens. Not only receptors, but also basic principles of their signal 
transduction pathways could be conserved throughout animal evolution. However, species-
specific pathway components may have evolved as well. In Hydra, the activation of NLR 
signalling may lead to apoptosis as an ancient form of immune response. 
The results of this study may lead to new and interesting questions that may form part of 
future investigations: 
 
 When in the evolution of Metazoa did the first NLRs appear? 
o Did these NLRs already have a role in immunity? 
o What is the mechanism of action of the ancestral NLR-signalling cascade? 
o How is it regulated? 
 Does the activation of NLR-signalling in Hydra lead to apoptosis in vivo? 




 What are the target genes of HyNLRs? 
 What is the result of their activation? 
Furthermore, the analysis of a tumour bearing strain of H. oligactis showed an altered 
microbial community. The cells that contribute to the tumour are female germline-restricted 
cells and the tumour formation resembles Hydra oogenesis in several aspects.  
Questions that arise as a result of these observations include: 
 What causes tumourigenesis? 
o Are bacteria or mutated oncogenes the reason for the tumour-formation? 
o Are environmental changes the trigger for the tumour growth? 
 Which genes are affected by tumour-formation with regard to their expression? 
 If tumour formation represents an incomplete misguided oogenesis, is there a cell that 
differentiates into an oocyte simultaneously with nurse cells? 







The initial sensing of invading potential pathogenic microorganisms by pattern recognition 
receptors (PRRs) of the innate immune system is pivotal for the survival of the host. 
Nucleotide binding and oligomerization domain (NOD)-like receptors (NLRs) are a family of 
cytoplasmic PRRs that recognize conserved microbe-associated molecular patterns (MAMPs) 
or endogenous danger signals. Upon activation, these proteins trigger the release of pro-
inflammatory cytokines and antimicrobial peptides (AMPs) via a variety of signal 
transduction cascades in mammals. All pathways have in common the initial formation of a 
multimeric complex of the activated NLR and downstream signalling proteins through 
homophilic interactions of effector domains. Many genetic variants of NLRs have been linked 
to chronic inflammatory disorders of the human epithelial barrier organs.  
Although these receptors are of fundamental importance for understanding the maintenance of 
the human barrier integrity not much is known about their evolutionary roots.  
This thesis involved screening the genomes of a variety of animal species with a focus on 
basal Metazoa and particularly on the freshwater polyp Hydra for NLR orthologues. It was 
subsequently demonstrated that the family of NLRs is evolutionary conserved and that 
frequently throughout animal evolution species-specific gene-amplifications occurred.  
Hydra is continually surrounded by potential pathogenic microorganisms and must rely on an 
effective epithelial defence machinery. Using Hydra as a model organism for epithelial 
defence, the expression profile of one of the identified Hydra NLRs, HyNLR type 1 was 
analysed in detail. This gene is predominantly expressed in the endodermal epithelium and is 
subject of alternative splicing. A co-expressed putative HyNLR-interactome has been 
identified as well. First functional in vitro studies using an artificially activatable chimeric 
protein including the N-terminal part of HyNLR type 1 could show that Hydra caspases may 
link NLR signalling to apoptosis as an ancient mechanism of innate immune defence.  
As well as a genetic background, environmental changes and an altered composition of the 
host’s microbiota are proposed to contribute to the development of barrier diseases. A tumour 
bearing Hydra strain with an altered microbial composition was analysed using histological 
and molecular biological techniques. The tumour was shown to be composed of female 
germline-determined interstitial stem cells. The tumour-like structure shows numerous 
parallels to oogenesis in Hydra, including lipid storage, the appearance of nurse cells and the 
expression of germline-specific genes. This first detailed description of tumour formation in a 






Das initiale Erkennen eindringender potenziell pathogener Mikroorganismen durch Muster-
Erkennungsrezeptoren (pattern recognition receptors (PRRs)) des angeborenen 
Immunsystems ist entscheidend für das Überleben des Wirts. Nucleotide binding and 
oligomerization domain (NOD)-like Rezeptoren (NLRs) stellen eine Familie von 
zytoplasmatischen PRRs dar, die konservierte Mikroben-assoziierte molekulare Muster 
(microbe-associated molecular patterns (MAMPs) oder endogene Gefahrsignale erkennen. 
Nach ihrer Aktivierung leiten diese Proteine in Säugetieren die Freisetzung 
proinflammatorischer Zytokine und antimikrobieller Peptide (antimicrobial peptides (AMPs)) 
über eine Vielfalt von Signaltransduktionskaskaden ein. Allen Signalwegen gemein ist die 
initiale Bildung eines multimeren Komplexes aus dem aktivierten NLR und nachgeschalteten 
Signalproteinen durch homophile Interaktionen ihrer Effektordomänen. Viele genetische 
Varianten der NLRs sind mit chronisch entzündlichen Erkrankungen der menschlichen 
Barriereorgane in Verbindung gebracht worden. 
Obwohl diese Rezeptoren von fundamentaler Bedeutung für das Verständnis der 
Aufrechterhaltung der humanen Barriere Integrität sind, ist nicht viel über ihre evolutiven 
Wurzeln bekannt. 
Diese Arbeit umfasste das Überprüfen der Genome zahlreicher Tierarten mit einem 
besonderen Fokus auf basalen Metazoen und insbesondere auf dem Süßwasserpolypen Hydra 
auf Orthologe für NLRs. Es konnte weiterhin gezeigt werden, dass die Familie der NLRs 
evolutionär konserviert ist und dass häufig während der Evolution der Tiere artspezifische 
Gen-Amplifikationen aufgetreten sind.  
Hydra ist stets von potenziell pathogenen Mikroorganismen umgeben und auf effektive 
epitheliale Abwehrmechanismen angewiesen.  
Hydra wurde als Modellorganismus für epitheliale Abwehr benutzt und das Expressionsprofil 
eines der identifizierten Hydra NLRs, HyNLR type 1, detailliert untersucht. Dises Gen wird 
vor allem im endodermalen Epithel exprimiert und unterliegt alternativem Spleißen. Ein 
koexprimiertes putatives Interaktom für HyNLRs konnte ebenfalls identifiziert werden. Erste 
funktionelle in vitro Studien mit einem künstlich aktivierbaren chimären Protein, das den  
N-terminalen Bereich von HyNLR type 1 enthält, konnten zeigen, dass Hydra Caspasen die 
NLR Signalgebung mit Apoptose als einer alten Form der angeborenen Immunantwort 
verknüpfen können. 
Es wird vermutet, dass nicht nur ein genetischer Hintergrund, sondern auch Veränderungen 




von Barriere-Erkrankungen beteiligt sind. Ein spontan aufgetretener Tumor in einer Hydra-
Linie, die eine veränderte mikrobielle Zusammensetzung aufwies, wurde histologisch und 
molekularbiologisch untersucht. Es konnte gezeigt werden, dass der Tumor von interstitiellen 
Stammzellen, die auf die weibliche Keimbahn festgelegt sind, gebildet wird. Die Tumor-
artige Struktur zeigt viele Parallelen zur Hydra-Oogenese auf. Dies beinhaltet die 
Speicherung von Lipiden, das Auftreten von Nährzellen und die Expression von Keimbahn-
spezifischen Genen. Diese erste detaillierte Beschreibung einer Tumorbildung in einem 








6.1 Organisms and cell lines 
Hydra strains:  H. magnipapillata (105) 
H. vulgaris (AEP) 
H. oligactis 
Tumour bearing H. oligactis  Dr. Boris Anokhin 
H. oligactis St. Petersburg  Dr. Boris Anokhin 
Feeding strain:  Artemia salina    Silver Star 
Cell line: HEK293 (ACC305)    German Collection of  
Microorganisms and Cell Cultures 
(DSMZ, Braunschweig, Germany) 
Bacterial strains: E. coli ElectroMAXTM DH5α-ETM invitrogen 
Pseudomonas fluorescens  Department of Dermatology, Kiel 
P. aeruginosa (ATCC33348)  Department of Dermatology, Kiel 
P. aeruginosa (ATCC33354)  Department of Dermatology, Kiel 
 
6.2 Media 
Artemia medium      31.8 g sea salt/l Millipore water 
DMEM medium (Ready Mix)   PAA Laboratories 
LB medium 10 g peptone, 5 g yeast extract, 5 g NaCl, 
water up to 1 l, autoclaved 
LB medium with ampicillin LB medium, add 50 µg/ml ampicillin, 
water up to 1 l, autoclaved 
LB agar LB medium, add 15 g agar agar, water up 
to 1 l, autoclaved 
TSB medium 3.0 g Tryptic Soy Broth, 17.0 g peptone, 
2.5 g  glucose, 5.0 g NaCl, 2.5 g K2HPO4, 
water up to 1l  
MG medium 40 mM K2HPO4, 30 mM glucose, 22 mM 
KH2PO4, 7 mM (NH4)2SO4, 0.5 mM 
MgSO4 
Hydra medium 1 mM CaCl2, 1 mM NaCl, 0.1 mM 
MgSO4, 0.1 mM KCl, 1 mM TRIS-HCl 
(pH 7,8) 
Volvic       Danone Waters 
SOB medium 20 g peptone, 5 g yeast extract, 0.55 g 
NaCl, 1.86 g KCl, water up to 1l, 
autoclaved, add 10 ml 1M MgSO4 und 
10 ml 1M MgCl2 (both sterile) 





6.3 Buffers and solutions 
6.3.1 General 
APS stock solution  10 % in Millipore water 
Denhardt´s (50x)  1 % Polyvinylpyrrolidone, 1 % Ficoll, 
1 % BSA fraction V in Millipore water 
(sterile) 
DNA loading buffer  50 % glycerol, 10 mM EDTA (pH 8.0), 
0.1 % SDS, 0.1 % Bromophenol blue, 
0.1 % Xylene cyanol 
EDTA solution     0.5M EDTA (pH 8.0) 
Hoechst stock solution    1mg/ml in Millipore water 
Mowiol 5 g Mowiol 4-88 in 20 ml 100 mM TRIS 
(pH 8.0), stir for 16h at room temperature, 
then add 10 ml glycerol, stir for 16h at 
room temperature. Clarification of the 
solution by centrifugation (5000 rpm, 
20 min). Stored at -20 °C in aliquots 
(500 μl). Prewarm to room temperature 
before use. 
Mowiol/DABCO 2 ml Mowiol, add some crystals of 
DABCO 
NTM buffer 100 mM NaCl, 100 mM TRIS-HCl, 
50 mM MgCl2, pH 9.5 
NTMT  buffer      NTM, add 0.1 % Tween20 
Paraformaldehyde stock solution 8 % paraformaldehyde in Millipore water, 
heat in water bath at 50 °C, add droplets 
of NaOH until the powder lyses, pH 7.4 
PBS buffer      150 mM NaCl, 80 mM K2HPO4, pH 7.34  
PBS/ glycerol      9:1 of PBS and glycerol 
PBT buffer      PBS, add 0.1 % Tween20 
Phalloidin stock solution    0.1mg/ml in Millipore water 
SDS stock solution  10 % in Millipore water 
Sheep serum      inactivation at 56 °C for 30 min 
SSC buffer (20x)     3M NaCl, 0.3M sodium citrate (pH 7.0)  
TAE buffer (50x) 242 g TRIS base, 57.1 ml 100 % acetic 
acid, 100 ml 0.5M EDTA, Millipore water 
up to 1l 
TBE (10 x) 0.89 M TRIS base, 0.89 M boric acid, 
0.02 M EDTA 
TBS buffer (10x)     200 mM TRIS, pH 7.6, 1.37 M NaCl 
TBST buffer      TBS, add 0.1 % Tween20 




Urethane relaxing solution     2 % urethane in Hydra medium 
 
6.3.2 In situ hybridisation 
Blocking Solution 80 % MAB-B, 20 % heat-inactivated 
sheep serum 
Glycine working solution    4 mg glycine per ml PBT 
Hybridisation Solution 50 % formamide, 5x SSC, 0.1 % 
Tween20, 0.1 % CHAPS, 1x Denhardt´s, 
100 µg/ml Heparin in Millipore water 
MAB 100 mM maleic acid, 150 mM NaCl, 
pH 7.5 
MAB-B      MAB plus 1 % BSA fraction V 
Triethanolamine     100 mM triethanolamine (pH 7.8)  
 
6.3.3 Southern blot 
Sephadex G-50 suspension 5 g Sephadex G-50 in 100 ml TE buffer, 
autoclaved 
Washing solution 1     2x SSC, 0.1 % SDS 
Washing solution 2     0.2x (0.5x) SSC, 0.1 % SDS 
Denaturating solution     1.5M NaCl, 0.5M NaOH 
Neutralisation solution    1M TRIS, pH 7.4, 1.5M NaCl 
Hybridisation solution 50 % formamide, 4.8x SSC, 10 mM 
TRIS-HCl, pH 7.5, 1 % SDS, 1x 
Denhardt’s, 10 % dextran sulfate 
 
6.3.4 Procaine 
Dissociation medium 3.6 mM KCl, 6 mM CaCl2, 1.2 mM 
MgSO4, 6 mM sodium citrate, 6 mM 
sodium pyruvate, 12.5 mM TES, pH 6.9, 
sterile 
Solution A 1:1:1 dilution of 1 % Procaine-HCl in 
Millipore water, Dissociation medium, 
Hydra medium, pH 4.5 
Solution B 1:1:1 dilution of 1 % Procaine-HCl in 
Millipore water, Dissociation medium, 
Hydra medium, pH 2.5 
 
6.3.5 TUNEL 
Blocking solution     20 % heat-inactivated sheep serum in PBS 





6.3.6 Western blot 
Blocking solution     TBST, add 5 % milk powder 
Coomassie solution 0.05 % Coomassie in decolourising 
solution 
Decolourising solution 50:1:40 of methanol, acetic acid, 
Millipore water 
Gel buffer 1      0.5M TRIS-HCl (pH 6.8) 
Gel buffer 2      1.5M TRIS-HCl (pH 8.8) 
Loading buffer (2x) 135 mM TRIS-HCl (pH 6.8), 20 % 
glycerol, 4 % SDS, 2 %  
β-mercaptoethanol, 0.001 % 
bromophenol blue 
Running buffer 125 mM TRIS, 0.96 M glycine, 0.5 % 
SDS 
Separating gel (12 %, 90 ml)  36 ml 30 % acrylamide/0.8 % 
bisacrylamide, 22.5 ml gel buffer 2, 
900 µl 10 % SDS, 45 µl TEMED, 450 µl 
10 % APS, 30.1 ml water 
Stacking gel (45 ml) 5.85 ml 30 % acrylamide/0.8 % 
bisacrylamide, 11.25 ml gel buffer 1 
450 µl 10 % SDS, 45 µl TEMED, 225 µl 
10 % APS, 27.45 ml water 
Transfer buffer 25 mM TRIS, 192 mM glycine,                
10 % methanol 
 
6.3.7 Coimmmunoprecipitation 
Anode buffer I     30 mM TRIS, 20 % methanol 
Anode buffer II     300 mM TRIS, 20 % methanol 
Cathode buffer 25 mM TRIS, 20 % methanol, 40 mM  
6-aminocaproic acid 
RIPA buffer 50 mM TRIS-HCl (pH 7.4), 1 % NP40, 
0.25 % sodium deoxycholate,             
150 mM NaCl 
 
6.3.8 FISH 
Hybridisation solution (4 ml) 360 µl 5M NaCl, 40 µl 1M TRIS-HCl 
(pH 7.4), 200 µl formamide, 1398 µl 
Millipore water, 2 µl 10 % SDS 
Washing buffer (50 ml) 4.5 ml 5M NaCl, 1 ml 1M TRIS-HCl, 






Maceration solution     1:1:13 of acetic acid, glycerol, water 
 
6.3.10 DNA extraction 
Lysis Buffer 100 mM TRIS-HCl, pH 8.0, 100 mM 
EDTA, 1 % SDS 
 
6.3.11 Histology 
Lead citrate solution 1.33 g Pb(NO3)2, 1.76 g sodium citrate in 
Millipore water, mix for 30 min, add 8 ml 
1M NaOH and fill up to 50 ml with 
Millipore water  
Richardson  0.5 % Methylene blue, 0.5 % borax, 0.5 % 
Azur II in ddH2O 
Sudan Black B Solution  1 g Sudan Black B in 100 ml 100 % 
ethanol, heat to cooking using a water 
bath, cool down and filtrate 
 
6.3.12 DNA sequencing 
Sequencing gel for LI-COR (41 cm) 10.5 g urea, 14 ml Millipore water, 
3.75 ml Rotiphorese® Gel 40, 2.5 ml 10x 
TBE, 38 µl TEMED, 175 µl 10 % APS 
Sequencing gel for LI-COR (66 cm) 21 g urea, 28 ml Millipore water, 5.55 ml 
Rotiphorese® Gel 40, 5 ml 10x TBE, 
76 µl TEMED, 350 µl 10 % APS 
 
6.4 Chemicals 
1,2-Propylene oxide       Roth 
6-Aminocaproic acid       Sigma 
Acetic acid         Roth 
Acetic anhydride        Roth 
Agar 100 resin       Agar Scientific 
Agar agar         Roth 
Agarose         Roth 
Ammonium persulfate (APS)     Merck 
Ammonium sulfate ((NH4)2SO4)     Roth 
Ampicillin         Merck 
AP20187        Ariad 
Azur II         Merck 
Boraxcarmin solution       Chroma-Gesellschaft 
Boric acid         Roth 
Bovine serum albumine (BSA) fraction V     Roth 
Bromophenol blue       Sigma 




CHAPS         Roth 
Chloroform         Roth 
Coomassie Brilliant Blue R-250     Serva 
DABCO        Sigma 
dCTP (100 mM)       Fermentas 
DEPC          Roth 
Developer        Agfa 
Dextran sulfate       Roth 
dGTP (100 mM)       Fermentas 
DIG-dUTP         Roche 
Dipotassium phosphate (K2HPO4)     Merck 
dNTP mix (10 mM)       Fermentas 
dTTP (100 mM)        Fermentas 
EDTA         Roth 
Ethanol         Roth 
Ethidium bromide        Roth 
Euparal         Roth 
Ficoll         Sigma 
Fixer         Tetenal 
Flagellin        Alexis 
Formamide         Roth 
FuGENE® 6 Transfection Reagent      Roche 
Gelatine        Sigma 
Glass wool         Serva 
Glucose         Roth 
Glutaraldehyde       Sigma 
Glycerol         Roth 
Glycine         Roth 
Heparin        Roth 
Hoechst        Calbiochem 
Hydrochloric acid (HCl)       Roth 
Isopropanol         Roth 
Lead (II) nitrate (Pb(NO3)2)      Merck 
Lead acetate        Merck 
Levamisole        Roth 
Lipopolysaccharide (LPS)      Borstel 
Magnesium chloride (MgCl2)     Merck 
Magnesium sulfate (MgSO4)      Merck 
Maleic acid         Roth 
Methanol         Roth 
Methylene blue        Merck 
Milk powder         Roth 
Monopotassium phosphate (KH2PO4)    Merck 
Mowiol 4-88        Calbiochem 
TES         Sigma 
NBT/BCIP        Roche 
Nitrogen (N2)        Westfalia 
Nonidet P40 (NP40)       Sigma 
Osmium tetroxide (OsO4)      Roth 
Paraformaldehyde       Sigma 




Phalloidin-Tetramethylrhodamine B isothiocyanate   Sigma 
Phenol         Roth 
Phosphatase inhibitor cocktail 2     Sigma 
Pioloform        Plano 
Polyvinylpyrrolidone       Sigma 
Potassium chloride (KCl)      Roth 
Procaine hydrochloride      Sigma 
Protease inhibitor tablets      Roche 
Protein A/G PLUS-Agarose       Santa Cruz Biotechnology 
Rhodamine B Isothiocyanate-Dextran R9379    Sigma 
Rotiphorese® Gel 30       Roth 
Rotiphorese® Gel 40       Roth 
Salmon sperm DNA       Invitrogen 
Sea salt (Reef crystalsTM)      Aquarium Systems 
Sephadex G-50       Pharmacia 
Sheep serum        Sigma 
Sodium acetate       Roth 
Sodium cacodylate       Sigma 
Sodium chloride (NaCl)       Roth 
Sodium citrate (Na3(C6H5O7))      Roth 
Sodium deoxycholate       Sigma 
Sodium dodecyl sulfate (SDS)      Roth 
Sodium hydroxide (NaOH)       Roth 
Sodium pyruvate       Sigma 
Sudan Black B        Merck 
Tetramethylethylenediamine (TEMED)    Serva 
Triethanolamine       Sigma 
TRIS base         Roth 
TRIS-HCl         Roth 
TritonX100        Merck 
TRIzol®        Invitrogen 
tRNA yeast        Sigma 
Tryptic Soy Broth       Sigma 
Tween20        Roth 
Uranyl acetate        Merck 
Urea         Roth 
Urethane         Sigma 
Volvic water        Danone waters 
Xylene cyanol        Sigma 
Yeast extract         Roth 
β-Mercaptoethanol       Sigma 
 
6.5 Kits 
Amersham ECL PlusTM Western Blotting Reagent Pack   GE Healthcare 
ARGENT™ Regulated Homodimerization Kit    Ariad 
BigDye® Terminator v1.1 Cycle Sequencing Kit    Applied biosystems 
DIG RNA Labeling Kit (SP6/T7)      Roche 
DNeasy Blood & Tissue Kit        Qiagen 




FITC Annexin V Apoptosis Detection Kit I      BD PharmigenTM 
NucleoSpin® Extract II       Macherey Nagel 
NucleoSpin® Plasmid QuickPure      Macherey Nagel 
pGEM®-T Kit        promega 
QIAfilterTM Plasmid Maxi Kit      Qiagen 
QIAfilterTM Plasmid Midi Kit      Qiagen 
RNeasy® Mini-Kit        Qiagen 
SequiTherm EXCELTM II DNA Sequencing Kit    Epicentre 
SuperSignal West Pico Chemiluminescent Substrate    Thermo Scientific 
 
6.6 Enzymes 
DNase I          Fermentas 
Gateway® BP Clonase® II enzyme mix     Invitrogen 
Gateway® LR Clonase® II enzyme mix     Invitrogen 
Klenow fragment         Fermentas 
Platinum® Taq Polymerase High Fidelity      Invitrogen 
Proteinase K         Sigma 
RNase A         Fermentas 
T4 ligase          Fermentas 
Taq DNA polymerase       GE Healthcare 
Terminal Deoxynucleotidyl Transferase (TdT)    Fermentas 
 
6.6.1 Restriction enzymes 
BsuRI         Fermentas 
EcoRI         Fermentas 
EcoRV        New England Biolabs 
FseI   New England Biolabs 
Hin6I         Fermentas 
HindIII        Fermentas 
PsyI         Fermentas 
XbaI         Fermentas 
 
6.7 Vectors 
pGEM®-T       Promega 
pCEV-GwA      provided by G. Jacobs (see appendix) 
pC4M-Fv2E       Ariad 
pCMV-Myc      Clontech 
pDONR®221      Invitrogen 
hydeath-fkbp      synthesised by GENEART (see appendix) 
ligR1       provided by K. Khalturin (see appendix) 
 
6.8 Oligonucleotides 





6.9 Radioactive nucleotides 
α-[32P]-dATP        GE Healthcare 
 
6.10 Antibodies 
Alexa Fluor® 488 donkey anti-mouse IgG (H+L)   Invitrogen 
Anti HA High Affinity Rat mAB (clone 3F10)   Roche 
Anti-Digoxigenin-alkaline phosphatase linked Fab fragments  Roche 
Anti-FLAG® M2 Antibody       Sigma-Aldrich 
Anti-Periculin antiserum N31  V. Klimovich 
Cy3 AffiniPure Donkey Anti-Mouse IgG    Jackson Immunoresearch 
ECLTM Mouse IgG Horseradish Peroxidase-linked Whole Ab GE Healthcare 
ECLTM Rabbit IgG Horseradish Peroxidase-linked Whole Ab GE Healthcare 
HA-Tag (6E2) mouse monoclonal antibody    Cell Signaling Technology 
Myc-Tag (71D10) Rabbit mAb     Cell Signaling Technology 
Peroxidase AffiniPure Goat Anti-Rat IgG    Jackson Immunoresearch 
 
6.11 DNA and protein size standards 
GeneRulerTM DNA Ladder Mix      Fermentas 
Precision Plus Protein Dual Color Standard    Bio-Rad 
Prestained Protein Marker, Broad Range    New England Biolabs 
 
6.12 Lab equipment and other materials 
6.12.1 PCR machines 
Cyclone gradient        Peqlab 
Primus 96 plus        MWG-Biotech 
Primus 25         MWG-Biotech 
7900HT Fast Real Time PCR-System    Applied Biosystems 
 
6.12.2 Power supplies 
E835         Consort 
PP3000        Biometra 
EPS-500/400        Pharmacia Biotech 
EPS-3500        Pharmacia Biotech 
 
6.12.3 Gel electrophoresis chambers 
MINI SUB-CELL®       Bio-Rad 
Novex Mini-Cell       Invitrogen 
SUB-CELL® GT       Bio-Rad 
SE250 PAGE gel chamber      Hoefer Scientific Instr. 





6.12.4 Incubators/ shakers 
CB150 (Cell culture incubator)     Binder 
Certomat® H        B. Braun 
Certomat® R        B. Braun 
HIS25         Grant BOEKEL 
KS10 (rotation shaker)      Edmund Bühler 
Thermoincubator       Heraeus Instruments 
Thermomixer Compact      Eppendorf 
ThermoStat plus       Eppendorf 
Oven/ incubator       Memmert 
C/R5 (waterbath)       Julabo 
Rotation incubator RM5      Assistant 
 
6.12.5 UV devices 
UV lamp Chroma 43       Vetter GmbH 
ImaGo Compact Imaging System     B&L Systems 
UV-Stratalinker® 1800      Stratagene 
 
6.12.6 Electroporation devices 
Gene Pulser II        Bio-Rad 
Pulse Controller II       Bio-Rad 
 
6.12.7 Centrifuges 
Centrifuge 5415 D       Eppendorf 
Centrifuge 5417 R       Eppendorf 
miniSpin        Eppendorf 
Multifuge 3 S-R       Heraeus 
Speed Vac® Plus       Savant 
Universal Vacuum System Plus     Savant 
 
6.12.8 Microscopy 
CLSM TCS SP/UV       Leica 
DC300F (digital camera)      Leica 
Transmission electron microscope EM 208 S   Philips 
Axiovert 100        Zeiss 
Axioskop 2        Zeiss 
AxioCam (digital camera)      Zeiss 
SZX16        Olympus 
DP71 (digital camera)      Olympus 
Wild M3C binocular        Heerbrugg 
KL1500 LCD        Schott 
 
6.12.9 Photometer 
Nanodrop ND1000 photometer     Thermo Scientific 





6.12.10 Sanger sequencing 
3730 DNA Analyzer        Applied Biosystems 
4300 DNA Analyzer        LI-COR 
 
6.12.11 Other devices 
AF-10 (ice machine)       Scotsman 
Air pump        WISA D.B.G.M. 
Curix 60         AGFA 
Eraser (erasing phosphoimager screens)     Raytest 
FACSCalibur flow cytometer      BD Biosciences 
FemtoJet         eppendorf 
Flaming/ Brown Micropipette Puller Model P-97    Sutter instrument 
Freezer -20 °C       Liebherr 
Freezer -80 °C       Forma Scientific 
LaminAir® HB 2448 (cleanbench)     Heraeus Instruments 
Micromanipulator 5171       Eppendorf 
Microwave        Moulinex 
Milli-Q Academic System      Millipore 
pH211 Microprocessor pH Meter     Hanna Instruments 
Phosphoimager FLA-5000       Fuji 
Phosphoimager-screen      Fuji 
Refrigerator        Liebherr 
Scintillation counter       Siemens 
SEDECM        Peqlab 
Ultratome Ultracut S       Leica 
UV-Stratalinker 1800       Stratagene 
VARIOKLAV Sterilizer Typ 400 EV     H+P Labortechnik GmbH 
Vortex-Genie2®       Scientific Industries 
Wallac WinSpectral        Perkin Elmer 
Weighing machine       Sartorius 
Combimag RTC magnet stirrer     IKA 
Laboratory scales 770      Kern 
 
6.12.12 Expendable materials 
Tube (15 ml, 50 ml)       Sarstedt 
10 ml pipettes        Sarstedt 
6-well microtiter plates      Greiner bio-one 
12-well microtiter plates      Greiner bio-one 
24-well microtiter plates      Greiner bio-one 
1 ml syringe        Braun 
20 ml syringe        Henke-Sass, Wolf 
Multiply®-µStrip Pro 8-strip      Sarstedt 
Multiply®- Pro cup 0.2 ml      Sarstedt 
Multiply®- Pro cup 0.5 ml      Sarstedt 
Multiply®-µStrip 0.2 ml chain     Sarstedt 
8-Lid chain, dome cap      Sarstedt 
Microtube 1.5 ml       Sarstedt 
SafeSeal tube 2 ml       Sarstedt 




Amersham Hyperfilm ECL       GE Healthcare 
Cover slips        Roth 
Membrane filter disc (0.025 µm)     Millipore 
Extra thick filterpaper       Invitrogen 
Amersham HybondTM N+ membrane    GE Healthcare 
UVette®        Eppendorf 
Cuvettes        Sarstedt 
Electroporation cuvettes (1mm)     Peqlab 
NuPAGE® 4-12 % Bis-TRIS Gel      Invitrogen 
Pasteur pipettes (150mm, 230mm)     Eydam 
Petri dishes (35x10mm, 60x15mm, 92x16mm)   Sarstedt 
Plastic dishes        Westmark 
Roti®-PVDF membrane      Roth 
Grid Box        Plano 
Grid G2500        Plano 
Scalpel blades        Merck 
Pipette tips (2.5 µl, 200 µl, 1000 µl, 5 ml)    Sarstedt 
Gel Blotting Paper GB002      Schleicher & Schuell 
BioMax MS (x-ray film)      Kodak 
Latex gloves        Roth 
Nitril gloves        Roth 
Microscope Slides       Walter-CMP 
Flat embedding mould G3690 (rubber)    Plano 
Filtropur S (0.2 µm, 0.45 µm)     Sarstedt 
Plastic foil         Aldi 
Micro mortar        Fisher 
Parafilm        Pechiney Plastic Packaging 
 
6.12.13 Other materials 
Sieves         Nuova 
Glass bottles        Schott 
Pipettes (2-20 µl, 20-200 µl, 0.1-1 ml, 0.5-5 ml)   Gilson 
Pipette (0.1-2.5 µl)       Eppendorf 
Easypet        Eppendorf 
250 ml tubes         Sorval 
Micro cannulation needle       Hamilton Bonaduz AG 
Beaker glasses       Schott 
BioMax® MS Intensifying Screen     Kodak 
X-ray cassettes       Kodak 
Erlenmeyer flasks       Schott 














AG Bosch internal BLAST server http://134.245.171.51/blast/ 
BLAST searches   http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Compagen    http://compagen.zoologie.uni-kiel.de/ 
Compagen_NG   http://134.245.171.51/compagen_ng/blast/blast_cs.html 





Genome Browser Daphnia  http://genome.jgi-psf.org/Dappu1/Dappu1.home.html 
Genome Browser Hydra  http://www.ncbi.nlm.nih.gov/ 
http://hydrazome.metazome.net 
Genome browser Nematostella http://genome.jgi-psf.org/Nemve1/Nemve1.home.html 
Ribosomal database project  http://rdp.cme.msu.edu/ 
SMART    http://smart.embl-heidelberg.de/smart/ 
Stellabase    http://evodevo.bu.edu/stellabase/ 
 
6.14 Software 
Axio Vision 3.1     Zeiss 
BioEdit     http://www.mbio.ncsu.edu/BioEdit/bioedit.html 
Cell^A Imaging software    Olympus 
DNAMAN4.15    Lynnon Coprporation 
e-Seq 3.0     LI-COR 
FigTree1.3.1      http://tree.bio.ed.ac.uk/software/figtree/ 
HMMER     http://hmmer.janelia.org/ 
IM 50 4.0      Leica 
InterProScan     http://www.ebi.ac.uk/Tools/InterProScan/ 
Jalview     http://www.jalview.org/ 
MEGA 3.0     http://www.megasoftware.net/index.html 
MEGA 4.0     http://www.megasoftware.net/index.html 
MINIMUS http://sourceforge.net/apps/mediawiki/amos/ 
index.php?title=AMOS 
MrBayes 3.1.2    http://mrbayes.csit.fsu.edu/ 
MUSCLE     http://www.ebi.ac.uk/Tools/muscle/index.html 
PhosphoImager AIDA Image Analyser  Raytest 
Photoshop CS4     Adobe 
Pintail      http://www.bioinformatics-toolkit.org/Pintail/ 








7.1 Cultivation and incubation of Hydra and HEK293 cells 
7.1.1 Cultivation of Artemia salina 
Artemia salina served as food for all used Hydra species. For hatching, eggs were incubated 
overnight at 32 °C in Artemia medium under permanent air supply. Afterwards, nauplii were 
kept at room temperature for several days. For feeding the Hydra polyps, nauplii were 
collected and, by using a close meshed sieve, washed with water to remove salts. Afterwards, 
Artemia were resuspended in Hydra medium.  
 
7.1.2 Cultivation of Hydra 
Hydra polyps were kept in plastic dishes at 18 °C in Hydra medium with a 12 h day-night 
cycle according to standard methods (Lenhoff and Brown, 1970). All animals were fed two to 
four times per week. For comparative incubation experiments all animals were kept under the 
same feeding conditions. All experiments for the NOD-like receptor study were performed on 
H. magnipapillata. The transgenic polyps were obtained using H. vulgaris (AEP). The tumour 
bearing polyps were kept in a petri dish that was replaced after each feeding. Only polyps 
with more than five tentacles were cut longitudinally to expand the culture. A laboratory male 
strain of H. oligactis and a female strain of H. oligactis isolated by Dr. B. Anokhin from the 
surrounding of St. Petersburg served as control strains. In H. oligactis gametogenesis was 
induced by incubating polyps at 10 °C for 14 days.  
 
7.1.3 HEK293 cell culture 
HEK293 cells were cultivated in 6-well plates containing DMEM medium at 37 °C and 5 % 
CO2.  
 
7.1.4 Tissue separation with procaine 
A modified protocol from Epp et al. and Bode et al. was used to separate the ectodermal and 
endodermal tissue of Hydra magnipapillata (Bode et al., 1987; Epp et al., 1979).  
Head and foot were removed; animals were incubated in solution A for 5 min and in solution 
B for 1.5 min at 4 °C. Polyps were transferred to dissociation medium at 18 °C. The 
ectodermal and endodermal tissues formed a ring- and a rod-like structure respectively and 





7.1.5 Preparation of Pseudomonas aeruginosa MAMP solutions 
P. aeruginosa (ATCC33354) was cultivated in TSB medium over night at 37 °C. The culture 
was centrifuged at 6000 rpm for 10 min. The pellet was resuspended in water and heat-
inactivated at 65 °C for 15 min. The sample was centrifuged and the supernatant was sterile-
filtered (0.45 µm).  
P.s aeruginosa (ATCC33348) was cultivated in MG medium without shaking. The 
supernatant was sterile-filtered.  
 
7.1.6 Incubation of Hydra polyps in bacteria and MAMPs 
E. coli DH5α and Pseudomonas fluorescens were cultured in 30 ml LB medium at 37 °C and 
room temperature respectively until they reached an OD600 of 5. The cells were centrifuged 
for 15 min at 2,500 g, washed three times with sterile Millipore water and resuspended in 
Hydra medium to an OD600 of 10. Furthermore, Pseudomonas aeruginosa (ATCC33348) 
supernatant in MG medium (cultivated without shaking) and Pseudomonas aeruginosa 
(ATCC33354) cell membrane components in Millipore water (bacteria were heat shocked and 
sterile filtered) were used as stimuli. Hydra medium and MG medium served as negative 
controls. Animals were incubated for 4 h in the different stimuli prior to extraction of RNA 
using TRIzol®.  
 
7.1.7 Injection of MAMPs into Hydra 
The animals starved for 48 h and were placed in fresh Volvic water over night prior to 
injection. LPS (200 ng/ml in Volvic water) or flagellin (2.5 µg/ml in Volvic water) were 
injected through the hypostome into the gastric cavity of 20 polyps without buds or gonads 
using a 1 ml syringe and a micro cannulation needle (Hamilton Bonaduz AG). Untreated 
animals and animals injected with pure Volvic water (wounding control) served as negative 
controls. MAMPs were injected and surrounded the animals in the same concentration. Polyps 
were incubated for 4 h prior to RNA isolation using TRIzol®.  
 
7.2 General molecular biologic methods 
7.2.1 Isolation of RNA from Hydra 
Before the isolation of RNA, polyps were starved for at least two days. At least 20 polyps per 
approach were collected within a 1.5 ml reaction tube on ice and washed several times with 
ice-cold Hydra medium. The supernatant was removed completely and 10 µl TRIzol® 
reagent (Invitrogen) per mg tissue were added. The sample was vortexed immediately until 




either stored at -20 °C or the extraction protocol was proceeded. Only RNase-free material 
and solutions were used from this point of time on. Per ml TRIzol® 0.2 ml Chloroform were 
added, followed by a vigorous shaking for 15 sec. After 3 min of incubation at RT the 
samples were centrifuged for 15 min at 4 °C and 12,000 g to separate the aqueous and the 
organic phase. The upper aqueous phase was collected and transferred into a fresh tube. Per 
ml TRIzol® 0.5 ml Isopropanol were added at room temperature and the tube was shaken 
softly for several times followed by incubation at room temperature for 10 min. Afterwards, 
the samples were centrifuged for 10 min at 4 °C and 12,000 g. The supernatant was removed 
and the pellet was washed in 1 ml 75 % ethanol per ml TRIzol® and centrifuged for 5 min at 
4 °C at 7,500 g. After removing the entire supernatant the pellet was air-dried on ice. The 
pellet was resuspended within 80 µl Millipore water on ice. 
To remove contaminations with genomic DNA the samples were treated with DNase I 
according to the pipetting scheme shown in Table 7.1. 
 
Table 7.1: Pipetting scheme for the treatment with DNase I. 
Component Volume [µl]
10x Buffer 10 
DNase I (1 U/µl) 8 
RNaseOUT Ribonuclease Inhibitor 2 
RNA 80 
Final volume 100 
 
The samples were incubated for 1 h at 37 °C. To stop the reaction 2 µl EDTA (25 mM) were 
added and the samples were heated to 65 °C for 10 min. 
Afterwards the RNA was purified using the “RNeasy® Mini-Kit” from QIAGEN according 
to the manufacturer’s “RNA Cleanup” protocol. The RNA was eluted by adding 20 µl 
Millipore water to the silica column. 
 
7.2.2 Quantification of nuclear acids 
The quantity and quality of isolated nuclear acids were determined at the absorbance at 
260 nm using the Nanodrop spectrophotometer.  
 
7.2.3 First strand cDNA synthesis 
The synthesis of cDNA was performed using the “First Strand cDNA Synthesis Kit” 
(Fermentas) according to the manufacturer’s protocol. For subsequent comparative analyses 




For synthesis either the included Oligo(dT)18 primer or sequence specific primers were used. 
For subsequent 3’RACE PCRs an adapter primer was used according to the manufacturer’s 
instructions. Afterwards the cDNA was diluted with 130 µl Millipore water. 
 
7.2.4 Polymerase chain reaction (PCR) 
7.2.4.1 Standard PCR 
A standard PCR reaction was set up in a final volume of 20 µl. Table 7.2 contains the 
pipetting scheme for the reaction. 
 
Table 7.2: Pipetting scheme for standard PCRs. 
Component Volume [µl] 
DNA + H2O 11.8 
Buffer containing MgCl2(10x) 2 
Forward primer (10 µM) 2 
Reverse primer (10 µM) 2 
dNTP mix (1 mM) 2 
Taq polymerase (5 U/µl) 0.2 
Final volume 20 
 
The used PCR program is shown in Table 7.3. 
 
Table 7.3: Standard PCR program. 
Step Temperature Duration 
Initial Denaturation 94 °C 3 min 
Denaturation 94 °C 40 sec 
Hybridisation * 40 sec 
Elongation 
30-40x 
72 °C ** 
Terminal Elongation 72 °C 3 min 
*  Hybridisation temperature was depending on the melting temperature of the used primer pairs.  
** Elongation time was depending on the length of the amplified PCR fragment. A synthesis rate of the 
Taq polymerase of 1,000 bp per minute was used to estimate elongation time.  
 
The PCR products were analysed via agarose gel electrophoresis.  
 
7.2.4.2 Colony check PCR 
A colony check PCR was performed to analyse plasmids for ligated inserts. A standard PCR 
reaction of a final volume of 10 µl was set up without template DNA. Single bacterial 
colonies carrying plasmids served as template. These were picked from agar plates and 
transferred directly to the reaction mix. The PCR was performed using the plasmid-specific 






7.2.4.3 High Fidelity PCR 
To analyse open reading frames of genes and for the amplification of DNA fragments for 
expression constructs, a DNA polymerase with proof reading ability (Platinum® Taq 
Polymerase High Fidelity, invitrogen) was used. The pipetting scheme for the reaction is 
shown in Table 7.4.  
 
Table 7.4: Pipetting scheme for high fidelity PCRs. 
Component Volume [µl] 
DNA + H2O 11 
Buffer (10x) 2 
MgSO4 (50 mM) 0.8 
Forward primer (10 µM) 2 
Reverse primer (10 µM) 2 
dNTP mix (1 mM) 2 
Platinum® Taq Polymerase High Fidelity (5 U/µl) 0.2 
Final volume 20 
 
The used PCR program is shown in Table 7.5. 
 
Table 7.5: High fidelity PCR program. 
Step Temperature Duration 
Initial Denaturation 94 °C 2 min 
Denaturation 94 °C 40 sec 
Hybridisation * 40 sec 
Elongation 
30-40x 
68 °C ** 
Terminal Elongation 68 °C ** 
*  Hybridisation temperature was depending on the melting temperature of the used primer pairs.  
** Elongation time was depending on the length of the amplified PCR fragment. A synthesis rate of the 
Taq polymerase of 1,000 bp per minute was used to estimate elongation time.  
 
7.2.4.4 3’ Rapid Amplification of cDNA Ends (RACE) PCR 
To elongate the sequence information of transcripts, RACE PCRs were performed. To obtain 
more sequence information in the 3’ direction of transcripts, the cDNA synthesis described 
before was conducted with an adapter primer that contains a specific sequence 5’ of the 
Oligo(dT) sequence. The 3’ RACE PCRs were performed using high fidelity Taq polymerase 
in two steps. In the first step a transcript-specific forward primer was used together with a 
reverse primer hybridising to the adaptor sequence. In addition, two reactions were prepared 
that contained only one of both primers to exclude unspecific amplifications. The products 
were separated using agarose gel electrophoresis and specific fragments were excised, 
purified and served as templates for the second PCR step. In this semi-nested PCR a transcript 
specific primer located in 3’ direction of the first specific primer is used together with the 





products were analysed via agarose gel electrophoresis and the specific fragments were 
excised, purified, cloned and sequenced.  
 
7.2.4.5 5’ RACE PCR using trans-spliced leader primers 
For the amplification of unknown 5’ ends of partially sequenced transcripts, forward primers 
hybridising in the trans-spliced leader sequence were used together with transcript-specific 
reverse primers in a high fidelity PCR. As described before, two steps with two strand-
specific primers were performed. The products were analysed via agarose gel electrophoresis 
and the specific fragments were excised, purified, cloned and sequenced. 
 
7.2.4.6 Semiquantitative reverse transcriptase PCR 
In order to compare expression levels of specific genes within different cDNA samples, like 
cDNA from MAMP treated animals, tumour bearing polyps or procaine-separated tissue, 
semiquantitative reverse transcriptase PCRs were performed using the standard PCR protocol. 
Before the first comparison of target gene transcript levels, the amounts of template cDNAs 
were equilibrated using primers for housekeeping genes, like actin (M32364) (Fisher and 
Bode, 1989) or glyceraldehydes 3-phosphate dehydrogenase (gapdh) (AF307863). Each time 
the housekeeping gene reactions were carried out together with the target gene reactions. For 
the tissue separation experiment the genes nb042 (FJ232916, expressed in ectodermal 
nematoblasts) (Milde et al., 2009) and HyDkk1/2/4 C (DQ127904, expressed in endodermal 
gland cells) (Augustin et al., 2006) served as separation controls. Template master mixes were 
prepared to ensure an accurate mixture of all samples. The PCR cycles were adjusted to the 
different expression levels of the genes taking into account that they represent the exponential 
amplification phase. All reactions were conducted twice. The products were analysed using 
agarose gel electrophoresis. 
 
7.2.4.7 Quantitative real-time PCR (qRT-PCR) 
In order to analyse the expression levels of HyNLR type 1 after MAMP injection, a 
quantitative real-time PCR (TaqMan) was performed according to the manufacturer’s 
guidelines (Applied Biosystems Inc, USA) using a 7900HT Fast Real Time PCR-System. 
Expression levels of HyNLR type 1 were compared to actin. Expression levels were calculated 
relative to actin using the standard-curve method (Livak and Schmittgen, 2001) and 





7.2.5 Electrophoretic separation of DNA samples 
DNA samples were separated using horizontal 1-1.5 % agarose gel electrophoresis in 1x TAE 
buffer. The gels contained 0.01 % ethidiumbromide. As size marker the “GeneRulerTM DNA 
Ladder Mix” (Fermentas) was used. 
 
7.2.6 Purification or extraction of DNA fragments from agarose gel fragments 
The desired PCR products or other DNA fragments were cut out on a UV illumination table 
and transferred into 1.5 ml reaction tubes. Afterwards DNA was extracted using the 
“NucleoSpin® Extrakt II” Kit by Macherey Nagel. The same kit was used for direct 
purification of PCR products. Both were performed according to the manufacturer’s protocol. 
DNA was eluted by adding 20 µl NE buffer to the silica column.  
 
7.2.7 Ligation of PCR products into the pGEM®-T vector 
For sequencing or probe generation for in situ hybridisation, PCR products were ligated into 
the pGEM®-T vector by promega via TA cloning. The Taq-polymerase generates adenosin 
(A) overhangs on the synthesised DNA strands. These “sticky ends” are used for the ligation 
into the vector carrying thymidin (T) overhangs. Reactions were set up as follows: 
 
Table 7.6: Pipetting scheme for the ligation of DNA fragments into the pGEM®-T vector. 
Component Volume [µl]
pGEM®-T (50 ng/µl) 0.25 
2x Buffer 5 
T4-Ligase (3 U/µl) 1 
DNA (4-70 ng) 3.75 
Final volume 10 
 
Ligations were carried out over night at 4 °C. Afterwards the samples were diluted 1:2 with 
Millipore water prior to a dialysis performed on a semi-permeable membrane filter disc on 
ice-cold water for 1 h. 
 
7.2.8 Generation of electrocompetent E. coli cells 
E. coli ElectroMAX DH5α-E cells (invitrogen) were stored at -80 °C and used as stock 
culture for the generation of electrocompetent cells. 1 µl of the stock culture was added to 
20 ml SOB medium and cells were cultured overnight at 220 rpm and 37 °C. 6 ml of this 
culture were added to 450 ml SOB medium twice in parallel. The culture was grown at 
220 rpm and 37 °C until the logarithmic growth phase was reached at OD600 = 0.6. The cells 




ice-cold Millipore water and centrifuged at 3,000 g for 10 min. This step was repeated. 
During resuspension the cells were merged successively. The pellet was re-suspended within 
36 ml of 15 % ice-cold glycerol. After a centrifugation step at 3,000 g for 10 min the pellet 
was dissolved in 3,600 µl 15 % ice-cold glycerol and aliquots of 40 µl were immediately 
frozen in liquid nitrogen prior to storage at -80 °C.  
 
7.2.9 Transformation of E. coli 
The cells containing 7µl of the dialysed ligation sample were electroporated with the “Gene 
Pulser II” (Bio-Rad) using the following conditions: 1.8 kV, 25 µF. Immediately after 
electroporation the cells were rinsed with 1 ml pre-warmed SOC medium and incubated at 
37 °C and 220 rpm for 1 h. 100 to 1000 µl were plated on ampicillin-containing LB-agar. 
Only cells containing the plasmid providing resistance against the antibiotics were able to 
grow over night at 37 °C. 
 
7.2.10 Preparation of plasmids 
7.2.10.1 Mini-preparation 
For sequencing and probe generation, Mini-preparations were performed using the 




For subsequent injection of expression constructs into Hydra embryos a Midi-preparation was 
performed using the “QIAfilterTM Plasmid Midi Kit” (Qiagen) according to the 
manufacturer’s instructions. Afterwards an additional precipitation step was performed by the 
addition of 1/10 volume 3 M Sodium Acetate and 2 volumes of Ethanol. The tubes were 
inverted and centrifuged for 15 min at 20,000g at 4 °C. The pellet was washed in 300 µl 75 % 
ethanol, the centrifugation step was repeated and the pellet was dried on air and dissolved in 
75 µl Millipore water over night at 4 °C. 
 
7.2.10.3 Maxi-preparation 
For the transfection of Hek293 cells expression constructs were isolated by a Maxi-






7.2.11 Sanger DNA sequencing 
Two different protocols were used for the method originally published by Sanger et al. 
(Sanger et al., 1977). 300 ng of Mini-prepped plasmid DNA served as template for all 
reactions. 
 
7.2.11.1 Sequencing using the LI-COR system 
For the reaction the “SequiTherm EXCELTM II DNA Sequencing Kit” (Epicentre) was used 
with IRD700® and IRD800® labelled 5’ ends of T7 and SP6 primers as shown in Table 7.7:  
 
Table 7.7: Pipetting scheme for the LI-COR sequencing reaction. 
Component Volume [µl] 
DNA (300 ng) + H2O 8 
Buffer (3.5x) 7.2 
SequiTherm EXCEL II DNA Polymerase (5 U/µl) 0.8 
IRD labelled primer (5 µM) 1 
Final volume 17 
 
A total of 4 µl of this mixture were added to 2 µl of nucleotide mix containing ddATP, 
ddCTP, ddGTP or ddTTP respectively. The samples were subjected to the following PCR 
program: 
 
Table 7.8: PCR program for the LI-COR sequencing reaction. 
Step Temperature Duration
Initial Denaturation 95 °C 5 min 
Denaturation 95 °C 30sec 
Hybridisation 50 °C 15sec 
Elongation 
30x 
70 °C 1 min 
 
The reaction was stopped by the addition of 3µl loading buffer. Prior to loading 0.7µl of the 
samples on a 41 or 66 cm sequencing gel in the “4300 DNA Analyzer” (LI-COR Biosciences) 
they were denatured for 10 min at 95 °C. The results were analysed using the e-Seq 3.0 
program.  
 
7.2.11.2 Sequencing using the capillary system 
For the reaction the “BigDye® Terminator v1.1 Cycle Sequencing Kit” (Applied Biosystems) 







Table 7.9: Pipetting scheme for the BigDye® sequencing reaction.  
Component Volume [µl]
DNA (300 ng) + H2O 6 
SB buffer (5x) 1 
BigDye 2 
Primer (5 µM) 1 
Final volume 10 
 
The PCR was performed using the following program: 
 
Table 7.10: PCR program for the BigDye® sequencing reaction. 
Step Temperature Duration
Initial Denaturation 96 °C 1 min 
Denaturation 96 °C 10 sec 
Hybridisation * 5 sec 
Elongation 
30x 
60 °C 4 min 
* depending on melting temperatures of used primers 
 
For visualisation of sequencing results the “3730 DNA Analyzer” (Applied Biosystems) was 
used according to the manufacturer’s instructions.  
 
7.2.12 Southern blotting 
7.2.12.1 Isolation of genomic DNA from Hydra 
For the isolation about 200 polyps were collected. After removing the Hydra medium 500µl 
Lysis Buffer were added and the animals were homogenised by using a plastic pistil. 50 µl of 
a 1 mg/ml Proteinase K solution were added and the homogenate was incubated at 50 °C for 
2 h. An equal volume of phenol was added; the tube was inverted several times and 
centrifuged for 15 min at 11,000 g at room temperature. The supernatant was transferred into 
a fresh tube and the phenol step was repeated. The supernatant was transferred into a fresh 
tube and an equal volume of chloroform was added. The tube was inverted carefully and 
centrifuged at 11,000 g for 10 min. This step was repeated as well. The supernatant was 
transferred into a fresh tube and sodium chloride was added to a final concentration of 0.2 M 
prior to the precipitation of the DNA with two volumes of 96 % ethanol. The tube was 
inverted carefully until the DNA formed a white clot. This clot was transferred into a fresh 
tube and washed in 70 % ethanol. The ethanol was removed completely and the pellet was air 
dried. The DNA was dissolved over night at 4 °C in Millipore water. RNA contaminations 
were removed by a digestion with RNase A. 10 mg/ml were added prior to an incubation of 






7.2.12.2 Restriction digestion of genomic DNA 
A total of 20 µg of the isolated DNA were digested using three different restriction enzymes 
independently. The pipetting scheme for the reaction is shown in Table 7.11. 
 
Table 7.11: Pipetting scheme for the digestion of genomic DNA. 
Component Volume [µl]
Enzyme (HindIII/ XbaI/ EcoRV) (10 U/µl) 5 
10x Buffer 5 
DNA (20 µg) + H2O 40 
Final volume 50 
 
The digestion was performed at 37 °C for 2 h. 
 
7.2.12.3 Southern blotting 
The digested DNA was separated on a 0.6 % agarose gel using a low voltage. The gel was 
photographed and depurinated for 10 min with 0.2 M hydrochloric acid. The gel was briefly 
rinsed with water and the DNA was denaturated by incubating the gel twice in denaturating 
solution for 20 min. Then the DNA was neutralised by two gel incubations in neutralisation 
solution for 20 min each. Afterwards the gel was rinsed with 20x SSC for 10 min. The DNA 
was transferred by capillary forces to a Hybond N+ membrane (GE Healthcare) using the 
construction shown in Figure 7.1 according to the method published by Southern (Sanger et 
al., 1977).  
 
 





The DNA was blotted for 18 h. The filter was equilibrated for 5 min in 6x SSC and dried on 
air. The DNA was UV-cross-linked to the membrane using 130 mJ in the stratalinker. 
Afterwards the membrane was incubated at 80 °C for 45 min. 
 
7.2.12.4 Radioactive labelling of DNA probes 
PCRs with sequence-specific primers were performed with cDNA or plasmids containing the 
desired insert to obtain the 300 to 400 bp templates for the labelling reactions. Purified PCR 
products served as template. Table 7.12 shows the pipetting scheme for the labelling of DNA 
with α-32P-dATP. 
 
Table 7.12: Pipetting scheme for the generation of radioactive DNA probes. 
Component Volume [µl]
DNA (100/150 ng) + H2O 72/62 
10x buffer 10 
Random hexamer primer (10 mM) 
or 




dCTP/ dGTP/ dTTP mix (0.5 mM) 4 
Klenow fragment (10 U/µl) 2 
α-32P-dATP 2 
Final volume 100 
 
A total of 100 ng DNA (150 ng for the NACHT-probe) were mixed with random hexamer 
primers (or sequence specific primers for the NACHT-probe) and denatured at 95 °C for 
5 min and cooled down slowly to room temperature. Afterwards the buffer, the dCTP/ dGTP/ 
dTTP mix, the Klenow fragment and the α-32P-dATP were added. The synthesis of DNA 
strands was carried out at 37 °C for 3 h.  
 
7.2.12.5 Purification of radioactive probes 
To remove non-integrated α-32P-dATP and primers the probes were purified using Sephadex 
G-50 columns. A 1 ml syringe was filled with a plug of glass wool and Sephadex suspended 
in 1x TE buffer, after a centrifugation at 194 g for 1 min. After addition of the probe, the 
column was centrifuged at 1,700 g for 1 min. For the determination of the integration rate, 
1 µl of the probe was measured using a scintillation counter using the Cerenkov-method 





7.2.12.6 Hybridisation of Southern blots 
The membranes were transferred into 50 ml tubes. Per cm2 of membrane 0.2 ml of pre-heated 
hybridisation solution were added, containing denatured salmon sperm DNA (final 
concentration 100 µg/ml). The membranes were pre-hybridised for 1 h at 42 °C.  
Per ml hybridisation solution one million counts of probe were added to the tube. Prior to the 
addition the probe was denatured at 95 °C for 5 min. The hybridisation was performed over 
night at 42 °C. Afterwards the excessive probe was removed by washing the membrane twice 
in washing solution 1 for 10 min at room temperature and once with washing solution 2 for 
30 min at 65 °C. The membrane was shrink-wrapped and exposed to a Phosphoimager-screen 
for various incubation times prior to the detection in the “Phosphoimager FLA-5000”. After 
the detection of specific bands the membrane was exposed to an X-ray film at -80 °C. After 
several time points the films were developed. 
 
7.2.13 Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) 
Polyps were relaxed for 2 min using freshly prepared urethane relaxing solution and fixed 
over night at 4 °C by adding an 8 % paraformaldehyde solution. Samples were transferred 
into 12-well plates and dehydrated for 2 min in 100 % ethanol and rehydrated with 50 % 
ethanol for 2 min. Afterwards they were washed twice in PBS for 5 min, twice in PBT for 
15 min and twice in PBS for 10 min. Next, the samples were equilibrated in Terminal 
Deoxynucleotidyl Transferase (TdT) buffer (Fermentas) for 30 min prior to the labelling 
reaction using 5 µM DIG-dUTP and 150 U/ml TdT in TdT buffer for 2 h at 37 °C. The 
samples were washed in TBS for 1 min and incubated in 0.5 M EDTA (pH 8.0) to stop the 
labelling. Afterwards all samples were washed twice with PBS containing 1 mM EDTA for 
1 min and heated to 65 °C for 30 min in PBS/EDTA to inhibit endogenous alkaline 
phosphatases. Animals were washed four times in PBS for 10 min each and once with PBT 
for 15 min prior to the incubation with blocking solution for 30 min. The binding of the anti-
Digoxigenin-alkaline phosphatase linked Fab fragments (Roche, 1:4,000 in blocking solution) 
was performed over night at 4 °C. Afterwards animals were washed four times in PBT for 
15 min to remove excess antibodies. The samples were equilibrated three times in NTMT for 
5 min. The colour reaction was performed with NBT/BCIP (1:100 in NTMT) and stopped by 
exchanging the solution with water. Animals were dehydrated with increasing ethanol 





7.3 In situ hybridisation 
7.3.1 Generation of a Digoxigenin-labelled RNA probe 
The desired transcript fragments 300 to 400 bp length were cloned from cDNA into the 
pGEM®-T vector and sequenced afterwards. Depending on the direction of integration a PCR 
was performed with one of the vector-specific primers (T7/SP6) and one gene-specific 
primer.  
A total of 0.5 µg purified PCR product were used as template for the “DIG RNA Labeling Kit 
(SP6/T7)” (Roche) according to the manufacturer’s protocol. 
 
7.3.2 Dot blot with the RNA probes 
In order to analyse the accurate labelling of all RNA probes a dot blot was performed. The 
probe templates were diluted 1:10, 1:102, 1:103, 1:104, 1:105 and 1:106 and 1 µl was spotted 
onto a Hybond N+ membrane. The membrane was dried and the DNA was UV-cross-linked 
to the membrane using 120 mJ in the stratalinker. The following steps were carried out at 
hybridisation temperature. The prehybridisation was conducted for 30 min with hybridisation 
solution prior to the hybridisation with a probe dilution of 1:10,000 for 4 h. Afterwards, the 
membrane was washed in 50 % hybridisation solution/50 % 2x SSC for 10 min and twice in 
2x SSC containing 0.1 % CHAPS. The following steps were conducted at room temperature. 
The membrane was washed twice with MAB for 5 min and once for 10 min with MAB-B 
prior to the incubation with anti-Digoxigenin-alkaline phosphatase linked Fab fragments 
(dilution 1:2,000 in blocking solution) for 1 h. The excess antibody was removed by washing 
the membrane in MAB for 10 min and twice in PBT for 10 min. Afterwards the membrane 
was equilibrated in NTMT for 5 min prior to the staining reaction with 10 µl NBT/ BCIP per 
ml NTMT. The reaction was stopped in water.  
 
7.3.3 Whole-mount in situ hybridisation with Hydra 
The protocol was adapted from previous works (Grens et al., 1996; Philipp et al., 2005).  
Day 1 
Only polyps that were starved for at least two days were used. Animals were relaxed in 
freshly prepared urethane relaxing solution for 2 min followed by a quick addition of a fresh 
8 % paraformaldehyde in Hydra medium (pH 7.4). The solutions were replaced by a new 4 % 







Only RNase-free materials were used. The following steps were performed at room 
temperature. The animals were treated in 99 % ethanol for at least 10 min until the animals 
were completely decolourised. The samples were rehydrated by a treatment with 75 % 
ethanol, followed by a treatment with 50 % ethanol and a treatment with 25 % ethanol in 
PBT. All steps were carried out for 5 min. Afterwards, the samples were washed three times 
with PBT for 10 min followed by a treatment with Proteinase K in PBT (end concentration 
10 µg/ml) for 20 min. The reaction was stopped by the addition of glycine working solution 
and the immediate exchange of this solution with new glycine working solution followed by 
10 min of incubation. The samples were washed three times with PBT for 10 min and 
afterwards treated twice with triethanolamine for 10 min. The triethanolamine was exchanged 
and 2.5 µl/ml acetic anhydride were added. After 5 min additional 2.5 µl/ml acetic anhydride 
were added. After three washing steps with PBT for 5 min the animals were refixed with 4 % 
paraformaldehyde in PBT for 1 h. The solution was removed by washing the samples three 
times with PBT for 7 min. Afterwards the animals were washed twice in 2x SSC for 7 min 
followed by a heating step in 2x SSC for 15 min at 70 °C. The following steps were 
performed at hybridisation temperature, usually 56 °C. The animals were washed in 50 % 2x 
SSC/50 % hybridisation solution for 10 min, followed by a washing step in hybridisation 
solution for 10 min. Afterwards the samples were pre-hybridised for at least 2 h in 
hybridisation solution containing 20 µl/ml tRNA. Different pre-dilutions of the probes were 
used ranging from 1:1 to 1:10. 1 µl probe per ml hybridisation solution was denatured in 50 µl 
hybridisation solution at 70 °C for 10 min. The hybridisation solutions of the samples were 
replaced with new hybridisation solution with tRNA and the probe was added to a final 
concentration of 1:1000 to 1:10,000 and the samples were incubated for 36 h. A sense and an 
antisense probe were always used in parallel. 
Day 3 
The probe was removed by the following 10 min washing steps: 100 % hybridisation solution, 
75 % hybridisation solution/25 % 2x SSC, 50 % hybridisation solution/50 % 2x SSC and 
25 % hybridisation solution/75 % 2x SSC. Afterwards the animals were incubated twice in 2x 
SSC containing 0.1 % CHAPS for 30 min.  
The following steps were performed at room temperature. The samples were washed twice in 
MAB for 10 min followed by a 1 h treatment in MAB-B. The samples were incubated in 
blocking solution for 2 h at 4 °C. The binding of the anti-Digoxigenin-alkaline phosphatase 






The samples were washed with blocking solution for 20 min, followed by a washing step with 
MAB-B for 30 min. After six additional washing steps with MAB, the samples were rinsed 
with NTMT for 5 min and treated with NTMT containing 1 mM Levamisole for 5 min. The 
solution was replaced by the staining solution containing 10 µl NBT/BCIP per ml NTMT 
with 1 mM Levamisole. The samples were incubated in the dark until a clear staining was 
detectable. The reaction was stopped by exchanging the staining solution with Millipore water 
twice. The animals were dehydrated with increasing amounts of Ethanol prior to embedding 
in Euparal.  
 
7.4 Analysis of Hydra-associated bacteria 
7.4.1 Extraction of DNA from Hydra-associated bacteria 
Genomic DNA was extracted from 10 Hydra polyps using the “DNeasy Blood & Tissue” Kit 
(Qiagen). Prior to DNA extraction, the animals were washed three times with sterile filtered 
Hydra medium. The animals were lysed in 180 µl of ATL buffer containing 20 µl 
Proteinase K for 3 to 6h at 56 °C. After the addition of 200 µl of AL buffer the samples were 
incubated for 10 min at 70 °C. 200 µl of 100 % ethanol were added and the lysates were 
purified using DNeasy columns and eluted with 100 µl AE buffer.  
 
7.4.2 Phylogenetic 16S rDNA analysis 
Bacterial 16S rRNA gene fragments were amplified via standard PCR (30 cycles) using the 
Eub_27F and Eub_1492R primers (Weisburg et al., 1991). The products were cloned into 
pGEM®-T vector and transformed into E. coli DH-5α as described before. The inserts were 
checked by performing a colony-check PCR. The PCR products were precipitated over night 
using sodium acetate and two volumes of ethanol. The samples were centrifuged at 4,000 g 
for 30 min and 4 °C. The pellet was dried on air and resuspended to subject them to restriction 
fragment length polymorphism (RFLP) analysis using the restriction enzymes BsuRI and 
Hin6I. The products were separated on a 1.2 % agarose gel. Representative plasmids were 
sequenced as described before. The sequences were subjected to the chimera check program 
Pintail to estimate chimeric sequences (Ashelford et al., 2005). Closely related sequences 
were identified by using the “Sequence match” of the ribosomal database project. An 
alignment was produced using Bioedit (Hall, 1999). The alignment was used to create a 
neighbor-joining tree (Saitou and Nei, 1987) by using MEGA4.0 (Kumar et al., 2008; Tamura 





7.4.3 Fluorescence in situ hybridisation (FISH) 
Macerates were produced as described before. Hybridisations of fixed Hydra cells were done 
according to the protocol used by Manz et al. with fluorescent-labelled rRNA oligonucleotide 
probes (Manz et al., 1992): a universal eubacterial probe (EUB338, 5’ labelled with 
fluorescein) and a probe specific for the Hydra oligactis endosymbiont (HoSym1030 E. coli 
positions 1030-1048, 5’ labelled with Cy3) (Fraune and Bosch, 2007). Hybridisations were 
performed at 46 °C for 90 min and washed at 48 °C for 15 min. The formamide concentration 
in the hybridisation buffer was varied between 0 and 30 %, while the sodium chloride 
concentration in the post-hybridisation buffer was adjusted accordingly. The fluorescence 
signal by probe HoSym1030 to target cells was stable; the intensity of this signal was stable 
between 0 and 20 % formamide and decreased slightly at 30 % formamide. With non-target 
cells, there was no signal even under low-stringency conditions (no formamide). Therefore, 
10 % formamide was used routinely for single hybridisations and for double hybridisations 
with EUB338. Afterwards the samples were stained with Hoechst and mounted with 
DABCO/Mowiol. Samples were analysed using the confocal laser scanning microscope.  
 
7.5 Overexpression of HyNLR type 1 in Hydra 
7.5.1 Generation of expression constructs for Hydra vulgaris (AEP) 
Three expression constructs were generated for Hydra. The first construct (HyNLR type 1 
short::FKBP2-HA) contained the DEATH domain coding part of HyNLR type 1 fused to two 
FKBP coding subunits fused to a hemagglutinin (HA)-tag coding sequence of the pC4M-Fv2E 
of the “ARGENT™ Regulated Homodimerization Kit” (Ariad). The sequences were codon-
optimized for the expression in Hydra by GENEART (hydeath-fkbp, vector backbone pGA4) 
and flanked by an FseI and EcoRI cutting site for the site-directed mutagenesis into the ligR1 
expression vector provided by Dr. K. Khalturin having the pGEM®-T vector as backbone. 
The DEATH and FKBP sequence were separated by a PsyI cutting site for the insertion of the 
NACHT-coding part of HyNLR type 1 in order to obtain the HyNLR type 1 long::FKBP2-HA. 
The NACHT coding part was amplified from cDNA with primers containing the PsyI cutting 
sites. The third construct (FKBP2-HA) contained the two FKBP subunits amplified with FseI 
and EcoRI cutting site containing primers from the GENEART vector. The NACHT and 
FKBP sequences were sub-cloned into the pGEM®-T vector and electroporated into E. coli. 
Afterwards, Mini-preparations were performed. The same was done with the GENEART 
vector. The NACHT sequence containing plasmid was cut with PsyI and the NACHT 
sequence was inserted into the GENEART vector using T4 ligase (Fermentas). The three 
different vectors were cut with FseI and EcoRI and the inserts were ligated into the ligR1 




the control of a Hydra actin promoter followed by the first 10 amino acids of actin and an 
actin terminator. All expression vectors were proofed by sequencing. Prior to the injection 
into Hydra embryos Midi-preparations of all plasmids were performed as described before.  
 
7.5.2 Generation of transgenic Hydra polyps 
Transgenic polyps were generated using the method published by Wittlieb et al. (Wittlieb et 
al., 2006). A plasmid concentration of 2 µg/µl was used and 1 % Rhodamine B 
Isothiocyanate-Dextran R9379 (Sigma) were added as tracer. The solution was injected into 
Hydra embryos within the 1 to 2 cell developmental stage. 
 
7.5.3 Western blotting with Hydra protein extract 
7.5.3.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
A total of 10 Hydra polyps of each tested line were lysed in 100 µl 2x loading buffer 
containing 20 µl/ml β-mercaptoethanol by denaturing them for 10 min at 99 °C and 
subsequent vortexing. Prior to loading them on the 12 % TRIS-glycine gel together with the 
broad range “Prestained Protein Marker” (New England Biolabs), the probes were centrifuged 
at 10,000 g. 20 µl of each probe were loaded following the method published by Laemmli 
(Laemmli, 1970). The run was started at 40 mA, when the bands reached the border between 
the stacking and the separating gel the amperage was raised to 100 mA. Two gels were run in 
parallel and the first gel was stained in Coomassie solution directly afterwards, whereas the 
second gel was used for Western blotting.  
 
7.5.3.2 Western blotting 
The gel was placed in transfer buffer for 15 min without shaking. A PVDF-membrane was 
rinsed with methanol for 1 min and afterwards placed into the transfer buffer together with the 
Whatman papers. Proteins were blotted using a semidry electro blotting device with amperage 
of 3 mA/cm2 for 80 min. After blotting the gel was stained with Coomassie to determine the 
amount of transferred protein. The membrane was dried. After a treatment with methanol for 
1 min and 5 min with transfer buffer the membrane was placed in TBST buffer for 5 min. The 
blocking was carried out in TBST containing 4 % milk powder at 4 °C over night. Afterwards 
the membrane was washed four times in TBST for 5 min. The membranes were incubated 
with the primary antibody (“Anti HA High Affinity” antibody (Roche) diluted 1:1,500 in 
blocking solution) for 1 h. By several washing steps (twice for 10 sec, once for 10 min and 
tree times for 5 min) with TBST the excess first antibody was removed. Afterwards, the 
membrane was exposed to the horseradish peroxidase-conjugated secondary antibody 




TBST) for 1 h. This antibody was removed using the same washing steps as before. The 
proteins were detected using the “SuperSignal West Pico Chemiluminescent Substrate” 
(Thermo Scientific) according to the manufacturer’s instructions. The signal was detected by 
exposing the membrane to the “Amersham Hyperfilm ECL” (GE Healthcare) for several time 
points ranking from 1 min to 1 h. 
 
7.6 Heterologous expression of Hydra genes in HEK293 cells 
7.6.1 Generation of the HEK293 cell expression constructs 
For heterologous expression in HEK293 cells, three different expression constructs were 
generated. The first expression construct contained the long variant of the HyNLR type 1 
fragment of the Hydra expression construct fused to two FKBP subunits (see section 7.5.1). 
Via Gateway® recombination cloning the insert should be transferred into the pCEV-GwA 
vector. Therefore the insert was amplified with gateway primers and sub-cloned into the 
pDONRTM221 vector (Invitrogen) using the “Gateway® BP Clonase® II enzyme mix” 
(invitrogen) according to the manufacturer’s protocol. Afterwards the insert was transferred 
into the pCEV-GwA expression vector using the “Gateway® LR Clonase® II enzyme mix” 
(Invitrogen) according to the manufacturer’s guidelines and thereby fused to an N-terminal 
Flag-tag.  
The HyDD-Caspase and the HyDED-Caspase were amplified from plasmids containing the 
entire open reading frame with restriction site containing primers. The open reading frames 
were ligated into the pCMV-Myc vector (clontech) using T4 ligase and thereby fused to  
N-terminal Myc-tags using the EcoRI and XhoI cutting sites. A Maxi-preparation was 
conducted prior to transfection of the HEK293 cells.  
 
7.6.2 Transfection of HEK293 cells 
HEK293 cells were grown for 24 h prior to transfection via lipofection. 3 µg of plasmid DNA 
(Flag-HyNLR type 1::FKBP2, Myc-HyDD-Caspase, Myc-HyDED-Caspase) were mixed with 
12 µl FuGENE®6-reagent and 100 µl of FCS-free DMEM-medium were added. The 
solutions were incubated for 30 min and added to the HEK293 cells after a replacement of the 





7.6.3 Coimmunoprecipitation  
7.6.3.1 Addition of AP20187 to the HEK293 cells 
Various amounts of AP20187 (final concentrations: 1 µM, 0.1 µM, 10 nM and 1 nM) were 
added to oligomerize and activate the FKBP-linked proteins. The cells were incubated at 
37 °C and 5 % CO2 for 24 h. 
 
7.6.3.2 Coimmunoprecipitation 
Transfected HEK293 cells were washed with PBS and rinsed with 500 µl RIPA buffer 
containing phosphatase- and protease-inhibitors (phosphatase-inhibitor: 1:100, protease 
inhibitor: 1 tablet per 10 ml RIPA buffer). Cells were shaken for 15 min at 4 °C using a plate 
shaker. The free-floating cells were transferred into a tube and vortexed tree times for 45 sec. 
The samples were centrifuged at 18,500 g and 4 °C for 15 min. The supernatant was 
transferred into two fresh tubes; the first sample was used for immunoprecipitation whereas 
the other one served as control extract. A preclearance step was performed with one sample 
by the addition of 10 µl “Protein A/G PLUS-Agarose” (Santa Cruz Biotechnology) and 
subsequent rotation of the probe on a roll-incubator for 90 min at 4 °C to remove the proteins 
that bind unspecifically to agarose beads. The samples were centrifuged for 5 min at 425 g 
and 4 °C and the supernatant was transferred into a fresh tube. Afterwards the precipitation 
antibody (“Myc-Tag Rabbit mAb”, Cell signalling technology, dilution 1:1,000) was added 
and the samples were rotated for 1 h at 4 °C. 20 µl Protein A/G PLUS-Agarose were added 
and the samples were rotated over night at 4 °C. After a centrifugation step for 5 min at 425 g 
the supernatant was discarded and the pellet was washed five times with 500 µl RIPA buffer 
for 20 min at 4 °C.  
 
7.6.3.3 SDS-PAGE 
The agarose beads were centrifuged for 5 min at 425 g and 4 °C and resuspended in 20 µl 
loading buffer, then heated to 100 °C for 10 min. Afterwards they were centrifuged at 425 g 
for 1 min and 12 µl supernatant were loaded on the “NuPAGE® 4-12 % Bis-Tris Gel” 
(Invitrogen) together with control extracts and the “Precision Plus Protein Dual Color 
Standard” (Bio-Rad). The gel electrophoresis was conducted at 50 mA for 90 min. 
 
7.6.3.4 Western blotting 
The “Amersham Hybond-P” membrane (GE Healthcare) was rinsed for 10 sec in methanol 
and placed in Millipore water for 5 min. Three pieces of “Extra thick filterpaper” (invitrogen) 




buffer II filter was placed at the base of the semidry blotting aperture, followed by the anode 
buffer II filter, the membrane, the separating gel and the cathode buffer filter. Blotting was 
conducted with 0.8 mA/cm2 and 300 V for 2 h.  
After blotting the membrane was placed into a 50 ml-tube for blocking with TBST containing 
5 % milk powder for 1 h prior to the incubation with the primary antibodies (“Myc-Tag 
Rabbit mAb” (Cell Signalling Technology), “Anti-FLAG® M2 Antibody” (Sigma-Aldrich)) 
in a dilution of 1:1,000 in TBST containing 5 % milk powder. One short and three 20 min 
washing steps with TBST removed excess antibodies. The incubation with the secondary 
antibody (“ECLTM Rabbit IgG Horseradish Peroxidase-linked Whole Ab” or “ECLTM Mouse 
IgG Horseradish Peroxidase-linked Whole Ab” (GE Healthcare), dilution 1:2,000) was 
conducted for 2 h at room temperature. After the same washing procedure as described 
before, the detection was performed using the “Amersham ECL PlusTM Western Blotting 
Reagent Pack” and the “Amersham Hyperfilm ECL” (both GE Healthcare) according to the 
manufacturer’s instructions for various exposure times. 
 
7.6.4 Annexin V staining and quantification of HEK293 cells 
HEK293 cells were co-transfected with the HyDD- or HyDED-Caspase and 
HyNLR type 1::FKBP2 expression constructs. Four samples were conducted in parallel within 
a 24-well plate. Cells were pre-treated with or without 100 nM AP20187 as described before. 
For the detection of apoptosis, the “FITC Annexin V Apoptosis Detection Kit I” (BD 
PharmigenTM) was used. Cells incubated in 1 µM Staurosporin for 2-4 h were used as positive 
control. Cells were washed in 1 ml PBS and were detached by pipetting up and down and 
transferred into a 15 ml-tube. 5 ml PBS were added for washing. Cells were centrifuged for 5-
10 min at 300 g. The supernatant was replaced with the staining solution containing 200 µl 
Annexin V binding buffer, 5 µl FITC-Annexin V and 10 µl propidium iodide staining 
solution. The samples were transferred into FACS tubes and incubated for 10 min in the dark. 
Afterwards 300 µl PBS were added. The amount of Annexin V positive cells was determined 
using the “FACSCalibur” flow cytometer (BD Biosciences). First the forward scatter and the 
side scatter of the cells were used to gate the main cell population. The total amount of 
apoptotic cells per 10,000 showing a FITC-Annexin V and a low propidium iodide staining 
was determined. The mean values and standard deviations were calculated. A student’s t test 





7.7 Histological methods 
7.7.1 Maceration of Hydra cells 
Single dying tumour bearing (2) and control polyps (2) were placed in a tube and the medium 
was replaced by 50 µl maceration solution as described previously (David, 1973). They were 
incubated in a water bath at 32 °C for 30 min. The cells were dissociated by flipping the tube. 
The cells were fixed by the addition of an equal volume of an 8 % paraformaldehyde solution. 
Aliquots of the suspension were placed onto gelatine-covered glass-slides with a droplet of a 
1 % Tween20 solution. Slides were air-dried over night and embedded with PBS/glycerol for 
microscopic analysis. Per animal the amount of interstitial cells per 100 epithelial cells was 
counted twice. 
 
7.7.2 Preparation of Hydra tissue for transmission electron microscopy 
Polyps were relaxed in freshly prepared urethane relaxing solution and fixed in 3.5 % 
glutaraldehyde in 0.05 M cacodylate buffer containing 10 mM MgCl2 (pH 7.4) for 18 h at 
4 °C. After a washing step using 0.075 M cacodylate buffer for 30 min the animals were post-
fixed with 1 % OsO4 in 0.075 M cacodylate buffer for 2 h at 4 °C. The animals were washed 
for 30 min prior to the 15 min dehydration steps using 30, 50, 60, 70, 80, 90, 100 and 100 % 
ethanol. After incubating the samples twice in 1,2-propylene oxide for 20 min they were 
infiltrated with agar 100 resin. The components were mixed according to the manufacturer’s 
descriptions for the “hard” version. Several 30 min steps of infiltration were performed using 
1,2-propylenoxide and agar 100 resin in mix ratios of 1:2, 1:1 and 2:1 followed by an over 
night incubation with pure agar resin at room temperature. Afterwards the samples were 
placed into rubber forms containing fresh resin and polymerized at 60 °C.  
 
7.7.2.1 Semi-thin sections and staining 
Tissue blocks were trimmed using a razor blade prior to cutting with the Ultracut S ultratome 
(~ 0.5 µm thickness). The sections were placed on a glass slide and stained as described by 
Richardson et al. (Richardson et al., 1960) at 60 °C for 1 to 2 min. Other sections were 
stained with Sudan Black B according to Lison for 5 to 10 min and washed with water (Lison, 
1934).  
 
7.7.2.2 Ultra-thin sections and contrasting 
Ultra-thin sections (thickness 60 to 70 nm) were cut with the Ultracut S ultratome and placed 
on round grids pre-treated with 1.2 % pioloform dissolved in chloroform. The sections were 




prepared lead citrate solution for 3 min (Reynolds, 1963) and analysed using the transmission 
electron microscope EM 208 S. 
 
7.7.3 Immunohistochemical staining of proteins in Hydra 
Animals were relaxed in freshly prepared urethane relaxing solution for 2 min and fixed by 
the addition of 8 % paraformaldehyde in Hydra medium for 1 h. During fixation some 
animals expressing the HA-tagged protein were cut longitudinally. Afterwards, animals were 
washed four times in PBT for 15 min followed by a washing step in PBS with 0.5 % 
TritonX100 for 30 min. A blocking was performed in PBT with 1 % bovine serum albumin 
(BSA) for 1 h. The incubation with the primary antibody was performed over night at 4 °C. 
The following dilutions were used: For the periculin 1a labelling: 1:500 dilution of the 
“antiserum N31” (Klimovich); for the detection of the HA-tagged protein: 1:200 dilution of 
the “HA-Tag (6E2) mouse monoclonal antibody” (Cell Signaling Technology®). The samples 
were washed four times in PBT containing 1 % BSA for 15 min. Afterwards the samples were 
treated with the fluorescence-labelled secondary antibody (for the α-periculin 1a antiserum: 
Alexa Fluor® 488 donkey anti-mouse IgG: 1:1,000; for the α-HA antibody: Cy3 AffiniPure 
Donkey Anti-Mouse IgG, dilution 1:1,000) in PBT with 1 % BSA for 2 h. The samples were 
washed four times with PBS containing 0.5 % Tween20 and 1 % BSA for 15 min. In the case 
of the periculin 1a staining the animals were treated with phalloidin (1:1,000 in PBS 
containing 1 % BSA and 0.5 % TritonX100 and Tween20) for 1 h. Afterwards, these samples 
were treated three times with PBS containing 1 % BSA and 0.5 % Tween20 for 10 min. All 
samples were treated with Hoechst (dilution 1:500 in PBS containing 1 % BSA and 0.5 % 
Tween20) and were directly embedded in DABCO/Mowiol and stored at 4 °C prior to 
microscopical analysis using the confocal laser scanning microscope.  
 
7.8 Computational analyses 
7.8.1 Analysis of DNA sequences 
The program DNAMAN 4.15 was used for general small scale sequence analysis like 
assemblies, alignments or the analysis of open reading frames.  
 
7.8.2 Screening for NLR orthologues within annotated genomes 
The genomes of Xenopus tropicalis, Oryzias latipes, Gallus gallus, Petromyzon marinus, 
Nematostella vectensis and Daphnia pulex were screened by hand via TBLASTN searches 
(Altschul et al., 1990) with mammalian NOD-like receptors and APAF1 and their NBD 




the keywords “NOD”, “NLRC”, “NLRP” or “NLRX”. All hits were controlled manually by 
checking their ORFs, domain compositions and best BLAST hits using DNAMAN 4.15, 
SMART (Letunic et al., 2006) and BLASTP. In Nematostella the annotated gene models from 
Stellabase (Sullivan et al., 2006) were screened for NACHT domains, LRRs and effector 
domains in addition. The hits were matched to the genome screening afterwards.  
 
7.8.3 Screening for NACHT domains in the whole genome shotgun (WGS) reads of 
Amphimedon queenslandica 
Using a NACHT domain consensus sequence from Nematostella vectensis a TBLASTN 
search was performed on a local installed WGS database of Amphimedon queenslandica using 
the compagen server. The hits with sequence identity of more than 94 % were assembled 
using the MINIMUS assembler included in the AMOS package (Sommer et al., 2007). Only 
contigs consisting of two or more reads were taken into consideration for further analysis. The 
ORFs were determined manually using DNAMAN and NACHT domains were predicted 
using SMART.  
 
7.8.4 Screening of Acropora millepora ESTs 
A local installation of Acropora millepora ESTs on the compagen server and ESTs of the 
workgroup of D. J. Miller were screened for NLR orthologues via TBLASTN and HMMER 
(Eddy, 1996) searches with the single domains of mammalian NLRs. All hits were screened 
for ORFs and the predicted domains. Best BLAST hits were obtained manually using 
SMART and BLASTP. 
 
7.8.5 Screening of the Hydra magnipapillata databases for NBD coding genes 
Two approaches were performed to detect Hydra NLR orthologues. To obtain a first 
overview, the Hydra magnipapillata EST were screened for effector, NACHT and NB-ARC 
domains and LRRs via TBLASTN searches with vertebrate NLR and APAF1 domains and 
via HMMER analysis. Second, the Hydra magnipapillata hydrazome genome browser was 
screened using the identified ESTs for further NBD-domain coding genes. To estimate the 
entire NACHT and NB-ARC coding gene repertoire, a TBLASTN screening was performed 
on the non-assembled whole genome shotgun reads using the Nematostella NACHT 
consensus sequence and one NB-ARC sequence (connected with a TPR) as query using 
compagen. All hits were assembled using MINIMUS to obtain haplotype representatives. The 
hits were matched to the Hydra genome “Celera Assembler” assembly (Chapman et al., 2010) 
via BLAST-searches and all scaffolds were screened for protein domains via InterProScan 




domain and encoded by the same strand) and TPRs (3’ of the NB-ARC domain and encoded 
by the same strand) were taken into consideration.  
Extensive searches for LRRs connected to NACHT domains were performed with different 
approaches: (i) the NACHT-coding genome scaffolds were screened for LRRs via 
InterProScan, (ii) TBLAST searches on the Hydra genome were performed using all 
published Strongylocentrotus purpuratus NLRs clearly connected to LRRs (Hibino et al., 
2006) as query sequence, (iii) PCRs were performed using primers hybridising in weakly 
predicted LRR regions in 3’ orientation to NACHT-coding genome sequences and (iv) PCRs 
were performed to connect NACHT-encoding ESTs with LRR-encoding EST. 
 
7.8.6 Screening of the Hydra magnipapillata databases for NLR interaction 
partners 
All ESTs coding for effector domains not connected to a NACHT domain were used to find 
putative interaction candidates for Hydra NLRs. They were matched against the hydrazome 
genome browser to identify putative further domains. Screenings for RIPK1 or 2 orthologs 
were performed via TBLASTN searches with the human protein sequences and via screening 
all Hydra genome scaffolds for protein kinase and effector domains using InterProScan. No 
true orthologs were detected. Similar searches were performed for caspase genes coding for 
effector domains. Using the assembled second generation Hydra transriptome assembly of 
various species (Compagen-NG), transcripts coding for effector domains connected with 
kinase domains were identified via TBLASTN searches with RIPK1 and 2. The sequences of 
the HyDD-Caspase and the HyDED-Caspase were provided by Prof. A. Böttger. All other 
interaction partners were detected by TBLASTN analysis using the hydrazome genome 
browser and human genes as query sequence.  
 
7.8.7 Calculation of phylogenetic trees 
The Hydra NBD-domain tree was calculated using MEGA 3.0 (Kumar et al., 2008) using the 
neighbor-joining algorithm (Saitou and Nei, 1987) and the amino acid alignments of 
completely predicted NBD-domains. These alignments were produced using MUSCLE and 
Jalview. Afterwards the branches were replaced manually by triangles to obtain a graphic 
overview of the different NBD-containing protein types in Hydra.  
For the calculation of the NACHT-domain tree SMART-predictions of rather complete 
NACHT-domains were used. For organisms with a large amount of NLR proteins (Hydra 
magnipapillata, Amphimedon queenslandica, Nematostella vectensis) previous trees were 
calculated on amino acid alignments using the ClustalW Multiple Alignment Tool (Thompson 




algorithm of MEGA 4.0 (Tamura et al., 2007) (Bootstrap:1,000; Poisson correction model; 
complete deletion). Representatives of all groups supported with a bootstrap value > 50 % 
were selected. For already published NLRs of Strongylocentrotus purpuratus and 
Branchiostoma floridae representatives were selected on the base of the published trees 
(Hibino et al., 2006; Huang et al., 2008). These prototype amino acid sequences were aligned 
by hand on the basis of the NACHT domain alignment published by Koonin and Aravind 
(Koonin and Aravind, 2000). As out-group the NB-ARC domain of an R protein (RPS4) of 
Arabidopsis thaliana was selected. The NACHT domains of Daphnia pulex were left out for 
the final tree because they appeared to produce too much noise. For the calculation of the tree 
a local install of MrBayes 3.1.2 (Huelsenbeck and Ronquist, 2001) was used. 2,600,000 
generations were calculated using the GTR model and four chains with a burnin of 25 % and 
the invgamma rate variation. Only posterior probabilities > 50 % are shown. The tree vas 
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Figure 9.1: Representative alignment for the phylogenetic tree. (continuation see next page) 





Figure 9.1 (continued): Representative alignment for the phylogenetic tree.  
The alignment was adjusted manually. The motifs are adapted from (Koonin and Aravind 2000). 
 
9.3 Hydra NACHT domains used for schematic tree 











9.4 Hydra NBD containing transcripts 
9.4.1  Hydra NLR transcripts 
9.4.1.1   HyNLR type 1 







688 AA, MW=81221 
 
1         AGTTAAAATGGATGAAAACATTCTTCAAAATCAACAGAATAGGTATCTATTTAGTCGAAG 
1                 M  D  E  N  I  L  Q  N  Q  Q  N  R  Y  L  F  S  R  S  
 
61        TGTCGGAATAGATTGGAAAGACCTTGGACGATGTTTACAAATTTTAGATAGCTATTTAGA 
19          V  G  I  D  W  K  D  L  G  R  C  L  Q  I  L  D  S  Y  L  D  
 
121       TGTGATAGATATTGAATCTAAAAATTGTTGTGATAAAGCATATCAAATGTTGACCAAATG 
39          V  I  D  I  E  S  K  N  C  C  D  K  A  Y  Q  M  L  T  K  W  
 
181       GACAGAAAAGGAAAATCCATCATTAAATGAACTAAAAAATGCTTTGCAAACTATGGAGAA 
59          T  E  K  E  N  P  S  L  N  E  L  K  N  A  L  Q  T  M  E  K  
 
241       AAACGATTTGATGAAAACATTGGAAGATCTTCAAATACGTTCATCAAAAGAAATTGAAAA 
79          N  D  L  M  K  T  L  E  D  L  Q  I  R  S  S  K  E  I  E  K  
 
301       AAGTAATTTAGTCAAGACAGATTTCTTGAGTGATGCGCTGAAAAATTTTTATCTCGAAAC 
99          S  N  L  V  K  T  D  F  L  S  D  A  L  K  N  F  Y  L  E  T  
 
361       TTATAAAACAATTGAGGAAATTCAACCACAATTAAACAAACCTTATCAAGTTAACTTTTT 
119         Y  K  T  I  E  E  I  Q  P  Q  L  N  K  P  Y  Q  V  N  F  L  
 
421       AGATAAATTTGTTGATCTTTATGTTGTTGATGAAGTTGAAGTCCAAAAAGATGCAATTAA 
139         D  K  F  V  D  L  Y  V  V  D  E  V  E  V  Q  K  D  A  I  N  
 
481       TATTGCAGAGCTAGATCAATTTTTAAAGAAACAAATGAGTTATACATCAATTCTATTTGA 
159         I  A  E  L  D  Q  F  L  K  K  Q  M  S  Y  T  S  I  L  F  E  
 
541       AAAGCATTTAAAAGATCTGTCTTTATTTCTAATATCTGGTATTGCTGCTATTGGTAAAAC 
179         K  H  L  K  D  L  S  L  F  L  I  S  G  I  A  A  I  G  K  T  
 
601       ATGGTTGCTTAGAAAATTTTTACTAGATTGGTCAAATGGTTTTATTTGGAAAAATATTGA 
199         W  L  L  R  K  F  L  L  D  W  S  N  G  F  I  W  K  N  I  D  
 
661       TTTAGTGTTTTACTTGGAGTGTAAACAACTTAATTTGTATGAAAATATTTCTAATATTAA 
219         L  V  F  Y  L  E  C  K  Q  L  N  L  Y  E  N  I  S  N  I  N  
 
721       TGAATTACTTGATGTTTTCTACAAAGATATTTTAAAAGGTTATAATATTTCTTTAGATTT 
239         E  L  L  D  V  F  Y  K  D  I  L  K  G  Y  N  I  S  L  D  F  
 
781       CATGCAATCTAAACCATCAATTATGTTTATAATTGATGGCTTAAACGAATTTAAATACTT 
259         M  Q  S  K  P  S  I  M  F  I  I  D  G  L  N  E  F  K  Y  F  
 
841       TGACCAATTAATAAGCAATACACACTGTAGTTCACAAGAAATTCCTATTCTTAATGTCTT 
279         D  Q  L  I  S  N  T  H  C  S  S  Q  E  I  P  I  L  N  V  F  
 
901       TACAGAAATTTATAAATACAAAGCTGTGATATCAGGAAGAGTAAATACAATATCACAATA 
299         T  E  I  Y  K  Y  K  A  V  I  S  G  R  V  N  T  I  S  Q  Y  
 
961       TGAAAATGTGGTCACGCGTTATAAAGATAAGTTAACCATTAGAGTTATGGGTTATAATGA 





1021      AAATGGAATAAAATATTATTTGAGGAATAATTTAATAAAAAAAACAAAACGCAGAGTGAA 
339         N  G  I  K  Y  Y  L  R  N  N  L  I  K  K  T  K  R  R  V  K  
 
1081      AACTATGTTAAAAGAGTCTTCGATTGCAAAAACCATGGCAAAAGTACCCTTTTTTTTATC 
359         T  M  L  K  E  S  S  I  A  K  T  M  A  K  V  P  F  F  L  S  
 
1141      ATGTATGTGTACAATTGTTGCTGATTTAAAAGTAAAATATAACTTTATAAATCTCACTAT 
379         C  M  C  T  I  V  A  D  L  K  V  K  Y  N  F  I  N  L  T  M  
 
1201      GACAGATTTGTATGCATATAATTTTTTATACTTTTTTCAAAGACACATTTTTAATGAAAA 
399         T  D  L  Y  A  Y  N  F  L  Y  F  F  Q  R  H  I  F  N  E  N  
 
1261      TCATGAACCAATTTTCAAAATAATGGAAAATAATCTAAACAAGCAATGTATTTTAAACAT 
419         H  E  P  I  F  K  I  M  E  N  N  L  N  K  Q  C  I  L  N  I  
 
1321      ATGTAAAATGGCATATATTTTTTTTATTGAAAATAAAACTACTTTTTCCGATATAGAAAT 
439         C  K  M  A  Y  I  F  F  I  E  N  K  T  T  F  S  D  I  E  I  
 
1381      CCAAACTTTTATCAGTGGTTTTGATCAAATTGAAAGTGGGCTCCTTGAAAAGGTGTTTTT 
459         Q  T  F  I  S  G  F  D  Q  I  E  S  G  L  L  E  K  V  F  L  
 
1441      AATGAAAAGTGGTTTTATTGAAAAGATTGAAACAAATTTTGGTTATCATTATCGGTTTTG 
479         M  K  S  G  F  I  E  K  I  E  T  N  F  G  Y  H  Y  R  F  C  
 
1501      TCAGACAGCAATGATAGAGCTATGTGTCTCTGTTCATGCATACTATAGTTATAGTGGGAA 
499         Q  T  A  M  I  E  L  C  V  S  V  H  A  Y  Y  S  Y  S  G  K  
 
1561      AAAGATTATGGAAAATCAAAAGTTAAAAGACTGTTTTTCAATTATATATGGTTTATTAAA 
519         K  I  M  E  N  Q  K  L  K  D  C  F  S  I  I  Y  G  L  L  N  
 
1621      TACAAATGAAAATAGTTTTATCAAGTACTTAGCTAACTTGACAAATTCAAATACTGAAAA 
539         T  N  E  N  S  F  I  K  Y  L  A  N  L  T  N  S  N  T  E  K  
 
1681      GATATCTTTGAATCATGTGATTGATGTGATTCCAAAAGAAATTAACTGTGATCGTGAGTA 
559         I  S  L  N  H  V  I  D  V  I  P  K  E  I  N  C  D  R  E  Y  
 
1741      TCAAGATAAACAAAAGTTGTTTATGCAATGTTTTTTTGAATCGCAGGCAACTATTACAGA 
579         Q  D  K  Q  K  L  F  M  Q  C  F  F  E  S  Q  A  T  I  T  D  
 
1801      CGATATTAAAGCATCAATTGATGAAAGAAAGTGGAAGATTTTGATAAATGGTACAAAAAC 
599         D  I  K  A  S  I  D  E  R  K  W  K  I  L  I  N  G  T  K  T  
 
1861      ATCTTATGAAGTTTTATGTGAAAAATATTTTGTAAACCATCTCGTTAACTCAGGAGGGAA 
619         S  Y  E  V  L  C  E  K  Y  F  V  N  H  L  V  N  S  G  G  K  
 
1921      GTTGACATCTTTAGAAATTGACAAAAATTTATTAACTGATAAAGAAAAAGATCTTATTAA 
639         L  T  S  L  E  I  D  K  N  L  L  T  D  K  E  K  D  L  I  K  
 
1981      GCAATGTTCAAGGAATGTAAAAGATATCCGTATAAAGCGGAGTTATCGTTTTTTTATTGA 
659         Q  C  S  R  N  V  K  D  I  R  I  K  R  S  Y  R  F  F  I  D  
 
2041      TCAATTCACGAAGCGATGGATAAGAAGTGAATAAAGTTGTTTTTATTGGAGGGTATTAAT 
679         Q  F  T  K  R  W  I  R  S  E  * 
 
Background Colour: Exon structure 
Red: DEATH domain 
Blue: NACHT domain 













517 AA, MW=60097 
 
1         CCCACGCGTCCGAAAAAAAGAAAAGTATTTTGTGGAAATGGATAATGAAGAACATAAAGA 
1           P  R  V  R  K  K  E  K  Y  F  V  E  M  D  N  E  E  H  K  D  
 
61        TATATTGCTAAAGATTGCAAATAATCTGCTGGAAAAAGATGTTAAAGCAATTAAGTTTTA 
21          I  L  L  K  I  A  N  N  L  L  E  K  D  V  K  A  I  K  F  Y  
 
121       TTATGCATCAAAAATTGGCTATGCTCATCTTGAAAAGATCAAAACTTCTATTGAATTAAT 
41          Y  A  S  K  I  G  Y  A  H  L  E  K  I  K  T  S  I  E  L  I  
 
181       TCAAACTTTAGAACATCGTATGGTTCTTGGGGTTGATCACTATGATGCTTTTGTTGAAGT 
61          Q  T  L  E  H  R  M  V  L  G  V  D  H  Y  D  A  F  V  E  V  
 
241       ACTTAACAAAATTGGAAGGAATGACCTGGCAAAACAATTTTCTCAAACTTTGAGTTCACC 
81          L  N  K  I  G  R  N  D  L  A  K  Q  F  S  Q  T  L  S  S  P  
 
301       AGAAAGTTCTACCAGAACTTCTTCTAAGAAAGATATATCAGAAATATGCACAGCACTCAA 
101         E  S  S  T  R  T  S  S  K  K  D  I  S  E  I  C  T  A  L  K  
 
361       AAGTTTCTATCTTACAAATTATGGGAACATAAATGAAGTTCAAGTACCACTAAGATTGCC 
121         S  F  Y  L  T  N  Y  G  N  I  N  E  V  Q  V  P  L  R  L  P  
 
421       TGCTAATGTTGATTTAATGCATAAATTTGTTGATCTATGTATTGTTGATGCAGGTAATAC 
141         A  N  V  D  L  M  H  K  F  V  D  L  C  I  V  D  A  G  N  T  
 
481       TCAAGTAGATGCTGTTTTTAGTGTTGAGCGAGAGGAGTTTCTAAAAAAGCAATTGCGTTA 
161         Q  V  D  A  V  F  S  V  E  R  E  E  F  L  K  K  Q  L  R  Y  
 
541       TACACCAATTCCATATAATGAAATTTTTATGAAAGAAAAATCTGTAACTCTAATATCTGG 
181         T  P  I  P  Y  N  E  I  F  M  K  E  K  S  V  T  L  I  S  G  
 
601       AATAGCTGGTATTGGGAAAACATGGTTGCTTAGAAAATGTTTGCTTGATTGGTCAAATGG 
201         I  A  G  I  G  K  T  W  L  L  R  K  C  L  L  D  W  S  N  G  
 
661       TCTAATTTGGAAAAATGTTAAACTTGTGTTTTATTTGGAATGCAGAAGGCTTAATCGATA 
221         L  I  W  K  N  V  K  L  V  F  Y  L  E  C  R  R  L  N  R  Y  
 
721       TCAAAATATTGGTAGTATTAACGAATTAATAAATTTTTTCTACAGAGATATTGTAAATGA 
241         Q  N  I  G  S  I  N  E  L  I  N  F  F  Y  R  D  I  V  N  D  
 
781       TTTTGATATTAGTATTTATTCTGCGCTGTTTATAATTGATGGATTAGATGAGTTTAAATA 
261         F  D  I  S  I  Y  S  A  L  F  I  I  D  G  L  D  E  F  K  Y  
 
841       TTTAAATGAATTAATAAATTGCAGTTCGACTAGTAACTATCCAATTGTTAATGTTTTAAC 
281         L  N  E  L  I  N  C  S  S  T  S  N  Y  P  I  V  N  V  L  T  
 
901       AGAAATTCGAAATAATAAATATGTAGTTGCTGGTAGAGTTTATGCAATTGATCAGTATCA 
301         E  I  R  N  N  K  Y  V  V  A  G  R  V  Y  A  I  D  Q  Y  Q  
 
961       AAGTATATCTACTGAGGATTGTGATAAGATAAACATTCAAATTATGGGATTTAATGAAGA 
321         S  I  S  T  E  D  C  D  K  I  N  I  Q  I  M  G  F  N  E  D  
 
1021      TGGAATAAATAATTATATAGAAAATAATGTTTTAGAGGAAAAAAAAGATGTTGTGAAAGC 
341         G  I  N  N  Y  I  E  N  N  V  L  E  E  K  K  D  V  V  K  A  
 
1081      AACTTTGAAGGAATCTGCAGTTGCAAAATCAATGTCATCTGTTCCATTTTTTTTATCTTT 
361         T  L  K  E  S  A  V  A  K  S  M  S  S  V  P  F  F  L  S  F  
 
1141      CATGTGTAAGATTATTAGTTGTTCAAATAATTTATACAGAAATTCTTTTTTAACAATGAC 





1201      AGACCTGTATGCAAATATTTTTTTACACTTTTTGCAAAAACACATTATCAAAAACAATGA 
401         D  L  Y  A  N  I  F  L  H  F  L  Q  K  H  I  I  K  N  N  E  
 
1261      ATCAATTTCTCAATTTATGGAAAACAATTCCAATAAAAAATATGTTCTAAACATTTGTAA 
421         S  I  S  Q  F  M  E  N  N  S  N  K  K  Y  V  L  N  I  C  K  
 
1321      AATTGCGTACCAATTGTTTGTTGAAAATAAAGTAATTTTTTTCAAAGAAGAAATTCAAAC 
441         I  A  Y  Q  L  F  V  E  N  K  V  I  F  F  K  E  E  I  Q  T  
 
1381      TTTTGTCAATGAGTTTGATAAAAATGAAGAAACTTTTTTTGGATTTATTGAGAGGATTGA 
461         F  V  N  E  F  D  K  N  E  E  T  F  F  G  F  I  E  R  I  E  
 
1441      AACAAGTCTAGGTGAATATATTTATCAATTTGCACATTTGACAATAATGGAGTTTTGTGC 
481         T  S  L  G  E  Y  I  Y  Q  F  A  H  L  T  I  M  E  F  C  A  
 
1501      ATCTATATATGCATATAATTGTTTAAGTAGTGAAGAGATTATGACCAATGAAAA 
501         S  I  Y  A  Y  N  C  L  S  S  E  E  I  M  T  N  E  
 
Background Colour: Exon structure 
Red: DEATH domain 
Blue: NACHT domain 
Bold: Start codon 
 
9.4.1.3   Other HyNLRs 
see CD-ROM 
 







9.4.2  Hydra TPR-NLR transcripts 
see CD-ROM 
 
9.5 Putative interactome of HyNLRs 
9.5.1  HSP90 (gene models) 
see CD-ROM 
 
9.5.2  HySGT1 
see CD-ROM 
 








9.5.4  HyDODE 




304 AA, MW=35528 
 
1         CCCACGCGTCCGCACATACTGAAACTTTTTAGTCCCTGTGTAATAAGATGACTCAAAATA 
1                                                         M  T  Q  N    
 
61        TATCTAGTTTGACAAAGTCAAAACTTGCACAATGTCTCGCTGAAATCTGGAAAGAGTTTG 
5         I  S  S  L  T  K  S  K  L  A  Q  C  L  A  E  I  W  K  E  F    
 
121       CAGAAGAAATCCCTTTACCAAAATATAAGATAGCTTCTATTGAACAAGAACAAAAACTGT 
25        A  E  E  I  P  L  P  K  Y  K  I  A  S  I  E  Q  E  Q  K  L    
 
181       TAGTAGAAAGAGCTTATCGTGTACTTACTTTTTGGTACCAATCTGATCCTGATGCATTTA 
45        L  V  E  R  A  Y  R  V  L  T  F  W  Y  Q  S  D  P  D  A  F    
 
241       ATGAAAACAACATAAAAATGAAGTTAAAAAGTTTAAAGCGGAATGATATAATTAGAGCTG 
65        N  E  N  N  I  K  M  K  L  K  S  L  K  R  N  D  I  I  R  A    
 
301       TGTTTGGAGAAGAAGATGATCAACCTGCAAAACCCAAAGAAACAAACGTCTCTAAAGTTG 
85        V  F  G  E  E  D  D  Q  P  A  K  P  K  E  T  N  V  S  K  V    
 
361       AGGACCTTTCTTATCGTCAGATTCGTGTGCTTTCAGACTTCTTAGATCCTGACTATGGGT 
105       E  D  L  S  Y  R  Q  I  R  V  L  S  D  F  L  D  P  D  Y  G    
 
421       GGGAAGAATTTGCCCATCACCTTTTTGAACATGACAATGAAATGATAAATGAAATACAAA 
125       W  E  E  F  A  H  H  L  F  E  H  D  N  E  M  I  N  E  I  Q    
 
481       AGCTTCGTCATGAGTATGCTGGAGGTGGTAACCCTGCATACCTGTTCTTAAAACAATTGC 
145       K  L  R  H  E  Y  A  G  G  G  N  P  A  Y  L  F  L  K  Q  L    
 
541       TTCAAAGAAGGCCAAACATACTTTTGAATGAATTTTTGGATGCTTGTAAGGAAGTAAAGA 
165       L  Q  R  R  P  N  I  L  L  N  E  F  L  D  A  C  K  E  V  K    
 
601       GAGCAGATATCATACACTATGCAAATGAAAATTTTAGTGGAATTAGTTATATCAGCGAAT 
185       R  A  D  I  I  H  Y  A  N  E  N  F  S  G  I  S  Y  I  S  E    
 
661       TAGATAAAAACCAACTAAGAGATTTCGCCGATAAGGTACGTGGAAATATAGTTCCAAGTA 
205       L  D  K  N  Q  L  R  D  F  A  D  K  V  R  G  N  I  V  P  S    
 
721       ATTGGGCTGAAATCGCAAGCGAGTTTGTCGAGTTTTCTTCTGAAGATATAAAAAGAATAG 
225       N  W  A  E  I  A  S  E  F  V  E  F  S  S  E  D  I  K  R  I    
 
781       AACTTGAAAGGCTGGCTCCAAATAGTTATAGTCCGACGAAAAAATTGTTTGAAAAGCTTA 
245       E  L  E  R  L  A  P  N  S  Y  S  P  T  K  K  L  F  E  K  L    
 
841       AACAAATTCATCCAAATATGGAGTTAGATAATTTAATAAATGTATGTGAAAAAATCAGGA 
265       K  Q  I  H  P  N  M  E  L  D  N  L  I  N  V  C  E  K  I  R    
 
901       GGAAAGATGTTGCTAATAAACTTCGTGAATTTGCAATAAATAATAGCAGCATAGCGCAAT 
285       R  K  D  V  A  N  K  L  R  E  F  A  I  N  N  S  S  I  A  Q    
 
961       AGTTATTTTTTTTAATGTTTTCAAGTTTTTTTATTAATTTTTTTGTATTATTTAATGATT 
320       *                                                             
 
1021      TTATTTTTTGAGTTTATTAGGTTTTTATCGGTAGTTGATAATATCTATTCTTTAATTAAA 
340                                                                     
 
1081      TGTTTAGAATGC 
360                     
 
Background Colour: Exon structure 




Bold: Start and Stop codon 
 
9.5.5  HyCARD-Caspase 
See CD-ROM 
 
9.5.6  HyDD-Caspase 




407 AA, MW=47096 
 
1         TGTAATAAGAAACAACAAAATGGCAGAAGACATTGTTTCTAATGAATCATTCATTTTTAA 
1                             M  A  E  D  I  V  S  N  E  S  F  I  F  K  
 
61        AATGAGCTCTAGTATTGGAACATATTGGGTAACACTTGGACGTGCTCTAGGAATCAAAGA 
15          M  S  S  S  I  G  T  Y  W  V  T  L  G  R  A  L  G  I  K  D  
 
121       CAGTGTTTTAGAAATGCTTGATAAGGAAAATCCCAAAGTTATAGATAAAGCATATGCTAT 
35          S  V  L  E  M  L  D  K  E  N  P  K  V  I  D  K  A  Y  A  M  
 
181       GTTAAAACATTGGACTGCAAAGAACACAAATGCAACTATTGACGAGTTGAAAATTGTTTT 
55          L  K  H  W  T  A  K  N  T  N  A  T  I  D  E  L  K  I  V  L  
 
241       AATGGAATTAGAAAGAAATGATTTAAAAAAAGAAGTAGAAAAAATTTCAAGTACTTTAAT 
75          M  E  L  E  R  N  D  L  K  K  E  V  E  K  I  S  S  T  L  I  
 
301       TTCAAAAATGACTATTGCTGACAAGAAAGTAAATAGCCAAAATCTATCATTAGGCAATGA 
95          S  K  M  T  I  A  D  K  K  V  N  S  Q  N  L  S  L  G  N  E  
 
361       ACAGGATTTAAATGTTGAGGAGAAGAAATCTATTCAAGAAACCCTAACCTCAAGTAAACA 
115         Q  D  L  N  V  E  E  K  K  S  I  Q  E  T  L  T  S  S  K  Q  
 
421       ATCTTTGTCATCAGAACATGAATCAACAGTAACAGATGAAAAACCTAATCAAGCTCAATG 
135         S  L  S  S  E  H  E  S  T  V  T  D  E  K  P  N  Q  A  Q  C  
 
481       CTATCCTATGACACGTAAAAAACTTGGCAAACTTTTCATTTTTAACAATATGCACAATGA 
155         Y  P  M  T  R  K  K  L  G  K  L  F  I  F  N  N  M  H  N  D  
 
541       TGAAAAGACTACTCATAGACTTGCAGCAAAATATGATGTCAAAAAAATTAAAGCAACCTT 
175         E  K  T  T  H  R  L  A  A  K  Y  D  V  K  K  I  K  A  T  F  
 
601       CAGCAAAATAGAATTTGAAGTCGTAGTTTATAAACCGAATAGCTTTGAAGAGATGAAAAA 
195         S  K  I  E  F  E  V  V  V  Y  K  P  N  S  F  E  E  M  K  K  
 
661       AAATTTAGAAGAAGTTTTAAAGGAACCATATGGCGAGTACAATATTTTTTCAATATTTTT 
215         N  L  E  E  V  L  K  E  P  Y  G  E  Y  N  I  F  S  I  F  F  
 
721       CATTGCTCATGGACAGGATGGTAAACTATTTGGACCAAATGAAACTAATAACAAAAAATC 
235         I  A  H  G  Q  D  G  K  L  F  G  P  N  E  T  N  N  K  K  S  
 
781       ATTTTCAATACTTGAATTGAAAAAAATGCTTGAGGATAACTCTTGGCTGAAAAATATTCC 
255         F  S  I  L  E  L  K  K  M  L  E  D  N  S  W  L  K  N  I  P  
 
841       CAAACTGGTCTTTTGCGAAAGCTGTCGCGGCTTCGATAAAGATTTTCAACAAATGACCCT 
275         K  L  V  F  C  E  S  C  R  G  F  D  K  D  F  Q  Q  M  T  L  
 
901       AACTAATTTTGAAGCTAAATCTAATGAAAAGAATGTAAATACGGCAAAATTTGCTGACTT 
295         T  N  F  E  A  K  S  N  E  K  N  V  N  T  A  K  F  A  D  L  
 
961       ATTTATTGGTTTTTCTACTGCTGAGTCTTTTGTATCAATATCTATGCCTTCAGATAATGA 





1021      TGTTCAAATGAAAAACTTTTACAGCCCGTGGGTCATTGAACTTTGCAAACAAATTCAGGA 
335         V  Q  M  K  N  F  Y  S  P  W  V  I  E  L  C  K  Q  I  Q  E  
 
1081      AAAATACATGACAACTGACTTTCTACAGATTTACCAGGACCTCCAGCGATACATGAGTAG 
355         K  Y  M  T  T  D  F  L  Q  I  Y  Q  D  L  Q  R  Y  M  S  S  
 
1141      CACACCTTTATTGTCTAATGGCGAAGAAGTTTATTTCCAGATGCCAGAACTTCAATCTAC 
375         T  P  L  L  S  N  G  E  E  V  Y  F  Q  M  P  E  L  Q  S  T  
 
1201      TTTAAGATATAAACTTTATCTTAATATGGAGAGAAAAACTTAAAAAAAATAATGTTAAAT 
395         L  R  Y  K  L  Y  L  N  M  E  R  K  T  * 
 
Background Colour: Exon structure 
Red: DEATH domain 
Green: Caspase domain 
Bold: Start and Stop codon 
 
9.5.9  HyDED-Caspase 
see CD-ROM 
 
9.5.8  HyDED-DD-Kinases 
see CD-ROM 
 
9.5.9  HyJUN 
see CD-ROM 
 

































































ATG GGT ACC TCT GAC TAC AAG GAC GAC GAT GAC AAG GGG CCC AGC GAT TAC 
BamHI
AAA GAC GAT GAT GAT AAG TCC GAC TAT AAG GAT GAC GAC GAC AAA GGA TCC   
EcoRI EcoRV
ACT AGT CCA GTG TGG TGG AAT TCT GCA GAT 
XhoI
ATC CAG CAC AGT GGC GGC CGC  
SalI
TCG AGT CTA GAG GGC CCG TTT AAA CGT CGA C T7-Promotor-Primer
M   G   T   S   D   Y   K   D   D   D   D   K   G   P   S   D   Y  
K   D   D   D   D   K   S   D   Y   K   D   D   D   D   K   G   S  
T   S   P   V   W   W   N   S   A   D   
I   Q   H   S   G   G   R
S   S   L   E   G   P   F   K   R   R
pCEV-GwA
 















9.6.2  pGA4 including hydeath-fkbp (GENEART) 
 





9.6.3  ligR1 (constructed and provided by Dr. K. Khalturin) 
 
Figure 9.4: Map of the ligR1 vector (vector backbone pGEM-T). 
 





9.7 Expression constructs 
9.7.1.  Expression constructs for HEK293 cell-based assays 





























Blue: Flag tag 
Pink: attR1 site 
Green: attR2 site 
Grey: PsyI cutting site 
Bold: Start and Stop codon 
Red: HyNLR type 1 DEATH domain-coding part 
Blue: HyNLR type 1 NACHT domain-coding part 


































Blue: Myc tag 
Pink: EcoRI cutting site 
Blue: XhoI cutting site 
Bold: Start and Stop codon 
 




















Blue: Myc tag 
Pink: EcoRI cutting site 
Blue: XhoI cutting site 









9.7.2  Expression constructs for transgenic Hydra 



























Pink: FseI cutting site 
Blue: EcoRI cutting site 
Grey: PsyI cutting site 
Red: HyNLR type 1 DEATH domain-coding part 
Blue: HyNLR type 1 NACHT domain-coding part 
Light blue: FKBP2 part 
Bold: Stop codon 
 



















Pink: FseI cutting site 




Grey: PsyI cutting site 
Red: HyNLR type 1 DEATH domain-coding part 
Light blue: FKBP2 part 
Bold: Stop codon 
 












Pink: FseI cutting site 
Blue: EcoRI cutting site 
Light blue: FKBP2 part 
Bold: Stop codon 
 
9.8 Bacteria of the tumour bearing Hydra 
9.8.1  Bacterial 16S rDNA sequence 
see CD-ROM 
 
9.8.2  Alignment of the bacterial 16S rDNA sequences 
see CD-ROM 
 
9.9 Hydra oligactis sequences for Ras orthologues 
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